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Abstract 
ABSTRACT 
Aortic valve disease represents a leading cause of morbidity and mortality for patients 
with cardiovascular disease.  The number of patients requiring aortic valve replacement 
is in fact expected to triple within the next 40 years.  To date, surgical valve replacement 
represents the only option for patients with aortic valve disease.  No treatments exist to 
slow down or reverse the disease process.  This is in large part due to the fact that for a long 
time, aortic valves were thought to be passive flaps which open and close in responses to 
changes in transvalvular pressures.  However, recent data suggests that aortic valves are 
dynamic structures with a complex, yet well-preserved macro- and microstructure and
unique features which differentiate it from surrounding structures.  In light of these find-
ings, we sought to further evaluate the intricate structure and function of the aortic valve.  
Our hypothesis was that as a living organ, aortic valves will have the capacity to modu-
late their own properties, to regulate structural changes within them, thus affecting their 
overall function.   
The aims of this work were to investigate the structural complexity of the aortic 
valve at a cellular level, to evaluate the role of aortic valve endothelium in actively reg-
ulating valve calcification and modulating valve mechanical properties.  We will also seek 
to evaluate the adaptive properties of heart valves in response to their biomechanical 
and biochemical environment and the role of a living valve substitute on aortic root flow 
dynamics.   Finally, the clinical implications of a living valve will be highlighted through 
results of a clinical trial evaluating outcomes following the Ross procedure, the only op-
eration which guarantees long-term viability of the aortic valve. 
Our findings support the notion that the aortic valve is a dynamic and living 
structure.  Its unique location which exposes it to a variety of side specific hemodynamic 
and mechanical stresses leads to significant structural and functional adaptive responses 
on either side of the valve.  These responses are operative in physiological conditions but 
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also appear to affect pathological processes within the valve, which could partly explain 
the pathophysiology of aortic valve disease.  In addition, our findings show that aortic 
valves adapt to their environment by modifying their mechanical properties, in particular 
their overall stiffness.  This could have a major impact on the patterns of flow within the 
aortic root and stress distribution on the cusps.  Using patient-specific computational 
modelling of aortic root flow dynamics, we show that a living aortic valve following aortic 
valve replacement such as with the Ross procedure, results in a pattern of flow which 
closely resembles that of normal subjects.  In contrast, non-living valve substitutes such 
as homografts and xenografts do not provide similar results.  Clinically, these differences 
play an important role as shown in a randomized clinical trial comparing autografts to 
homografts showing improved survival following autograft root replacement, along with 
other clinically-relevant endpoints.   
In conclusion, the aortic valve is a living, dynamic organ with unique features and 
intricate complexity which allows it to adapt to its complex hemodynamic and 
biomechanical environment and ensure adequate function.  The clinical relevance of a 
living valve substitute in patients requiring aortic valve replacement is confirmed and 
highlights the importance of developing tissue-engineered heart valve substitutes.  
Additional work is required to further understand the molecular complexity of heart 
valves and understand their immediate impact in the body through new in vivo 
functional imaging techniques. 
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THE HEART 
The heart is a complex organ with a simple function: to pump the blood in one direction thus 
maintaining the circulation and ensuring adequate tissue oxygenation.  To do so, it depends on 
the interplay between its structural components and a number of signalling pathways which 
ensure coordinated movements and maximum contractile efficiency.  The heart is composed of 
fours chambers (2 atria and 2 ventricles) and four valves (2 atrioventricular valves and 2 
ventriculo-arterial valves) (Figure 1.1).  Functionally, it is divided into a “right” heart which 
pumps deoxygenated blood returning to the heart from the venae cavae into the pulmonary 
circulation to fill with oxygen and release carbon dioxide.  Oxygenated blood then returns to the 
“left” heart via pulmonary veins and is ejected into the systemic circulation.  The aortic valve lies 
at the junction between the left ventricle and the aorta and constitutes the last step before blood 
exits the heart into the systemic circulation. 
 
Figure 1.1 - Anatomy of the heart (SVC, superior vena cava).  Adapted from Netter’s Atlas of Human Anatomy 
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1.1 THE AORTIC VALVE 
1.1.1 Developmental Biology of The Aortic Valve 
The heart is the first organ to form during embryogenesis and develops via a series of complex 
steps involving simultaneous morphogenesis and differentiation (
 
Figure 1.2).  It has become increasingly clear that understanding the developmental biology of 
cardiac structures is essential to understanding their behaviour in adult life, both in health and 
disease.  Indeed, several of the signalling pathways and molecular mechanisms involved in 
cardiac, and more specifically valve morphogenesis remain operative at later stages.   
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Figure 1.2 – Overview of Cardiac Development.  Adapted from High et al. (High & Epstein, 2008) 
 
1.1.1.1 Valve Development 
Development of both the atrioventricular and semi-lunar valves consists of a series of 
delamination, migration, transdifferentiation and maturation of specific cells.  At the time the 
heart goes from a tubular structure to a looped configuration, it is composed of 2 layers of cells: 
the endocardium and the myocardium.  During the looping process, the primary myocardium 
secretes a hyaluronan-rich matrix, termed the cardiac jelly which forms gelatinous-looking 
swellings, the endocardial cushions at the site of the eventual atrioventricular junction and 
outflow tract (Figure 1.2).  These cushions form the basis of what will become the heart valve 
cusps.  Following signals from the adjacent myocardium, endocardial cells delaminate and 
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migrate into the cardiac cushions through activation of the Snail family of proteins which leads to 
downregulation of the cell adhesion molecule vascular endothelial cadherin (VE-cadherin).  In 
addition, these cells undergo a process of epithelial to mesenchymal transition (EMT) characterized by 
the expression of smooth muscle α-actin (SMA), thus forming the major cell population of cardiac 
valves.  It has been suggested that a subset of endocardial cells derived from a unique area of 
the anterior heart field are pre-determined to undergo EMT even prior to heart tube formation 
(Eisenberg & Markwald, 1995).  Ex vivo studies have shown that 10% to 20% of endocardial 
cells undergo EMT.  Once in the cardiac jelly, these cells digest the hyaluronan and start secret-
ing an extracellular matrix (ECM) rich in collagens I, II and III, versican and other proteoglycans, 
making the original jelly significantly more rigid.  Factors involved in migration and EMT of en-
docardial cells include the Notch signalling pathway, members of the transforming growth factor 
β (TGFβ) superfamily: TGFβ 1-3) and bone morphogenic proteins (BMP), the wnt/β-catenin 
signalling pathway, vascular endothelial growth factor (VEGF) and the NFAT family of proteins, 
a series of five related transcription factors.  Recent work suggests that endothelial nitric oxide 
synthase (eNOS) signalling also plays an important role in the maturation of the cardiac cushions 
and the formation of the valve cusps.  Full understanding of the complex network of interactions 
between the different signalling molecules and pathways during development remains to be de-
termined.  Nevertheless, it is clear that overexpression or underexpression of any of these ele-
ments can result in an abnormal EMT process and valvulogenesis.  
1.1.1 Outflow Tract Development  
The cardiac outflow tract encompasses the arterial pole of the heart where the right and left 
ventricles empty into the pulmonary artery and aorta.  The predominant source of cells 
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populating the outflow tract derives from the neural crest.  The neural crest is a multipotent 
population of precursor cells derived from the dorsal neural tube that give rise to melanocytes, 
nerve tissue, cartilage, muscle and bone among others.  In addition, neural crest cells play an 
important role in the formation of the cardiac outflow tract.  Although fate mapping studies 
using wnt-1 as a definitive marker of neural crest cells suggests the absence of neural crest cells 
in the aortic and pulmonary valves (de Lange et al., 2004), their role is critical for left 
ventricular outflow tract formation, aortic arch development and aorto-pulmonary septation 
(Figure 1.) (Jiang, Rowitch, Soriano, McMahon, & Sucov, 2000).  Prior to migrating into the 
outflow tract, neural crest cells undergo EMT in the neural tube, a process mediated by Notch 
signalling (High et al., 2007; Niessen & Karsan, 2008).  Migration of these cells into the outflow 
tract is mediated by BMP activation (Kaartinen et al., 2004; Kim, Robertson, & Solloway, 2001).  
In addition, recent evidence suggests that eNOS signalling also plays an essential role in 
mediating neural crest cell migration, proliferation and outflow tract septation (Fernández et al., 
2009).  A study performed on eNOS knockout Syrian hamsters showed an increased incidence of 
bicuspid aortic valves (BAV) characterized by right and left coronary cusp fusion.  This is 
thought to be due to abnormal outflow tract septation due to abnormal behaviour of neural 
crest cells (Fernández et al., 2009). 
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Figure 1.3 - Fate mapping of neural crest cells (blue) in adult hearts. Taken from Jiang 
et al. (Jiang et al., 2000) 
1.1.1.3  From Developmental Biology to Clinical Applications 
Understanding of the steps involved in valve and cardiac outflow tract development h elps to 
explain a number of congenital cardiac malformations such as the tetralogy of Fallot, truncus 
arteriosus, transposition of the great arteries and more.  Moreover, identification of the involved 
signalling pathways at various stages of development in conjunction with animal models 
of disease has allowed establishment of a direct link between specific mutations and cardiac 
anomalies.  As mentioned previously, eNOS knockout animals h ave been associated with 
BAV and the phenotype of the fused cusps appears to be related to the site of action of 
eNOS in particular cases (Fernández et al., 2009).    Mutations in Notch-1 illustrate the concept 
that pathways that are operative during cardiac development can also be responsible for valve 
disease in adult life.  Garg et al. identified Notch-1 mutations in 2 families with an increased 
incidence of BAVs and outflow tract anomalies such as tetralogy of Fallot and h ypoplastic left 
ventricles (Garg et al., 2005).  Interestingly, unaffected subjects in these families 
developed early aortic valve calcification even in the presence of normal tricuspid valves, 
suggesting a potential role of the 
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Notch-1 signalling pathway in osteogenesis.  Similarly, the wnt/β-catenin signalling pathway 
has been implicated in calcification.  These pathways and their potential role in aortic valve 
calcification will be discussed later in further detail. 
 
1.1.2 Macrostructure of the Aortic Valve  
The aortic valve is formed of 3 semi-lunar cusps which attach to the aorta forming a crown-
shaped annulus.  The cusps are part of a functional unit: the aortic root, which lies at the 
junction between the left ventricular outflow tract and the ascending aorta.  In addition to the 
aortic cusps, the aortic root is composed of the aortic annulus, the sinuses of Valsalva and the 
sinotubular junction.  Changes in the shape or function of one or more of these components can 
lead to dysfunction of the aortic valve mechanism.  At its base, the aortic root connects to the 
interventricular muscular septum along two-thirds of its surface and the remaining part 
connects to fibrous tissue forming the aortic-mitral continuity (Figure 1.).  At both ends of the 
subaortic curtain lie the right (also called central fibrous body) and left fibrous trigones which 
act as hinge points between the aortic and mitral valves during the cardiac cycle.  The sinuses of 
Valsalva constitute outpouches of aortic wall and correspond to the 3 aortic cusps.  The 
coronary arteries originate from 2 of the sinuses, aptly termed the left and right coronary 
sinuses, while the remaining sinus is called the non-coronary sinus.  Due to their semi-lunar 
attachment line to the aorta, the space between the cusps is triangular in shape and lies within 
the left ventricular outflow tract rather than the aorta.  The highest point in these triangles 
corresponds to the highest point of leaflet attachment, referred to as the commissure.  The 
circumferential line connecting these commissures is the so-called sinotubular junction.  The 
inlet diameter usually exceeds the sinotubular junction diameter by a 15% to 20% (Dagum et 
al., 1999; Kunzelman, Grande, David, Cochran, & Verrier, 1994; Lansac, Lim, Shomura, Lim, Rice 
et al., 2002)).   
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Figure 1.4 - Photograph of an open aortic root showing its structural components (annulus, cusps, 
sinuses of Valsalva and sinotubular junction [dashed line]) and their relationship with the left ventricular 
outflow tract and the mitral valve.  AML, anterior mitral leaflet; LC, left coronary cusp; LFT, left fibrous 
trigone; MS, membranous septum; Musc Sep, muscular septum; NC, non-coronary cusp; RC, right coronary 
cusp; RFT, right fibrous trigone. Adapted from Yacoub, El-Hamamsy et al. (M.H. Yacoub et al., 2009) 
Aortic valve competence depends on adequate cusp coaptation during diastole.  The 
central point of cusp coaptation is characterized by the presence of raised nodules called the 
nodules of Arantius.  These nodules are helpful to demarcate the midpoint along the free edge of 
the cusps.  In each individual, cusp length and aortic root diameter are in direct relationship, 
which suggests there is variability in the size of cusps between individuals (Kunzelman et al., 
1994).  In addition, there is consistent asymmetry of individual cusp surface area within indi-
viduals.  According to a study of 200 normal hearts, the right coronary cusp is most frequently 
the largest (43%), followed by the non-coronary cusp (37%) and the left coronary cusp (20%) 
(Vollebergh & Becker, 1977).  Interestingly, a recent study has shown that variation 
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in aortic root size is associated with genetic variants between individuals, suggesting a degree of 
genetic predetermination of aortic root dimensions (Vasan et al., 2009). 
 
1.1.3 Microstructure of the Aortic Valve 
The aortic valve shows a highly preserved microstructural architecture across humans and 
different species, both from a cellular and extracellular composition.  The aortic valve is a thin 
structure measuring 300μm - 700μm in thickness.  Histologically, it is composed of 3 distinct 
superposed layers: the fibrosa, spongiosa and ventricularis (Figure 1.5).  The fibrosa lies on the 
aortic side of the cusp while the ventricularis lies on the ventricular-facing side.  The spongiosa 
lies in between these 2 layers.  The fibrosa which represents about 45% of the cusp thickness is 
rich in circumferentially oriented collagen fibers providing structural strength to the cusps.  In 
contrast, the ventricularis (20% of the thickness) is mainly composed of radially-aligned elastin 
fibers conferring elasticity to the leaflets.  The spongiosa layer (35% of thickness) is rich in 
proteoglycans and glycosaminoglycans which have a high hydrous content allowing smooth 
sliding of the fibrosa and ventricularis during the various phases of the cardiac cycle, thereby 
minimizing repeated microtrauma related to valve deformation.   
 Aortic valve cusps are covered on both sides by a monolayer of endothelial cells which 
lies in direct continuity with the aortic endothelium on one side and the ventricular 
endocardium on the other side.  The body of the cusp is populated by a mix population of cells 
commonly termed the interstitial cells.  These cells are a dynamic population of cells comprising 
a minimum of 3 distinct cell types: smooth muscles cells, fibroblasts and myofibroblasts (Figure 
1.5).  In addition, a small but likely significant population of resident stem cells has recently 
been identified to reside within the body of the cusps (Chen, Yip, Sone, & Simmons, 2009).  The 
precise role and contribution of these cells to aortic valve structure and physiology will be 
discussed in further detail in this section. 
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Figure 1.5 - Microstructure of aortic valve cusps showing the characteristic trilaminar architecture.  
Adapted from El-Hamamsy et al. (El-Hamamsy, Chester, & Yacoub, 2010) 
    
 Further characterization of heart valves has revealed the presence of an intricate and 
elaborate network of nerve cells populating the valves (Marron et al., 1996).  Though The 
distribution of these nerve networks varies between the four valves, it is remarkably conserved 
between species.  Aortic valve innervation arises from ventricular endocardial plexuses while 
some fibers originate from the aortic adventitial wall penetrating the leaflets through the raphe. 
These nerves are predominantly localized to the ventricularis (the lower part of the leaflet).  
The entire length of the leaflets is covered with nerves except for the coapting edge which is 
devoid of any nerve terminals.  The left and right coronary cusps are equally innervated, 
whereas the non-coronary cusp is less extensively so. Due to its non-juxtaposition to the 
ventricular endocardium, it receives its nerve endings from both contiguous cusps (the right 
and left) which may account for the uneven nerve density.  Interestingly, nerve cells are 
circumferentially aligned, mirroring the orientation of endothelial cells and collagen fibers (De 
Biasi & Vitellaro-Zuccarello, 1982).  Nerve terminals present on the aortic valve express 
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immunoreactivity for tyrosine hydroxylase and neuropeptide Y, both markers of post-ganglionic 
sympathetic nerves as well as acetylcholinesterase activity.  Using double immunostaining 
techniques, nerve endings are shown to be in close proximity to SMA-positive interstitial cells in 
the matrix, suggesting a direct role of these nerves on valve function.  The precise role of these 
nerves on aortic valve structure and function is increasingly understood (El-Hamamsy, Yacoub, 
& Chester, 2009). 
 
1.1.3.1 Aortic Valve Endothelial Cells 
The endothelium forms a monolayer of cells throughout the body which separates blood 
components from underlying microstructural elements of various organs.  For a long time, 
endothelial cells from different locations were considered to be similar both at the structural 
and functional levels.  The vascular endothelium was therefore the most widely studied type of 
endothelium and assumptions were made about endothelial cells in other locations.  However, it 
has now been clearly demonstrated that the endothelium is a superfamily of cells that share 
several common features but also express many differences which have an impact on their 
function (Yano et al., 2007).  In light of these findings, aortic valve endothelial cells have gained 
significant interest in recent years both to understand normal valve physiology and more 
importantly in an attempt to elucidate valvular disease mechanisms.  This has stemmed from a 
paradigm of the pathophysiology of aortic valve disease which suggests that aortic valve 
endothelial dysfunction is the first step in a series of events leading to valve calcification, similar 
to what happens in the vasculature (Otto, Kuusisto, Reichenbach, Gown, & O'Brien, 1994).  The 
role of the endothelium is thus understood to be central to aortic valve function.   
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1.1.3.1.1 The Structure and Function of Normal Endothelium 
Endothelial cells form a layer that separates the blood lumen from underlying structures.  In 
blood vessels, vascular smooth muscle cells lie directly underneath the endothelium whereas in 
aortic valves, interstitial cells constitute the body of the cusp.  Endothelial cells have a typical 
cobblestone-like appearance which distinguishes them morphologically from other types of 
cells.  The main “traditional” roles of the endothelium are as follows: 
• Inhibition of platelet aggregation 
• Inhibition of the expression of adhesion molecules and hence the rolling and 
penetration of inflammatory cells into the wall, including macrophages 
• Prevention of smooth muscle cell proliferation and contraction 
The endothelium exerts these properties in response to a variety of different stimuli, which can 
be chemical, physical or mechanical, by secreting specific endothelium-derived substances as 
well as by regulating cell-cell and cell-matrix adhesions.   
 Endothelial-derived substances can be divided into 2 broad categories: endothelial-
derived relaxing factors (EDRF) and endothelial-derived contracting factors (EDCF), both names 
derived from the role of the endothelium on vascular tone. The main relaxing factors are nitric 
oxide (NO), prostacyclin and endothelium-derived hyperpolarizing factor (EDHF).   
• Nitric Oxide 
NO is a soluble gas which is released by endothelial cells and acts in a paracrine fashion by 
acting on underlying smooth muscle cells in the vasculature.  Autocrine effects of NO on 
endothelial cells have not been excluded.  NO is produced in response to various stimuli such as 
acetylcholine, bradykinin, hypoxia and shear stress.  L-arginine serves as a substrate for the 
production of NO in a reaction mediated by an intracellular enzyme, endothelial nitric oxide 
synthase (eNOS or NOS III), an NADPH-dependent oxidase that requires tetrahydrobiopterin 
(BH4), Fad and FMN as cofactors.  Two more isoforms of NOS are found throughout the system: 
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neuronal NOS (nNOS or NOS type I) present among other locations in central and peripheral 
neurons, islets, endometrium and skeletal muscle and inducible NOS (iNOS or NOS type II) 
found in macrophages, liver, smooth muscle, heart and other sites (Murad, 2006).  All 3 isoforms 
of NOS are encoded by 3 different genes on different chromosomes and have 50%-60% 
homology with each other (Murad, 2006).  Once released by endothelial cells, NO diffuses into 
the subendothelial space and activates soluble guanylyl cyclase (sGC) in smooth muscle cells 
(Figure 1.).  This leads to increased formation of cyclic guanosine monophosphate (cGMP).  
cGMP in turn activates cGMP-dependent protein kinase which results in protein 
phosphorylation and decreased cytosolic calcium by extrusion from the cell, thereby limiting 
contraction of the cell (Lincoln, Komalavilas, & Cornwell, 1994).  In addition, dephosphorylation 
of myosin light chain occurs which also contributes to relaxation.  Finally, activation of 
potassium channels leads to hyperpolarisation of the cell membrane, thereby preventing action 
potential formation.  Biochemical mediators of eNOS activation include serotonin or 5-
hydroxytryptamine (5-HT) which can be released by platelets.  5-HT stimulates endothelial 
5HT1D receptors coupled to eNOS through pertussis toxin-sensitive Gi-coupled proteins.  This 
results in NO production and release.  Thus, 5-HT can act as a useful probe for endothelial NO-
mediated activity. 
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Figure 1.6 - Endothelium-Dependent Relaxation of Smooth Muscle.  NO activates soluble guanylyl cyclise (sGC) to 
form cyclic guanosine monophosphate (cGMP).  cGMP activates cGMP-dependent protein kinase, resulting in protein 
phosphorylation, decreased cytosolic calcium levels, myosin light chain dephosphorylation and relaxation.  Taken 
from Murad F. (Murad, 2006) 
 
• Prostacyclin 
The action of prostacyclin (prostaglandin I2, or PGI2) depends on the presence of receptors 
coupled to adenylate cyclase which once activated lead to increased cyclic adenosine 
monophosphate (cAMP) in smooth muscle cells.  cAMP in turn stimulates ATP-sensitive 
potassium channels leading to cell membrane hyperpolarisation and inhibition of contraction 
(Parkington, Tonta, Coleman, & Tare, 1995).  Similar to the effect of cGMP, cAMP leads to 
extrusion of calcium from the cytosol (Abe & Karaki, 1992).  In addition, prostacyclin facilitates 
the release of NO from endothelial cells, acting in a synergistic fashion (Shimokawa, 1998). 
 
• Endothelial-dependent hyperpolarizing factor (EDHF) 
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In addition to NO and prostacyclin, a third mediator of smooth muscle relaxation has been 
recognized for many years but its exact identity remains to be defined.  It is known as EDHF due 
to its mechanism of action.   
 
• Endothelial-dependent contracting factors (EDCF) 
 Aside from its role as a smooth muscle relaxant, the endothelium can also release 
contractile elements, commonly termed EDCF.  These comprise superoxide anions, 
endoperoxides, thromboxane A2 and endothelin-1 (ET-1) (Murad, 2006).  In the normal 
vascular wall, there is a homeostatic balance between EDRFs and EDCFs favouring the former.  
However, the contracting agents are prominent in several pathophysiological conditions, 
including hypertension, atherosclerosis and plaque formation.  Superoxide anions and 
endoperoxides are prominent in oxidative stress injuries. 
 ET-1 is a potent vasoconstrictor peptide which is stored and released by endothelial 
cells.  There are 2 ET receptors, ET-A receptor and ET-B receptor.  Both endothelial cells and 
smooth muscle cells have receptors to ET-1, with ET-B receptors being most prevalent on 
endothelial cells.  Although ET-1 stimulation of smooth muscle cells results in contraction, 
stimulation of ET-B receptors on endothelial cells results in the release of NO, forming a 
negative feedback loop (Ahlborg & Lundberg, 1997; Flavahan & Vanhoutte, 1990, 1995).  In 
addition, NO inhibits the expression and production of ET-1 (Boulanger & Luscher, 1990; 
Luscher, 1992; Luscher et al., 1990).  In healthy vessels, ET-1 plays a minor role in constitutive 
vasomotor tone.  However, as the endothelium becomes dysfunctional, it loses Gi protein-
mediated responses (Flavahan & Vanhoutte, 1995), which leads to increased and unrestricted 
ET-1 production.  The most convincing evidence of the role of NO on ET-1 activity is from 
experiments showing that vasoconstriction due to inhibition of NOS is inhibited by the addition 
of ET-A antagonists (Thorin, Cernacek, & Dupuis, 1998; Thorin, Nguyen, & Bouthillier, 1998). 
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 In addition to their synthetic properties, endothelial cells act as a selective barrier to 
blood products through cell-cell and cell-matrix adhesions.  Recent evidence suggests that these 
junctions act as more than barriers by participating in mechanosensing and 
mechanotransduction of mechanical stimuli.  Two main types of junctions are found on the 
surface of endothelial cells: adherens junctions and tight junctions.  In addition, platelet 
endothelial cell adhesion molecule-1 (PECAM-1 or CD31), though not considered adhesion or 
tight junctions, is found in intercellular spaces.  Of the different adhesion molecules, PECAM-1, 
VE-cadherin and claudin-5 are proper to endothelial cells and not found on epithelial cells.  
Together, these cell surface proteins maintain cell connections and communication.  Moreover, 
these junctional proteins are linked to the cytoskeleton and constitute the basis of 
mechanotransduction mechanisms. 
 
1.1.3.1.2 Aortic Valve Endothelial Cells 
Until recently, aortic valve endothelial cells were thought to play a minor role in valve 
physiology because valves were considered passive structures that opened and closed in 
response to changes in transvalvular pressure.  More recently, several studies focusing on the 
structural and functional properties of aortic valve endothelial cells suggest that valvular 
endothelium possesses unique properties which distinguish it from other endothelial beds, 
particularly the endothelium lining the aorta with which it lies in direct continuity.  The most 
striking difference between valvular and vascular endothelial cells is cell alignment with 
regards to flow orientation.  Whereas the vascular endothelium throughout the body aligns with 
the long axis of the cell parallel to flow (Imberti, Seliktar, Nerem, & Remuzzi, 2002) (except in 
areas of turbulent flow) (Passerini et al., 2004), aortic valve endothelial cells are aligned 
perpendicular to the direction of flow (Butcher, Penrod, Garcia, & Nerem, 2004; Deck, 1986).  
This was first described by Deck et al. (Deck, 1986) by electron microscopic analysis of 
explanted aortic valves and further validated by in vitro studies (Butcher et al., 2004).  Cultured 
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porcine aortic valve endothelial cells were compared to aortic (vascular) endothelial cells from 
the same animal in response to unidirectional non-pulsatile laminar flow at 20 dynes.cm-2.  
Whereas vascular cells were aligned parallel to flow after 24 hours, instead, aortic valve 
endothelial cells aligned perpendicular to flow even without the presence of an aligned 
substrate (Butcher et al., 2006).  These adaptations were dependent on cytoskeletal 
reorientation, a process involving different mechanotransduction pathways in each type of 
endothelium.  Laminar flow induced activation of Rho-kinase, phosphatidylinositol-3-kinase and 
calpain pathways in vascular endothelial cells, whereas valve endothelial cells did not require 
activation of the latter for cytoskeletal reorganization (Butcher et al., 2004).  In addition, aortic 
valve endothelial cells also appear to have a higher proliferation rate than vascular endothelial 
cells (Farivar et al., 2003).   
Furthermore, both sets of cells possess different transcription profiles.  In a study 
examining the transcription profiles of 847 genes, there was common expression of 55 activated 
genes whereas a further 48 genes were differentially activated.  Among those genes with a 
higher activation in the valvular endothelial cells were transcription factors associated with 
higher proliferation rate such as jun D and protein kinase C (Farivar et al., 2003).  Notably, both 
vascular endothelium and valve endothelial cells expressed markers linked with calcification 
such as osteonectin, bone morphogenic protein-7 and -9 (BMP-7 and BMP-9).  Differences in 
gene expression profile between vascular and valvular endothelium were further validated by 
another study showing different gene expression profiles in response to shear stress 
stimulation of cultured porcine aortic endothelial cells or aortic valve endothelial cells (Butcher 
et al., 2006).  In that study, Butcher et al. showed preferential expression of genes associated 
with chondrogenesis by aortic valve endothelial cells whereas vascular endothelial cells 
expressed more genes associated with osteogenesis.  Shear stress reduced the expression of 
osteogenic genes (Butcher et al., 2006). 
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Aortic valve calcification is a major clinical problem in elderly patients and those with 
bicuspid aortic valve disease.  In recent years, it has become increasingly clear that aortic valve 
calcification is an active cell-driven process that shares many similarities with atherosclerosis.  
Among those, early endothelial dysfunction has been shown to act as an initial occurrence in the 
cascade of events leading to valve calcification (Otto et al., 1994).  Histologically, aortic valve 
calcification occurs almost exclusively on the aortic side of the valve.  Simmons et al. developed 
an innovative technique to separately analyze gene expression of aortic valve endothelial cells 
from either side of the valve (Simmons, Zilberberg, & Davies, 2004).  This modified Hautchen 
technique for en face isolation of aortic valve endothelial cells allowed extraction of mRNA for 
analysis of gene expression profiles between both aortic-side and ventricular-side aortic valve 
endothelial cells.  The authors reported the differential expression of 584 genes in situ between 
both sides of the valve (Simmons, Grant, Manduchi, & Davies, 2005).  However, the gene array 
used was a human array and only covered 12,000 genes.  Currently, porcine gene arrays that 
cover >23,000 genes are commercially available and could provide additional clues into the 
functional side-specificity of aortic valve endothelial cells.  
Differences in flow patterns between both sides of the valve as described later in the 
Introduction, are sensed by a thin layer of glycoproteins on the luminal surface of endothelial 
cells called the glycocalix, which communicates with the cytoskeleton and can activate several 
signalling pathways in response to flow (P. F. Davies, 1995; Lopez-Quintero, Amaya, Pahakis, & 
Tarbell, 2009; Pahakis, Kosky, Dull, & Tarbell, 2007; Wang, Butler, & Ingber, 1993).  This 
process of translating mechanical stimuli into biological signals is commonly termed 
mechanotransduction.  Studies on vascular endothelial cells have demonstrated that differences 
in shear stress translate into activation of different signalling pathways, illustrated by the 
presence of atherosclerotic plaques in areas of low wall shear stress in the vasculature such as 
the carotid artery bifurcation.  One of the major activated signalling pathways is the nuclear 
factor-kB (NFkB), a highly conserved transcription factor which translocates to the nucleus 
when activated, triggering the production of pro-inflammatory molecules (Helderman et al., 
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2007; Partridge et al., 2007).  To date, the glycocalix has not been identified or characterized on 
the surface of aortic valves.  Nevertheless, it is thought that flow characteristics at the level of 
the aortic valve have major implications in health and disease.   
1.1.3.2 Aortic Valve Interstitial Cells 
The matrix of aortic valve cusps is rich with a mixed population of cells commonly termed valve 
interstitial cells.  Phenotypic studies suggest the presence of at least 2 distinct populations of 
cells within the matrix: a smooth muscle α-actin (SMA)-positive population of cells and 
fibroblasts.  SMA-positive cells are themselves thought to include pure smooth muscle cells and 
an “activated” subset of fibroblasts which express contractile proteins, called myofibroblasts.  
Myofibroblasts are thought to be involved in some of the pathological mechanisms involving 
aortic valves, such as valve calcification or myxomatous valve degeneration (Rabkin et al., 2001; 
Walker, Masters, Shah, Anseth, & Leinwand, 2004).  This dual cell population confers on valve 
interstitial cells 2 main properties: the ability to contract and the capacity to synthesize extra-
cellular matrix (ECM) components, thereby constantly remodelling the valve.  Valve interstitial 
cells are different from cells from other sources.  We have previously shown that valve-derived 
fibroblasts have different properties than dermal fibroblasts or pericardial cells (Taylor, Allen, 
& Yacoub, 2000).  In addition, valve interstitial cells express a range of specific skeletal and non-
muscle cell markers such as β-myosin heavy chain and markers of the troponin complex (Brand, 
Roy, Hoare, Chester, & Yacoub, 2006).       
Valve interstitial cells are a dynamic population of cells which can move from one phen-
otype to another within a cell’s lifespan.  (Rabkin-Aikawa, Farber, Aikawa, & Schoen, 2004).  It 
has been speculated that valve interstitial cells are composed of 5 identifiable phenotypes that 
define their molecular structure-function relationships (Table 1.1).  These include embryonic 
progenitor endothelial/mesenchymal cells, quiescent VICs (qVICs), activated VICs (aVICs), pro-
genitor VICs (pVICs), and osteoblastic VICs (obVICs).   These phenotypes exhibit plasticity 
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allowing them to convert from one form to another.  Indeed, work from our laboratory has 
recently shown the capacity of valve interstitial cells to transdifferentiate into other cell 
phenotypes including osteoblasts, adipocytes and chondrocytes (L. Osman, M. H. Yacoub, N. 
Latif, M. Amrani, & A. H. Chester, 2006).      
Table 1.1  Structural-functional classification of aortic valve interstitial cells.  Adapted from Liu 
et al. (Liu, Joag, & Gotlieb, 2007) 
Cell type Location Function 
Embryonic 
progenitor 
endothelial/ 
mesenchymal 
cells 
Embryonic cardiac 
cushions 
Give rise to qVICs through an activated stage or 
EMT 
qVICs Valve leaflet Maintain valve structure and function and 
prevent angiogenesis 
pVICs Bone marrow, blood ± 
valve leaflet 
Enter valve or are resident. 
Provide aVICs for valve repair. 
May be CD34-, CD133- and/or S100+ 
aVICs Valve leaflet SMA-containing VICs with activated cellular 
repair processes (proliferation, migration, 
remodelling). 
Respond to valve injury and abnormal 
hemodynamic or mechanical forces. 
obVICs Valve leaflet Calcification, chondrogenesis and osteogenesis 
in the leaflet. 
Secrete ALP, osteocalcin, osteopontin and bone 
sialoprotein. 
 
Valve interstitial cells actively respond to their local cellular, matrix and hemodynamic 
environment through a range of specific molecules which allow to adapt to its environment.  
Studies by Merryman et al. show that valve interstitial cells isolated from different valves have 
different mechanical properties, with cells from the left side of the heart significantly stiffer 
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(Merryman, Youn et al., 2006).  This underlines the direct correlation between cells strcture and 
function.  Cell-cell communication at the interstitial cell level occurs via cell-cell junction 
molecules such as cadherens, desmosomal junctions and gap-junction proteins (connexion-26 
and -43) (Latif et al., 2006).  Cell-matrix communication is thought to be a major component of 
valvular responses to changing mechanical conditions.  Integrins are present in high 
concentrations in valve interstitial cells and are thought to contribute to linkage of force 
transmission between the ECM and the cellular components (Latif et al., 2007). 
 Aortic valve interstitial cells have recently been the focus of much attention because of 
the important role they are thought to play in valve disease.  Some authors suggest valve 
interstitial behaviour is the main orchestrator of valve pathobiology.  Studies from our group 
and others (J. N. Clark-Greuel et al., 2007; Mohler, 2004; Mohler et al., 1999; L. Osman et al., 
2006) have shown that human aortic valve interstitial cells  are directly involved in the 
calcification process of aortic valves.  However, the precise mechanism by which calcification 
occurs through aortic valve interstitial cells  action is still unclear.  Some studies suggest that as 
a result of aortic valve interstitial cell apoptosis, calcium accumulates in matrix vesicles which 
are released by these apoptotic bodies, leading to mineralization.  Other groups suggest a 
phenotypic transdifferentiation of aortic valve interstitial cells  in osteogenic-like cells, capable 
of producing mineralized bone (L. Osman et al., 2006).  Others have suggested the presence of 
resident stem cells within the valve matrix, which are capable of undergoing differentiation and 
bone formation, and could be the main culprits in valve disease (Chen et al., 2009).  Though the 
precise mechanisms are yet to be fully understood, the combined evidence suggests an active 
participation of cells residing within the valve interstitial space in pathological processes 
affecting the function of the valve. 
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1.1.3.3 Nerves 
A rich and highly preserved network of nerves is also found in aortic valves.  To date, the precise 
function of these neural networks remains to be elucidated, but there is increasing evidence that 
they play an active role in normal valve physiology as well as a potential contributory role in 
valve disease (El-Hamamsy, Yacoub et al., 2009).  Marron et al. (Marron et al., 1996) reported 
the most comprehensive anatomical study of the neural distribution in human heart valves.  
They showed that aortic valve innervation arises from ventricular endocardial plexuses 
(Marron et al., 1996) while some fibers originate from the aortic adventitial wall penetrating the 
leaflets through the raphe (Kawano, Shirai, Kawano, & Okada, 1996).  These nerves are 
predominantly localized to the ventricularis (the lower part of the leaflet).  The entire length of 
the leaflets is covered with nerves except for the coapting edge which is devoid of any nerve 
terminals.  The left and right coronary cusps are equally innervated, whereas the non-coronary 
cusp is less extensively so.  Due to its non-juxtaposition to the ventricular endocardium, it 
receives its nerve endings from both contiguous cusps (the right and left) which may account 
for the uneven nerve density.  Although the mitral valve (which lies in continuity with the left 
and non-coronary cusps) is more densely innervated than the aortic valve, none of its nerve 
fibers extend into the aortic cusps (Kawano et al., 1996).  Thus, each valve seems independently 
innervated and controlled.  Most aortic valves studied showed no large nerve terminals.  Rather, 
groups of thin nerve terminals originate from large individual nerves that cross the entire 
leaflet.  These thin nerves have a dot- and brush-like ending whereas the thicker proximal 
nerves appear to have a varicose-like structure (Kawano, Kawai, Shirai, & Okada, 1993; Kawano 
et al., 1996).  According to De Biasi et al. (De Biasi & Vitellaro-Zuccarello, 1982), they follow a 
circumferential distribution within the leaflets, mirroring the orientation of muscle fibers in the 
valve (Steele, Gibbins, & Morris, 1996).  Nerve terminals present on the aortic valve express 
immunoreactivity for tyrosine hydroxylase and neuropeptide Y (NPY), both markers of post-
ganglionic sympathetic nerves as well as acetylcholinesterase (AchE) activity (Marron et al., 
1996).  Previous studies from our laboratory have highlighted the functional significance of 
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nerves on aortic valve contractile properties (Chester, Kershaw, Sarathchandra, & Yacoub, 
2008) and recent evidence suggests a role for the sympatho-adrenergic system in valve 
calcification (Osman et al., 2007). 
   
1.1 AORTIC ROOT DYNAMICS 
As mentioned by Zimmerman in his Hunterian Lecture to the Royal College of Surgeons of 
England in 1966, “...an understanding of the anatomical shape of the heart requires that we 
visualize it as a structure-function continuum” (Zimmerman, 1966).  The aortic root is a fine 
example of this intricate relationship which remains to be fully understood.  Nevertheless, it has 
become increasingly clear that the aortic root constitutes a structural and functional unit 
comprising several components, including the aortic valve cusps.  Therefore, any study of the 
aortic valve cusp behaviour should include mention of the root as a whole.    
 
1.2.1 Function of the Aortic Root 
The aortic root lies in direct continuity with the LVOT proximally and gives origin to the tubular 
ascending aorta distally.  In summary, the aortic root has 3 main functions: to ensure laminar 
unobstructed flow from the LVOT to the ascending aorta in systole in an energy-efficient 
manner, to facilitate the instantaneous opening and closing movements of the aortic valve cusps 
thus reducing stresses on them and to optimize coronary blood flow during both diastole and 
importantly systole.  
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1.2.2 Structure of the Aortic Root 
The aortic root represents a structural unit composed of 4 pillars: the cusps, the annulus, the 
sinuses of Valsalva and the sinotubular junction.  Each of these anatomic components is an 
essential and indispensable contributor to the normal function of the root.  The aortic root is a 
3-dimensional dynamic structure.  The aortic annulus which constitutes the base of the aortic 
root corresponds to the tip of the LVOT.  Part of its circumference is formed by thick ventricular 
myocardium and the other part is fibrous, representing the aortic-mitral continuity.  The right 
and left fibrous trigones lie at both ends of this fibrous portion, also known as the subaortic 
curtain.  During diastole, the aortic annulus assumes an oval or clover shape rather than a 
circular one and becomes fully circular during cardiac ejection (Lansac, Lim, Shomura, Lim, Rice 
et al., 2002; Tops et al., 2008).  The area of the base of the aortic root corresponding to the 
annular level is larger than that at the sinotubular junction (Dagum et al., 1999; Lansac, Lim, 
Shomura, Lim, Rice et al., 2002).  Longitudinally, this confers to the aortic root a “conical” shape 
which is important in generating a velocity gradient across the root because as blood ﬂow 
moves from a larger cross section to a smaller cross section, conservation of mass dictates that 
velocity must increase proportionally. 
 The sinuses of Valsalva lie between the annulus and the sinotubular junction.  Their 
diameter and area significantly exceeds those of the base or sinotubular junction of the root.  
Their importance has been highlighted by several recent studies using computational flow 
dynamics and computer simulations showing the importance of the sinuses in facilitating 
smooth closure of the aortic valve cusps starting in late systole and into early diastole.  In 
addition, their 3-dimensional configuration allows for recirculation of blood in the sinuses 
during systole (Grande-Allen, Cochran, Reinhall, & Kunzelman, 2000; Grande, Cochran, Reinhall, 
& Kunzelman, 1998; Katayama, Umetani, Sugiura, & Hisada, 2008), which can flow into the 
coronaries, an element which is often disregarded in terms of coronary flow physiology (J. E. 
Davies, Parker, Francis, Hughes, & Mayet, 2008).  Beyond the physiological interest of 
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understanding the role of each of the components of the aortic root on its function, these 
considerations are of major importance for surgical decision-making as will be discussed later.  
1.2.3 Structure-Function Dynamics 
Using a closed-chest ovine model with radiopaque markers placed at key points in the aortic 
root, Dagum et al. studied aortic root deformations during the cardiac cycle (Dagum et al., 
1999).  Interestingly, changes in aortic root shape are asymmetric and dictated both by 
structure and changes in transvalvular pressure. For instance, during the early isovolumic 
contraction phase, circumferential expansion of the base was greatest in the left annular region 
and least in the non-coronary (NC) annular region which is continuous with the anterior mitral 
annulus (aortic–mitral continuity and right ﬁbrous trigone) and primarily composed of ﬁbrous 
tissue.  Importantly, this is accompanied by a simultaneous increase in circumferential diameter 
at the level of the commissures.  This conformational change is proportional to the end-diastolic 
volume.  In other terms, before the aortic valve opens, the aortic root prepares to accommodate 
a large volume of blood exiting from the LV thereby improving transvalvular hemodynamics 
and reducing turbulent damage to the aortic cusps (Dagum et al., 1999; Lansac et al., 2005). 
 Additional evidence for Zimmerman’s structure-function continuum is apparent during 
ventricular systole.  It is known that aortic root  expansion is asymmetric but importantly, it 
generates precise changes in its tilt angle.  The aortic root tilt angle (between the basal plane 
and the commissural plane) is ~16° degrees at end-diastole (angle oriented posteriorly and to 
the left) (Lansac et al., 2005).  During systole, it is reduced by ~7°, aligning the LV outflow tract 
with the ascending aorta (Lansac et al., 2005).  This tilt angle reduction results in a straight 
cylinder which undoubtedly facilitates ejection; whereas during diastole, the tilt angle 
increased, probably reducing leaflet stress. 
 Of particular importance in our case are the dynamics of aortic valve opening and 
closing.  Valve instantaneous movements can impose major stresses on the cusps, especially 
closing velocity during end-systole.  It has been clearly demonstrated that aortic valve cusps 
Chapter 1 
   56 
initiate the closure movement during the second half of systole.  From a dynamic perspective, 
the conformational change of the aortic root from a conical shape generating a velocity gradient 
to a cylindrical shape, negates any gradient.  In terms of fluid dynamics, when the velocity 
gradient disappears, the pressure across the aortic valve reverses as the blood ﬂow begins to 
decelerate.  Deceleration of ﬂow implies a negative value for δv/δt, and consequently a positive 
pressure gradient δp/δz must exist in moving across the valve from LV to aorta.  This gradient 
applied to the leaﬂets begins to move them towards closure.  If the velocity gradient across the 
aortic root persists, ﬂow deceleration is offset by the positive velocity gradient and pressure 
reversal occurs later in ejection, which means that the leaﬂets begin to close later in systole.  
Considering the leaﬂet edges must traverse the same distance within a shorter time period, this 
results in an increase in the speed at which the leaﬂets close, therefore increasing the closing 
stress on the cusps.  Furthermore, the generation of vortex patterns of flow in the sinuses of 
Valsalva early in systole generate momentum which allows timely initiation of valve closure 
during systole (Katayama et al., 2008; Robicsek & Thubrikar, 1999; M. J. Thubrikar, Nolan, 
Aouad, & Deck, 1986).   
 
1.2.4 Mechanical Stresses in the Aortic Root 
The aortic root itself is exposed to 2 main stresses: normal radial stress or pressure, and a shear 
stress tangential to the aortic root structures, which is caused by blood ﬂow.  Characterizing the 
patterns of flow and measuring shear stress levels in vivo remain significant challenges which 
can only be overcome through computational fluid dynamics in idealized models of aortic root 
geometry.   
 In addition, aortic valve cusps are subjected to unique stress profiles for 2 reasons.  
First, they are subjected to a range of stresses consisting of shear stress, leaflet strain in both the 
radial and circumferential directions, mechanical pressure during diastole and bending forces.  
Second, both sides of the valves are exposed to different forces, particularly shear stresses.  The 
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ventricular side of the valve is exposed to a high-velocity high-shear stress whereas the aortic 
side is exposed to a low-velocity complex pattern of shear.  Combined with the microstructural 
differences between ventricularis and fibrosa as discussed earlier, defining precise stress maps 
for aortic valve cusps represents a major challenge.  Nevertheless, early work by Thubrikar et al. 
using in vivo fluoroscopy to image radiopaque markers placed on the valve cusps demonstrated 
the presence of important dynamic strains on the cusps during diastole, reaching 10% in the cir-
cumferential axis and 30% in the radial direction (M. Thubrikar & Eppink, 1982; M. Thubrikar, 
Skinner, Aouad, Finkelmeier, & Nolan, 1982; M. J. Thubrikar, Aouad, & Nolan, 1986).  This cor-
responds to strain rates of 440%/s and 1240%/s in the circumferential and radial directions, 
respectively.  Additional studies have further characterized the behaviour of aortic valve cusps: 
they exhibit a highly non-linear stress-strain relationship, undergo large deformations, are an-
isotropic tissues, have complex viscoelastic properties and undergo complex axial coupling be-
haviours (Sacks & Yoganathan, 2007).  In terms of stress on the cusps, Grande-Allen et al. have 
produced finite element models of aortic roots, specifically looking at the stresses and strains on 
the cusps.  They showed that the magnitude of stresses on the cusps varies across the surface of 
the cusp, reaching a maximum at the level of the free margin and belly and a minimum at its 
basal attachment to the aortic wall (Grande-Allen et al., 2000; Grande et al., 1998).  In addition, 
right and non-coronary sinus stresses were 21% and 10% greater than the left sinus and in all 
sinuses, stresses near the annulus were higher than near the sinotubular junction (Grande et al., 
1998). 
From the present data, it is clear that the aortic root is a highly dynamic structure which 
forms a highly regulated structural and functional unit.  Understanding the normal physiology of 
aortic root function in addition to its adaptation to changing hemodynamic conditions can have 
a major impact on the management of patients with aortic valve or root disease. 
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1.2 AORTIC VALVE DISEASE 
1.2.1 Natural History of Aortic Valve Disease 
Aortic valve disease represents a major source of morbidity and mortality both in the developed 
and the developing worlds.  The increase in overall life expectancy, the improvements in cardiac 
imaging techniques and the increased accessibility to primary health care all contribute to the 
increasing prevalence of this affliction.  Estimates suggest that the prevalence of aortic valve 
disease requiring aortic valve replacement will triple by 2050 (M. H. Yacoub & Takkenberg, 
2005).  Aortic valve disease can result from different structural abnormalities which cause valve 
dysfunction.  Valve dysfunction manifests as either valve stenosis or regurgitation, thus 
imposing in either case, an important hemodynamic burden on the left ventricle.  In the case of 
valve stenosis, the increased resistance at the outlet causes left ventricular pressure overload, 
left ventricular hypertrophy, and an increase in energy demand.  In neglected cases this can lead 
to  severe irreversible ventricular dilatation which carries a very poor prognosis for the patient.  
Similarly, aortic valve regurgitation results in left ventricular volume overload because of the 
regurgitant volume at each cardiac cycle.   
 Patients with aortic valve disease can range from asymptomatic to severely 
symptomatic.  The principal symptoms are dyspnea at rest or with effort, chest pain and 
syncope.  The presence of any of these symptoms in patients with aortic valve stenosis is 
associated with a markedly decreased vital prognosis, with most patients being deceased at 5 
years from the onset of symptoms (Figure 1.7) (Ross & Braunwald, 1968).   
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Figure 1.7 – The natural history of patients with aortic valve stenosis.  Survival is markedly 
reduced with the onset of cardinal symptoms: angina, dyspnea or syncope.  Adapted from Ross and 
Branwald (Ross & Braunwald, 1968). 
 
1.2.2 Current Therapies for Aortic Valve Disease 
Currently, the only treatment for patients with symptomatic aortic valve disease remains 
replacement of the aortic valve.  Traditionally, aortic valve replacement remains a surgical 
procedure, though in recent years, percutaneous methods for aortic valve implantation have 
also been developed.  Irrespective of the method to substitute the native valve, it remains that 
native aortic valves require substitution, highlighting the fact that to date, no treatments have 
been developed to alter the natural history of the disease or to slow the progression of aortic 
valve disease, which most often presents as aortic valve calcification.  Various clinical trials 
assessing the role of different medications have produced disappointing results in terms of 
disease progression or patient outcomes, most notably studies involving the use of statins 
(Hermans et al., 2010).  Considering recent advances into the understanding of aortic valve 
calcification as an active cell-mediated process involving inflammatory mechanism and the fact 
that aortic valve stenosis shares many epidemiological risk factors with atherosclerosis such as 
hypertension, smoking and dyslipidemia, it was hoped that statins could be as effective in aortic 
Chapter 1 
   60 
valve disease.  These findings underline the need for increased research into understanding the 
pathophysiological mechanisms behind aortic valve calcification as will be addressed in this 
thesis. 
 
1.2.3 Surgical Options for Aortic Valve Replacement 
Several options are available for surgical replacement of the aortic valve.  Detailed discussion of 
the technical aspects of each valve substitute are beyond the scope of this thesis.  Nevertheless, 
important differences exist between the different substitutes which will be addressed in 
Chapters 5 and 6.  Native aortic valves can be replaced using homografts (aortic root from a 
different human being), xenografts (using porcine or bovine tissues), mechanical valves or 
pulmonary autografts (the patient’s own pulmonary root placed in the aortic position while 
substituting the pulmonary root with a pulmonary homograft), also known as the Ross 
procedure (Figure 1.8).  
 
Figure 1.8 – Schematic representation of autograft aortic root replacement, also known as the 
Ross procedure.  The pulmonary autograft is placed in the aortic position while a pulmonary 
homograft is used to replace the pulmonary root.  This technique has the advantage of placing a 
living substitute in the aortic position.    
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The most important difference in the intrinsic properties of these different valve substitutes is 
the fact that all represent non-living aortic valves, except pulmonary autografts.  This includes 
homografts which become acellular within weeks after implantation, even when used as 
“homovital” homografts.  Various studies examining the outcome of patients following aortic 
valve replacement show lower survival following surgery than the general population matched 
for gender and age (Figure 1.10) (van Geldorp et al., 2009). 
   
Figure 1.10 – Survival following biological or mechanical aortic valve replacement compared to 
survival of the general population showing reduced patient survival after surgery compared to 
the general population.   Adapted from von Geldorp et al. (van Geldorp et al., 2009). 
 
   
  In contrast, the pulmonary autograft is the only substitute which has been shown to remain 
viable over many years after implantation.  We believe that in light of the sophisticated 
structure and functions of the aortic valve which we will further examine in this thesis, 
implantation of a living pulmonary autograft in the aortic position should translate into 
improved clinically-relevant patient outcomes, including survival.   
1.3 HYPOTHESIS 
The aortic valve has unique structural features which allow it to function adequately in a highly 
dynamic mechanical environment.  As a living organ, it is capable of actively adapting its shape, 
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structure and function to changing local conditions.  As a result, a living valve substitute is 
thought to translate into significantly better clinically relevant outcomes.  
1.4 AIMS AND OBJECTIVES 
In recent years, the complex structure and function of the aortic valve is slowly being elucidated 
at the cellular, molecular and genetic levels.  Nevertheless, many questions remain unanswered, 
particularly with regards to the role of the endothelium in regulating valve structure and 
function.  The aim of this thesis was to unveil more of the specific and unique features of aortic 
valves in order to better understand their physiology in health and disease.  It is hoped that the 
present work could add important blueprint information into the requirements for tissue-
engineered heart valves.   
The specific aims of this work were: 
1- To develop a reliable and reproducible technique to separately isolate aortic valve 
endothelial cells from either side of the valve in order to evaluate side-specific 
heterogeneity with a particular focus on cell markers, single-cell mechanical properties 
and gene expression profiles. 
 
2- To assess the differential role of aortic valve endothelium from either side of the valve 
on modulating aortic valve calcification in vitro.   
 
3- To determine the role of the endothelium in regulating aortic valve mechanical 
properties using a biaxial micromechanical testing system.  Importantly, one of the aims 
was to evaluate the communication between endothelial and interstitial cells in 
regulating aortic valve mechanical properties. 
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4- To determine the importance of a living valve on aortic root biomechanics through 
functional imaging techniques by comparing results following  aortic root replacement 
using living versus non-living aortic valve substitutes. 
 
5- To determine the impact of a living aortic valve substitute on clinically relevant 
endpoints.   
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II Aortic Valve Endothelial Cell 
Heterogeneity 
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2.1 BACKGROUND 
As mentioned earlier, although most endothelial cells throughout the body share the same basic 
anti-thrombogenic, anti-adhesive and anti-proliferative properties, there is a considerable 
amount of heterogeneity between the endothelium from different regions of the body both at 
the structural and functional levels (Aird, 2006).  Structurally, although most endothelial cells 
have a typical cobblestone appearance, they can vary significantly in thickness.  Endothelial cells 
in the aorta can reach up to 20 times the thickness of those from capillaries or veins.   The 
number, distribution and properties of tight and adherens junctions between endothelial cells 
also varies considerably from one vascular bed to another.  These structural differences result 
from the adaptation of endothelial cells to local biochemical (pH, oxygen tension, growth 
factors, cytokines etc...) and biomechanical factors (mechanical and shear stress).  In addition, 
this heterogeneity reflects epigenetic factors which are dynamic in nature.  Importantly, these 
structural variations translate into functional differences which serve to adapt specifically to the 
local environment. 
Based on these assumptions, the aortic valve represents a compelling model of 
endothelial cell heterogeneity.  As previously mentioned, the valve is lined with endothelial cells 
on both sides.  Yet, despite the thinness of the valve and its small overall surface area, both sides 
are exposed to vastly different biomechanical environments, suggesting that if one were able to 
study both sides independently, differences should be observed in their structural and 
functional properties.  This is further supported by the fact that aortic valve calcification, the 
most common valve pathology, occurs almost exclusively on the aortic surface of the valve.  
Defining the differences between endothelial cells from either side of the valve could therefore 
provide valuable insight into disease mechanisms and suggest potential therapeutic avenues.   
Previous work from Simmons et al. looking at endothelial cells extracted from porcine 
aortic valves  shows significant differences in gene expression profiles between cells from either 
side of the valve (Simmons et al., 2005).  A total of 516 genes were differentially expressed.  This 
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side-specific heterogeneity of endothelial cells was in addition to concurrent studies from other 
groups showing site-specific structural and functional differences between valvular and 
vascular endothelial cells (Butcher et al., 2004; Butcher et al., 2006; Farivar et al., 2003).  
Together, these data confirm the unique properties of valve endothelial cells and highlight the 
necessity of exploring both sides of the valve separately in order to understand the intricate 
mechanisms in health and disease.   
Aortic valve endothelium has been shown to play an important role in valve function.  
Thus far, our understanding of this role is derived from observations linking aortic valve disease 
to endothelial dysfunction, both from a histological standpoint in explanted calcified aortic 
valves (Otto et al., 1994)and a clinical standpoint showing an association between systemic 
endothelial dysfunction and aortic valve disease (Huseyin Bozbas et al., 2008; Chenevard et al., 
2006; Poggianti et al., 2003).  Considering the suspected role of valve endothelium in valve 
disease, it is therefore imperative to further investigate the differences between both sides.   
In order to analyze endothelial cells in vitro, a technique to isolate endothelial cells from 
both sides of the valves separately is required.  In their study, Simmons et al. used a novel and 
innovative technique to obtain mRNA from endothelial cells using an ice-cold rod to induce en-
dothelial cells from an explanted valve to stick to a glass coverslip (Simmons et al., 2004).  This 
method proved very effective in obtaining mRNA from pure populations of endothelial cells; 
however it did not allow obtainment of live primary cultures of endothelial cells from both sides 
of the valve.  It should also be mentioned that due to the absence of porcine gene arrays at the 
time of their study, a human array was used to assess gene expression profiles.  Though the 
homology between both genomes is thought to exceed 90%, this represents a limitation which 
requires further investigation. 
2.2 AIMS 
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The overall aims of this work were to develop methods and to perform studies to characterize 
differences between endothelial cells from the aortic and ventricular sides of the aortic valve.  
Specifically, the aims were as follows: 
• To develop a reliable and reproducible technique of selective isolation of aortic valve 
endothelial cells from either side of the valve 
• To evaluate differences in responses of cultured endothelial cells from both sides of the 
aortic valve to similar stimuli 
• To compare the gene expression profiles of aortic valve endothelial cells from either side 
following in vitro isolation and culture 
• To compare structural differences in the biomechanical properties of endothelial cells 
from both sides and determine their functional responses to similar stimuli 
2.3 METHODS 
2.3.1 Aortic valve endothelial cell isolation 
Isolation of endothelial cells from whole aortic valve cusps is based on a technique of enzymatic 
digestion.  This method was initially described for isolation of vascular endothelial cells and 
subsequently adapted for valve endothelial cells (Butcher et al., 2004; Paranya et al., 2001).  The 
technique herein described represents a modified version of these methods. 
2.3.1.1 Isolation of Aortic Valve Endothelial Cells    
Porcine hearts (12-18 months old) were obtained within 12 hours from animal sacrifice from a 
commercial abattoir (Cheale Meats, Essex, UK).  Hearts were immediately placed in cold-
buffered Hanks solution for transport.  Under sterile technique, aortic valve cusps were 
dissected and washed in 1% phosphate-buffered saline (PBS) at room temperature, and kept in 
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cold, serum free M-199 (Sigma UK) until use.  Care was taken during dissection to avoid 
excessive cusp manipulation which could damage the cellular structure of the cusps.  Only fine 
forceps were used to handle them and gentle traction was exercised only by holding the nodule 
of Arantius.  Various methods were tested to obtain aortic valve endothelial cells in a reliable 
and reproducible manner.  These will be discussed in detail in the Results.  The favoured 
technique consists of selective “clonal” expansion of aortic valve endothelial cells to ensure their 
purity. All 3 cusps from a single heart were placed in a 50mL Falcon tube containing 10mL of 
sterile-filtered Collagenase type II solution (Clostridium histolyticum, Sigma UK [PN: C6885]) 
diluted in PBS (600U/mL) and maintained at 37C. The tube was placed in a 37C incubator 
(95%02, 5%CO2) for 12 minutes to extract the endothelial cells.  Following this period, an equal 
volume of cold serum-free M199 solution (10 mL) was added to the tubes.  The tubes were 
vigorously vortexed for a period of 60 seconds to dislodge the endothelial cells from the surface 
of the valve following weakening of their attachments to the basal membrane.  The cusps were 
then removed from the tubes in a sterile fashion using fine forceps.  The resultant medium was 
placed in a centrifuge at 1000g for 5 minutes.  The supernatant was discarded and the pellet 
resuspended in 1 mL of endothelial growth medium (EGM 2, Promocell, UK).  Cells were 
counted and a volume equivalent to ~150-200 cells was aspirated and diluted in 25 mL of final 
endothelial growth medium which consisted of EGM 2 solution mixed with a supplement rich in 
growth factors (epidermal growth factor, basic fibroblast growth factor, insulin-like growth 
factor, vascular endothelial growth factor, ascorbic acid, heparin and hydrocortisone), 10% 
heat-inactivated fetal calf serum, 100 U/mL (1%) penicillin (Life Technologies, UK), 100 µmol/L 
(1%) streptomycin (Life Technologies, UK) and 4 mmol/L (1%) L-glutamine (Invitrogen, UK).  
This volume was then distributed in five 96-well plates with a volume per well of 50 µL, to 
achieve a density of 0.3 cells/well (or 1 cell per 3 wells).  All wells were coated with a thin layer 
of sterile 1% gelatine (Sigma UK) which was maintained for 60 minutes in a 37C incubator 
before use.  Following cell seeding, the dishes were maintained in a 95%02, 5%CO2 incubator at 
37C for a period of 48 hours.  All wells were then examined daily and wells exhibiting cells 
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morphologically suggestive of endothelial cells were marked.  The medium in these wells was 
then replaced every 3 days until the cells reached confluence.  At confluence, cells were 
passaged by detaching them using a 1% trypsin/EDTA solution for 2 minutes.  In order to 
dislodge the cells, a 100 µL pipette was used to vigorously aspirate the medium and mobilize 
the cells.  Cells from each well were then seeded into 12-well plates coated with 1% sterile 
gelatine.  Each well’s contents were transferred to a single well, so that no mixing of the cells 
was performed in the early passages to avoid cross-contamination.   Once confluent, cells were 
then moved to a T25 flask (25 cm2) and used between passages 3 and 7 or frozen until further 
use. 
 
2.3.1.2 Aortic Valve Endothelial Cell Characterization 
Cells were characterized by immunocytochemistry.  Cells staining positive for PECAM (CD31) 
and von Willebrand factor (vWF) while showing negative staining for smooth muscle α-actin 
(SMA) were considered pure endothelial cell colonies.  In cases where >1-2% of the cells stained 
positive for SMA, the isolate was discarded because of cross-contamination with interstitial 
cells.  To perform immunocytochemistry, cells were seeded on small gelatine-coated glass cover 
slips at a density of 30,000 cells per cover slip.  Once reaching 80% confluence, the cover slips 
were washed 3 times in PBS and fixed for 5 minutes in ice-cold acetone.  They were then air-
dried and either frozen for later staining or used immediately.  In both cases, this was followed 
by incubation with 2% bovine serum albumin (BSA) in 0.05% Tween PBS (PBST-BSA) for 30min 
to block nonspecific binding sites.  Cells on cover slips were incubated separately with primary 
antibodies against mouse anti-CD31 (1/40) (Serotec, UK), goat anti-vWF (1/200) (Dako, UK) 
and mouse anti-SMA (1/200) (Dako, UK) in PBST-BSA for 1hr. A control of PBST-BSA was also 
used. The cover slips were washed 3 times in PBS before incubation with a secondary antibody 
for 30min, either alexa 594/488 goat anti-mouse (1/500) or alexa 594/488 goat anti-rabbit 
(1/500) (both Invitrogen, UK).  Excess secondary antibodies were removed by washing with 
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PBS containing DAPI for nuclear staining (1/10000; Sigma, UK).   Cover slips were blotted to dry 
and mounted using PermaFluor aqueous mounting medium (Thermo-Scientific, UK).  Cells on 
cover slips were then visualised using the Ziess Axioskop microscope (x20 and x40 objective).  
Digital micrographs were taken using Nikon DMX1200 camera.   
2.3.1.3 Selective Side-Specific Aortic Valve Endothelial Cell Isolation    
Following development of a successful technique to isolate aortic valve endothelial cells, we 
sought to develop a method to isolate them separately from the aortic and the ventricular sides.  
To do so, aortic valve cusps freshly obtained from the abattoir were placed in a custom plate 
normally used for our bioreactor flow simulation system (discussed in the following Chapter).  
As shown in Figure 2.1, cusps from a single heart were placed in the same orientation, so that 
either the aortic or the ventricular surfaces would face upwards.  A glass plate was then 
superposed and firmly tightened, creating a tight seal, so that only a single surface was exposed 
to enzymatic digestion.  The same protocol for selective isolation of valve endothelial cells as 
previously described, was performed.  In order to ensure the side-specificity of the cells 
isolated, cusps were immediately fixed and en face immunohistochemical staining was 
performed on both sides to ensure side selectivity (data not shown). 
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Figure 2.1 – Photographs depicting the different steps leading to selective isolation of aortic valve 
endothelial cells.  A) The custom-made plate used for cell isolation.  The slots are fitted with 
stainless steel plugs that bulge up from the level of the holes.  B) Up to 3 aortic valve cusps from 
the same heart are laid on the stainless steel plugs.  Each cusp sits on a single plug.  All cusps are 
placed so that a single side (aortic or ventricular) is facing upward.  [NB: in this photograph, a total 
of 9 cusps are plated.  However for cell isolation, only 3 cusps are plated so that the cells correspond 
to a single animal at a time].  C) A glass plate with 9 circular holes to fit the tips of the plugs is 
placed on top of the cusps.  D) The glass plate is screwed thereby sealing any gaps.  The plate is 
then filled with collagenase so that only the side facing up is exposed to enzymatic digestion.  
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2.3.2 Differences Between Aortic and Ventricular Side Aortic Valve Endothelial 
Cells 
2.3.2.1 Immunocytochemistry 
Immunocytochemical analysis of primary cultures of aortic versus ventricular-side aortic valve 
endothelial cells in vitro was performed as described above.  The different markers examined 
were CD31 (1/40) (Serotec, UK), vWF (1/200) (Dako, UK), eNOS (1/100) (BD Biosciences, UK), 
VE-Cadherin (1/100) (Serotec, UK), TGF-β receptor 1 (1/100) (Sanata Cruz, UK), TGF-β 
receptor 2 (1/100) (Sanata Cruz, UK), nuclear factor ΚB (NF ΚB ) (1/50) (BD Biosciences, UK) 
and vimentin (1/200) (Dako, UK).     
 
2.3.2.2 Endothelial Cell Activation 
Primary cultures of endothelial cells from either side of the cusp were seeded on gelatine-
coated glass cover slips.  At 80% confluence, the medium was supplemented with porcine 
tumour necrosis factor-α (TNFα, 1 ng/mL) for 12, 24 and 48 hours.  Cells from the same animal 
were always compared to each other.  A control group was always included in the analysis.  In 
addition, similar experiments were performed by adding 10ng/mL of porcine TGFβ1 (R&D 
Biosystems, UK) and examining the cells at similar time points.  Markers used to evaluate 
endothelial cell activation were intercellular adhesion molecule-1 (1/100) (ICAM-1, Southern 
Biotech, USA), vascular adhesion molecule-1 (1/100) (VCAM-1, SanatCruz, USA), NF ΚB (1/50) 
(BD Biosciences, UK), phosphorylated JNK (1/100) (Cell Signaling, UK) and phosphorylated p38 
(1/100) (Cell Signaling, UK).  Relative expression of the various markers was semi-
quantitatively evaluated to compare groups.  
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2.3.3 Analysis of Gene Expression Profiles  
2.3.3.1 RNA Extraction 
RNA extraction was achieved using the RNeasy extraction kit (Qiagen Ltd, UK).  The lysates 
were removed from storage and transferred to a clean sterile 1.5 mL eppendorf.  This was 
mixed with 350µL of 70% ethanol (ETOH) (made with RNase free water and High grade ETOH). 
700µL of the 70%ETOH/lysate mixture was transferred to an RNeasy mini column sitting in a 
2mL collection tube and then centrifuged for 15sec at full speed.  The flow through was 
discarded as the RNA binds to the silica gel membrane in the column.  To remove contaminants, 
the column was washed with 350µL of buffer RW1 (ethanol based).  A DNase treatment was 
then performed on the lysate.  80µL of DNaseI (Qiagen Ltd, UK) made according to 
manufacturer’s guidelines, was added to the RNeasy mini spin column for 15min at room 
temperature.  This was then followed by 1 wash with 150µL RW1 buffer, the column was spun 
for 15sec at full speed and the flow through was discarded.  This was followed by two further 
washes with 500µL of buffer RPE.  The last wash with RPE buffer was centrifuged for 2min to 
help remove all traces of ethanol which would inhibit subsequent enzyme reactions.  To elute 
the RNA, the mini column was transferred to a new sterile 1.5mL eppendorf, 40µL of RNase-free 
water was added.  The column was left for 10min at room temperature and then was 
centrifuged for 1min at full speed.  The eluted RNA was put on ice prior to analysis of the purity 
and concentration of the RNA.  
 
2.3.3.2 RNA Quantification 
Absorption spectroscopy was performed to assess the purity and the concentration of the 
isolated RNA in each sample, using the GeneQuant II spectrophotometer (Pharmacia Biotech, 
UK).   5µl of sample was diluted in 70µl of TE buffer (10mM Tris, 1mM EDTA; pH 8.0) and 
optical density (OD) readings were taken at 260nm and 280nm using a double beam 
spectrophotometer.  The spectrophotometer was corrected for background absorbance by 
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comparing the 75µl chamber test cuvette, containing dH20, with a reference cuvette containing 
only TE buffer.   RNA concentration was calculated using the rule that at 260nm an OD of 1.0 
represents an RNA concentration of 40µg/ml.  It is important to note that absorbance readings 
cannot discriminate between DNA and RNA since single and double-stranded DNA also absorbs 
at 260nm.  Thus, to minimise DNA contamination, the RNA extraction protocol included a DNase 
I step.  RNA purity was measured using OD at 280nm.   In a pure RNA sample, the OD at 280 nm 
is twice that at 260nm and the sample has an A260/A280 ratio of 2.0.   Proteins absorb at 280nm 
and an A260/A280 ratio lower than 2.0 indicates protein contamination.  Additionally the 
A260/A280 ratio is dependent on pH and ionic strength.   As pH increases from 5.4 to 7.5, the A280 
decreases whilst the A260 is unaffected, resulting in an increased A260/A280 ratio.  To ensure 
accurate readings, TE buffer (pH 8.0) was used as a diluent.  The obtained RNA was placed in a -
80C fridge and kept until use. 
 
2.3.3.3 Gene Expression Analysis 
Gene expression analysis was performed using a commercial porcine gene chip containing more 
than 23,900 genes obtained from Affymetrix (GeneChip Porcine Genome Array, Affymetrix, UK).  
A total of 6 RNA samples of aortic valve endothelial cells obtained from 3 animals (3 aortic side, 
3 ventricular side) were sent in dry ice to the EMBL labs in Heidelberg, Germany for DNA 
extraction and performance of the gene chip analysis.    
 
2.3.4 Analysis of Endothelial Cell Mechanical Properties 
2.3.4.1 Principle of Scanning Ion Conductance Microscopy (SICM) 
SICM is a non-optical method which uses a nanopipette as a scanning probe to image cell 
surface structures with nanometer resolution (Gorelik et al., 2008; Korchev et al., 2000; Novak 
et al., 2009).  The probe used is a sensitive glass nanopipette which detects ion current and uses 
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the current as an interaction signal to control the vertical (z axis) position of the cell relative to 
the pipette tip (Gorelik et al., 2006). The hardware used is manufactured by Ionscope (UK), 
whereas acquisition and analysis software were custom-made.  Several imaging modalities are 
available with SICM such as split mode and hopping mode imaging.  Hopping probe SICM allows 
imaging of convoluted cell surfaces at nanoscale resolution by ensuring the pipette always 
approaches the cell surface from above (Figure 2.2) (Novak et al., 2009).  Briefly, at each 
imaging point, the pipette approaches the sample from a starting position that is above any of 
the surface features. The reference current is measured while the pipette is well away from the 
surface and the position of z-dimension actuator when the current achieves this reduction is 
recorded as the height of the sample at this imaging point. The z-dimension actuator then 
withdraws the pipette away from the surface and the sample is moved laterally to the next 
imaging point. By continuously updating the reference current while the pipette is away from 
the surface, the method automatically adjusts for any slow drifts in the pipette current. 
 
Figure 2.2 – Illustration of the principle of hopping mode SICM.  In a), the nanopipette scanning in 
continuous mode collides with the sample to be imaged, whereas in b) the nanopipette is 
constantly withdrawn to a position well above the level of the sample at each scanning point, thus 
allowing better resolution and functional imaging.  Adapted from Novak et al. (Novak et al., 2009). 
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2.3.4.2 Measurement of Single-Cell Mechanical Properties 
We recently developed a SICM modification permitting to apply quantified positive and negative 
force at defined positions to the surface of cells.  With this method hydrostatic pressure (0.1–50 
kPa) was applied through a pipette.  To prevent any surface contact or contamination of the 
pipette, the distance between the pipette and cell surface was kept constant using ion 
conductance-based distance feedback, allowing fast and repeated measurements (Sanchez et al., 
2008). 
2.3.4.3 Experimental SICM Protocol 
Aortic valves (n=30 cusps) were obtained from porcine hearts obtained from a commercial 
abattoir (Cheale Meats, Essex).  The cusps were pinned under basal stretch inside a 30mm dia-
meter plastic dish with careful attention to the aortic versus ventricular orientation of the cusp.  
A total of 3 mL of growth medium was added inside the dish to cover the cusp.  The dish is then 
placed under the scanning microscope and a nanopipette with pre-determined internal diamet-
er is prepared and mounted for the scanning.  An initial scan is performed to visualize the sur-
face topography of the tissue over an 80x80 nm area.  This allows clear visualization of the nuc-
leus, cytoplasm and cell junctions.  Based on this, specific points are chosen with fine precision 
to measure localized cell stiffness.  A controlled and quantifiable pressure is applied using the 
nanopipette tip is applied to the cell surface and the resultant displacement is quantified.  Based 
on this, stress-displacement maps can be determined, thus reflecting cell stiffness.   
Basal stiffness of endothelial cells was initially compared between the aortic and ventricular 
sides of the aortic valve.  Each cusp served as its own control by splitting the cusps in half and 
exposing both sides to SICM testing.  In addition, changes in response to sodium nitroprusside 
(SNP, 10-5M), endothelin-1 (ET-1, 10-10 to 10-8M) and L-nitroarginine methyl ester 
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(L-NAME, 10-4M) were evaluated.  For each measurement, a minimum of 20 cells were randomly 
examined from the belly of the cusp.   
 
2.3.5 Statistical Methods 
Data are expressed as mean ± standard error of the mean (SEM) for continuous data and 
analyzed using paired or unpaired Student’s t-test as indicated.  Categorical variables are 
expressed as a percentage and compared using Fisher’s exact test.  Differences between groups 
for each assay were assessed using either a one-way ANOVA followed by a Dunn’s multiple 
comparison post-test or an un-paired students t-test.  All analyses were performed using SAS 
software (SAS Institute, Cary, NC).  P-values <0.05 were considered statistically significant. 
  
2.4 RESULTS 
2.4.1 Development of a Side-Selective Endothelial Cell Isolation Technique 
2.4.1.1  Isolation of Valve Endothelial Cells 
The initial objective was to develop a means of isolating valve endothelial cells (aortic and 
ventricular sides combined) in a reliable and reproducible way.  Previous work from other 
groups had described isolation techniques which all relied on enzymatic digestion of the tissue 
using collagenase followed by selective clonal explansion or cell-sorting using flow cytometry 
(Butcher et al., 2004; Farivar et al., 2003; Hoerstrup et al., 1998; Paranya et al., 2001).  Based on 
the previously described methods in the literature, we set out to evaluate the most reliable 
technique for isolation of endothelial cells from healthy porcine aortic valves freshly obtained 
within 4 hours of animal sacrifice from a local abattoir (Cheale Meats Inc., UK).  Four criteria 
were evaluated in comparing different isolation protocols: purity of the cells after several 
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passages, rate of infection ease of the method and reproducibility of the technique.  Different 
protocols were used as summarized in Table 2.1.   
 
Table 2.1 – Summary of the different aortic valve endothelial cell isolation protocols tested.   
Protocol 
Collagenase 
concentration 
Duration of digestion 
EC removal 
after 
digestion 
Growth 
medium 
Purification 
technique 
A 
600 U/mL 
vs. 
1000U/mL 
5min. 
vs. 
10 min. 
+Gentle shaking at 37C 
Shaking of 
the cusps 
using 
forceps 
-EGM 
-10% FCS 
-1% L-glut 
-1% Pen 
-1& Strep 
None 
B 
600 U/mL 
vs. 
1000U/mL 
5min. 
vs. 
10 min. 
+Gentle shaking at 37C 
Shaking of 
the cusps 
using 
forceps 
-EGM 
-10% FCS 
-1% L-glut 
-1% Pen 
-1& Strep 
Cell-sorting 
Using flow 
cytometry 
C 
600 U/mL 
vs. 
1000U/mL 
5min. 
vs. 
10 min. 
+Gentle shaking at 37C 
Shaking of 
the cusps 
using 
forceps 
-EGM 
-10% FCS 
-1% L-glut 
-1% Pen 
-1& Strep 
Dynabeads 
using CD-
31-positive 
magnetic 
beads 
D 
600 U/mL 
vs. 
1000U/mL 
7min 
vs. 
12 min  
at rest at 37C 
Gentle 
vortex for 1 
min. 
-EGM 
-10% FCS 
-1% L-glut 
-1% Pen 
-1& Strep 
Selective 
clonal 
explansion 
EC, endothelial cell; EGM, endothelial growth medium; FCS, fetal calf serum; L-glut, L-glutamine; 
Pen, penicillin; Strep, streptomycin 
 
The following table shows results obtained following each of the different isolation protocols 
used (Table 2.2). 
Table 2.2 – Summary of the efficacy of different aortic valve endothelial cell isolation protocols 
tested.  Evaluation criteria used were purity of the obtained cells, risk of infection, ease and 
reproducibility of the technique. 
 
Protocol* Purity of the cells Risk of infection Ease of Reproducibility 
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technique 
A1 - + +++ +++ 
A2 - + +++ +++ 
B1 + +++ ++ +++ 
B2 - +++ ++ +++ 
C1 - + ++ +++ 
C2 - + ++ +++ 
D1ǂ +++ + + ++ 
D2 ++ + + ++ 
D3 + + + ++ 
D4 + + + ++ 
* Refers to the protocols presented in the previous Table.  Each protocol was subdivided into “1” 
and “2” where “1”=600U/mL and “2”=1000U/mL.   
ǂ D1, 600U/mL for 7 min; D2, 600U/mL for 12 min; D3, 1000U/mL for 7 min and D4, 1000U/mL for 
12 min 
 
Following these various iterations of enzymatic digestion of aortic valve cusps to isolated 
endothelial cells, the following can be concluded.  Obtaining a pure population of endothelial 
cells is a particularly challenging technique due to the high risk of contamination with 
interstitial cells using any of the mentioned techniques.  In our case, cell sorting using flow 
cytometry proved unsuccessful because of the high risk of infection associated with the 
technique.  This might simply be due to the fact that the cell-sorting flow cytometer in our lab is 
a multi-user apparatus that is most often used for non-sterile techniques.  Therefore, preventing 
infectious contamination of the cell samples was almost impossible which made this technique 
highly impractical in our context.  Magnetic bead separation of the cells was disappointing in 
that interstitial cell contamination was surprisingly high immediately after separation which 
inevitably led to complete overtake of the cultures by interstitial cells.   
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The technique of isolating cells using static exposure to collagenase for a longer period 
of time followed by gently vortexing the cusps to detach the endothelial cells from the 
underlying matrix to which they’ve become weakly attached represents the most successful 
technique.  This is followed by selective clonal expansion based on cell morphology.  Valve 
endothelial cells are cuboidal in shape although they sometimes assume a more elongated 
shape.  Endothelial cells tend to grow in little clusters as shown in Figure 2.3.     
 
Figure 2.3 – Light microscopy photographs of cultured aortic valve endothelial cells showing 
their typical appearance in vitro.  Cells are small, cuboidal in shape and tend to grow in clusters as 
shown on the left and right panels. 
 
 
In addition, valve endothelial cells are easily distinguishable from valve interstitial cells 
which are significantly longer and wavier than endothelial cells (Figure 2.4).  In addition, 
interstitial cells grow much faster than endothelial cells.   
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Figure 2.4 – Light microscopy photographs illustrating the morphological differences between 
cultured porcine aortic valve interstitial (left) and endothelial cells (right).  Interstitial cells are 
elongated and wavy.  In addition, they tend to grow much faster than endothelial cells. 
 
Table 2.3 Summary of the morphological differences between aortic valve endothelial and 
interstitial cells. 
 Valve Endothelial Cells Valve Interstitial Cells 
Shape Cuboidal (sometimes 
elongated but much less than 
interstitial cells) 
Very elongated and wavy 
Proliferation rate Slow Rapid 
Growth pattern Clusters Uniformly across plate 
Distribution in culture Monolayer even when 
confluent 
Can grow in multi-layers 
when over-confluent 
Ease of detachment when 
passaging with EDTA 
Easy Easy 
 
2.4.1.2  Separate Isolation of Aortic and Ventricular Side Endothelial Cells  
Following the successful application of a reproducible technique to isolate valve endothelial 
cells, a side-selective endothelial cells isolation technique was developed using the same 
principles, but exposing only a single side of the aortic valve to the collagenase.  The setup 
consisted of a plate which only allowed exposure of the aortic or the ventricular side to solution 
while the other side was totally excluded (Figure 2.1). 
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2.4.2 Phenotypic and Morphological Differences Between Aortic and Ventricular 
Side Aortic Valve Endothelial Cells 
2.4.2.1  Morphological Differences 
Primary cultures of aortic versus ventricular-side aortic valve endothelial cells were compared.  
From a morphological standpoint, cells on the ventricular side appeared more elongated than 
those on the aortic side as shown in Figure 2.X with vimentin staining.  (Figure 2.5).  The shape 
of cells from the ventricular side in culture sometimes mimicked that of valve interstitial cells, 
although much less swirly than the latter.  However, cells were positive for endothelial markers 
(CD31 and vWF) and negative for SMA. 
 
Figure 2.5 – Vimentin expression (red) in primary cultures of porcine aortic valve endothelial cells from 
the aortic (A) and ventricular side (B) of the cusp.  Aortic-side endothelial cells have a more typical 
cobblestone appearance than cells from the ventricular side which often appeared elongated in culture 
under static conditions. 
 
2.4.2.2  Immunocytochemistry 
The only differences observed in the expression of various phenotypic markers between 
endothelial cells isolated from the aortic and ventricular sides of aortic valve cusps were 
observed in vWF and eNOS expression.  Primary cultures of porcine aortic valve endothelial 
cells showed more vWF expression in cells isolated from the aortic side than the ventricular 
side of the cusp (Figure 2.6; vWF=green, CD31=red).   
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Figure 2.6 – vonWillebrand factor expression (green) in primary cultures of porcine aortic valve 
endothelial cells from the aortic (A) and ventricular side (B) of the cusp.  Aortic-side endothelial cells 
express more vWF than their ventricular counterparts. 
 
In addition, cultured cells from the aortic side of the cusps express more eNOS than their 
ventricular counterparts (Figure 2.7; eNOS=red).   
 
Figure 2.7 – Endothelial nitric oxide synthase (eNOS) expression (red) in primary cultures of porcine 
aortic valve endothelial cells from the aortic (A) and ventricular side (B) of the cusp.  Aortic-side 
endothelial cells express more eNOS than their ventricular counterparts. 
 
 
2.4.3 Functional Responses to Inflammatory Stimulation 
No differences were observed in the expression of inflammatory markers (ICAM-1, VCAM-1, 
NFKB, phosphorylated p38 and phosphorylated JNK)  with the addition of TNFα or TGFβ1 for 
12, 24 or 48 hours, on endothelial cells from either side of the valve.  
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2.4.4 Differences in Gene Expression Profiles 
The pig genome was expected to be released in December 2009.  Unfortunately, to this day, it 
remains unpublished, therefore precluding any definitive conclusions of the gene array 
performed.  Nevertheless, preliminary analysis of the data shows a total of 61 genes that are 
differentially expressed with a p-value <0.001 and a total of 423 genes with a p-value <0.01.  
This data represents a unique comparison of primary cultures of live aortic valve endothelial 
cells and may hold important clues into the functional and pathological differences observed 
between both sides of the aortic valve.   
 
2.4.5 Structural and Functional Differences in Biomechanical Properties 
2.4.5.1 Baseline Stiffness of Aortic Valve Endothelial Cells 
Baseline analysis of aortic valve endothelial cell mechanical properties using SICM showed a 
significant difference between cells from either side of the cusp.  AVECs on the ventricular 
surface of the aortic valve are significantly stiffer than cells on the aortic side of the valve (mean 
displacement: 11 ± 2 nm/kPa versus 32 ± 4 nm/kPa; p<0.01) (Figure 2.8).  
Chapter 2 
   85 
 
Figure 2.8 – Mean baseline stiffness of aortic valve endothelial cells from the ventricular and aortic sides 
of the aortic valve.  Endothelial cells on the ventricular side are significantly stiffer than their aortic 
counterparts as evidence by reduced displacement in response to pressure. 
*p<0.01 
A: Aortic; V: Ventricular 
 
2.4.5.2 Changes in Stiffness of Aortic Valve Endothelial Cells from the Aortic Surface of the Cusp  in 
Response to Different Mediators 
Changes in the stiffness of aortic valve endothelial cells from the aortic surface of the cusp  in 
response to various mediators was assessed (Figure 2.9).  Addition of SNP (10-5M) did not affect 
the stiffness of endothelial cells.  However, addition of ET-1 (10-8M) resulted in a significant 
increase in cell stiffness (mean displacement: 13 ± 1 nm/kPa following ET-1 administration 
versus 32 ± 4 nm/kPa in controls; p<0.01).  The presence of L-NAME when adding ET-1 did not 
affect these results (mean displacement: 16 ± 3 nm/kPa with ET-1 and L-NAME versus 32 ± 4 
nm/kPa; p<0.01).  Furthermore, inhibition of NO production by adding L-NAME alone (10-5M) 
resulted in similar findings with a significant increase in the stiffness of the tissue in the same 
range as addition of ET-1 (mean displacement: 11 ± 1 nm/kPa in the presence of L-NAME 
versus 32 ± 4 nm/kPa; p<0.01).  
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Figure 2.9 – Mean changes in stiffness of aortic valve endothelial cells on the aortic surface of the 
valve in response to different vasoactive agents.  There was no change in stiffness following SNP 
administration.  Addition of ET-1, L-NAME significantly increased the stiffness of endothelial cells.  
Addition of L-NAME to ET-1 did not change the results. 
*p<0.01 vs. Control 
SNP, sodium nitroprusside; ET-1, endothelin-1; L-NAME, L-Nitroarginine methyl ester. 
 
In order to determine the direct role of ET-1 in inducing changes in cell stiffness, concentration-
dependent responses to increasing concentrations of ET-1 were analyzed.  As shown in Figure 
2.10, there was an almost linear relationship between ET-1 concentrations and the degree of 
stiffening of endohtelial on the aortic surface of the cusps (ANOVA p<0.05).   
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Figure 2.10 – Concentration-dependent changes in aortic valve endothelial cells on the aortic 
surface of the valve in response to increasing concentrations of ET-1. 
*ANOVA p<0.05  
 
Changes in cell stiffness in response to ET-1 administration are more clearly depicted in Figure 
2.11 where individual measurements are each depicted by a seprate line.  Black lines represent 
control cusps showing baseline cell stiffness.  The slope of the curve is indicative of cell stiffness.  
The less steep the slope is, the less stiff the cells are.  This figure shows a quasi-linear 
relationship between increasing pressure and displacement of cell surface.  In contrast, after 
addition of ET-1 to the solution (red lines), increasing applied pressure on the cells resulted in 
little change in cell surface displacement, indicating increased stiffness. 
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Figure 2.11 – Relationship between pressure and displacement of cell membrane in endothelial 
cells from the aortic surface of the aortic valve at baseline (black) and after addition of ET-1 (red). 
ET-1, endothelin-1 
2.4.5.3 Changes in Stiffness of Aortic Valve Endothelial Cells from the Ventricular Surface of the 
Cusp  in Response to Different Mediators 
Similarly, changes in aortic valve endothelial cell stiffness in response to similar agents were 
studied on the ventricular surface of the cusps.  Figure 2.12 shows that, in contrast to cells from 
the aortic side, addition of SNP resulted in a significant decrease in endothelial cell stiffness 
(mean displacement: 32 ± 2 nm/kPa after addition of SNP versus 11 ± 2 nm/kPa in control 
cusps; p<0.01).  However, addition of maximum concentrations of ET-1 (10-8M) resulted in no 
significant change in the stiffness of endothelial cells (mean displacement: 9 ± 2 nm/kPa after 
addition of ET-1 versus 11 ± 2 nm/kPa in control cusps; p<0.01).  Similarly, addition of L-NAME 
induced no significant change in cell stiffness (mean displacement: 13 ± 2 nm/kPa after addition 
of L-NAME versus 11 ± 2 nm/kPa in control cusps; p<0.01). 
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Figure 2.12 – Mean changes in stiffness of aortic valve endothelial cells on the ventricular surface 
of the valve in response to different vasoactive agents.  There was a significant increase in 
stiffness following SNP administration (p<0.01).  Addition of ET-1 or L-resulted in no changes in 
the stiffness of endothelial cells.   
*p<0.05 vs. Control 
SNP, sodium nitroprusside; ET-1, endothelin-1; L-NAME, L-Nitroarginine methyl ester. 
 
Figure 2.13 illustrates the decrease in cell stiffness through various measurements in response 
to SNP (red lines ) versus control (black lines). 
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Figure 2.13 – Relationship between pressure and displacement of cell membrane in endothelial 
cells from the ventricular surface of the aortic valve at baseline (black) and after addition of SNP 
(red). 
SNP, sodium nitroprusside 
 
2.5 DISCUSSION 
In this chapter, we have described a novel, reliable and easily reproducible technique to 
selectively isolate primary cultures of aortic valve endothelial cells from either side of the valve 
in vitro.  This has allowed to study morphological and phenotypic differences between cells 
from either side of the valve as well as analysis of gene expression profiles, confirming 
significant differences between the 2 sides, though precise knowledge of these differences 
awaits full identification of the pig genome.  In addition, in the present chapter, we have shown 
that endothelial cells from either side of the valve analyzed in situ using SICM, have different 
baseline mechanical properties and exhibit different responses to the same vasoactive agents.   
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As mentioned previously, there is very compelling evidence that endothelial cells across the 
body have different properties on many levels, ranging from structure (size, shape), molecular 
composition, gene expression and ultimately, function.  In this set of experiments, we have 
demonstrated that endothelial cells from either side of the aortic valve also further differ in terms of 
their in situ mechanical properties.  Endothelial cells on the ventricular surface of the valve are 
significantly stiffer than cells on the aortic side.  In addition, they exhibit different responses to 
similar vasoactive agents.  The stiffness of eukaryotic cells is mainly determined by the cytoskeleton.  
Although the name suggests a static structure, the cytoskeleton is a highly dynamic and adaptive 
structure whose components are in constant flux.  In addition to determining the stiffness of the 
cells, the cytoskeleton has 3 main functions: it physically and biochemically connects the cell to 
the extracellular environment, it allows the cell to move and change shape through coordinated 
movements and it spatially organizes the contents of the cell (Fletcher & Mullins, 2010).  The 
cytoskeleton consists of 3 main polymers: actin filaments, microtubules and a group of polymers 
collectively known as intermediate filaments.  They differ mainly in their mechanical stiffness, 
their assembly dynamics, their polarity and the molecular motors they associate with.  Microtu-
bules are the stiffest of the 3 polymers while intermediate filaments are the least rigid.  Most 
cells in the cardiovascular system are mainly exposed to pressure-type mechanical forces.  How-
ever, endothelial cells are additionally exposed to shear stress which is defined as the frictional 
force per unit area from flowing blood.  The magnitude of shear stress can be estimated in most 
of the vasculature by Poiseuille’s law stating that wall shear stress is proportional to blood flow 
viscosity and volumetric flow rate and inversely proportional to the third power of the internal 
radius (P. F. Davies, 1995).  While actual wall shear stress is very difficult to estimate, mean 
shear stress along an artery is estimated at 20 dynes/cm2.  Unlike blood vessels, the aortic valve 
is not a cylindrical structure, therefore estimation of shear stress levels on either side of the 
valve requires more complex modelling.  A number of potential mechanotransducers thought to 
mediate endothelial cell responses to shear stress have been described such as integrins, ion 
channels, apical glycocalix, the primary 
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cilia, heterotrimeric G-proteins, CD31 and VE-cadherin.  A question that remains however is: 
What is the value of determining the mechanical properties of single cells? 
 A cell is more than the sum of its individual components.  It is a hierarchically ordered 
system which lies within a dynamic environment.  The cytoskeleton is an integral part of this 
structural, molecular and functional continuum.  Cellular mechanosensing is based on force-
induced conformational changes in mechanosensitive proteins that result in opening of 
membrane channels or altered affinities to binding partners, thereby activating signalling 
pathways.  Therefore, any differences in intrinsic mechanical properties or any changes in the 
normal intracellular force transmission through changes in cellular (or extracellular) structure 
and organization can lead to altered molecular forces acting on these proteins, resulted in 
attenuated or increased mechanosensitive signals (Jaalouk & Lammerding, 2009).  Our findings 
indicate that endothelial cells on both sides of the aortic valve have different baseline 
mechanical properties with cells on the ventricular surface being significantly stiffer than their 
counterparts on the aortic side.  Whether these differences are present from the developmental 
origins of the cells or represent an evolutionary adaptation to their local mechanical 
environments remains to be determined.  Endothelial cells on the aortic surface of the valve are 
exposed to low shear disturbed flow mainly during diastole whereas the ventricular side is 
exposed to high shear laminar systolic flow.  This inevitably translates into different mechanical 
signals and requires distinct adaptive changes.  Differences in the expression of vWF and eNOS 
were observed between both sides, with cells on the aortic side expressing more of both in 
static culture conditions.  In addition, morphological differences were also observed.  Although 
cells in static culture do not align in a particular orientation, yet cells from the ventricular side 
show a significantly more elongated shape which likely reflects the type of flow they are 
exposed to in vivo.  Cytoskeletal form meets function in vivo and cytoskeletal arrangement in 
vitro can certainly serve as a map of the cell’s previous mechanical environment (Fletcher & 
Mullins, 2010).  A point of major importance will be to evaluate the effect of various clinical risk 
factors for aortic valve disease such as hypertension (increased pressure and strain), 
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smoking/dyslipidemia (endothelial dysfunction) or high circulating 5-HT levels (carcinoid 
disease) on the mechanical properties of the cells.  It might be that some of these factors can 
directly alter cytoskeletal prestress which controls the stiffness of tensed cytoskeletal filaments 
(such as stress fibers and intermediate filaments), thereby modulating the fidelity and speed of 
intracellular mechanical signalling responses (Janmey, Euteneuer, Traub, & Schliwa, 1991; 
Kumar et al., 2006; Luo, Xu, Lele, Kumar, & Ingber, 2008).    
Another important element to take into consideration when evaluating differences in 
cell mechanobiology is the fact that the ECM composition differs between the fibrosa and the 
ventricularis.  Changes in the mechanical properties of the substrate or the matrix has been 
demonstrated to have major effects on cell behaviour (Engler, Sen, Sweeney, & Discher, 2006).  
The fibrosa is rich in collagen whereas the ventricularis contains most of the elastin.  Knowing 
that the cytoskeleton interacts directly or indirectly with ECM components during 
mechanotransduction and that collagen and elastin have different elastic moduli and 
importantly have important functional roles, studying aortic valve endothelial cell 
mechanobiology has to take these elements into account.  Finite element modelling using 
acquired mechanical information of the different elements and incorporating shear stress and 
strain data represents a plausible approach at this stage (Charras & Horton, 2002). 
 There are several available techniques to assess the mechanical properties of 
cells, whether in culture or in situ, including SICM, atomic force microscopy (AFM), optical 
trapping, magnetic bead microrheometry and micropipette aspiration.  Of these, SICM and AFM 
allow studying non-fixed living cells in an aqueous environment.  As described in the Methods, 
SICM is based on the differences in electrical charge between the scanning nanopipette and the 
medium, while maintaining the distance between the pipette and the sample constant.  Because 
of that difference in charge, there is a constant flux of ions through the nanopipette.  Any 
reduction in the distance between the pipette tip and the sample will automatically translate 
into reduced flow of ions through the pipette.  This determines cell surface deformations during 
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testing.  On the other hand, AFM uses a tapered probe, typically made of silicon or silicon 
nitride, which is attached to a cantilever arm.  When the probe tip interacts with the sample, the 
arm is deflected.  Deflections are simultaneously measured by sensing the position of a laser 
beam that reflects off the cantilever arm.  Displacements of less than 1nm can be accurately 
detected.  Both techniques can provide morphological data of cell topography as well as 
mechanical and molecular information of living cells (Charras & Horton, 2002; Gorelik et al., 
2008; Horton, Charras, & Lehenkari, 2002; Nikolaev et al., 2010; Novak et al., 2009).   
 The pig represents an excellent model to study normal cellular and molecular 
physiology due its close similarity with human beings.  In fact, porcine aortic roots are used 
everyday in cardiac surgery as valves or roots (eg., Medtronic Freestyle®, Medtronic, 
Minneapolis, MN, USA).  Nevertheless, there are significant differences between the pig and the 
human species at several levels.  Anatomically, the pig heart presents some differences 
compared to the human heart: there is a significant muscle shelf below the subcoronary cusp, 
the height of the coronary arteries and the intercoronary angle are consistently different from 
humans.   At the immunological level, the swine leucocyte antigen (SLA) system is different from 
the human leukocyte antigen (HLA).  Importantly, from a clinical relevance standpoint, it has 
always been thought that pigs do not develop aortic valve calcification, though that remains to 
be determined in a scientific fashion.  Along with these differences between pigs and humans, it 
is expected that differences in the human and pig genomes are inevitable.  Though there are 
many similarities between both genomes and the separation between the pig and human 
genomes is less than between the mouse and human ones (Wernersson et al., 2005), yet it 
would be inaccurate to analyze porcine gene arrays using the human genome.  In a previous 
study, Simmons et al. had however accepted this extrapolation and sued a human gene array on 
pig-derived aortic valve endothelial cells (Simmons et al., 2005).  Their findings were interesting 
because they showed differences in gene expression profiles between both sides.  However, the 
specific pattern of differences remains to be confirmed using pig-specific tools.  There are 
several collaborative projects currently in progress attempting to map the full porcine genome, 
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but to date, the it remains incompletely mapped.  Therefore, until this is completed, it was 
thought more accurate to delay analyzing the gene array data obtained. 
The observed heterogeneity in endothelial cell properties could have important 
implications in the understanding of aortic valve disease.  As will be discussed in the following 
chapter, aortic valve calcification (the most common aortic valve pathological presentation) 
occurs almost exclusively on the aortic side of the cusp.  In addition, it is proposed that 
mechanisms similar to those involved in atherosclerosis are operative in aortic valve 
calcification.  As is well demonstrated, endothelial dysfunction is a first step in the sequence of 
events leading to plaque formation and rupture.  Endothelial dysfunction which was once 
thought to be restricted to the inability of the endothelium to produce and release vasodilatory 
agents such as NO, could also represent alterations in cell mechanobiology, mechanosensing or 
mechanotransduction.   
 
2.6 LIMITATIONS 
This set of experiments has several limitations.  First, we used a pig model both to isolate aortic 
valve endothelial cells as well to study their mechanical properties in situ.  As mentioned in the 
Discussion, there are inter-species differences which could make our results invalid in humans.  
However, the lack of availability of healthy human valves for research purposes makes it almost 
imperative to undertake such studies on an animal model.  The pig is well suited for such 
experiments since the cardiac anatomy and the hemodynamics are largely comparable to 
humans.  Although gene expression profiles were examined in aortic and ventricular endothelial 
cells, the absence of full porcine genome mapping makes it yet difficult to fully exploit this data.  
Once the genome is fully sequenced, this data will provide significant insight into differences 
between cells on either side of the valve.  Mechanotransduction implies by definition the 
presence of mechanical stimuli.  In the case of aortic valves, theses stimuli are mainly strain, 
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shear stress, compression and bending forces.  Though we have demonstrated significant 
differences in the mechanical properties of cells from both sides of the valve, these experiments 
were performed in static conditions.  This, in itself, may constitute a pathological state.  
Nevertheless, experiments were always performed within hours of animal sacrifice at which 
time it is thought that cells still carry their in vivo cytoskeletal arrangement memory. 
     
2.7 CONCLUSIONS AND FUTURE DIRECTIONS 
In conclusion, the present experiments demonstrate for the first time the feasibility of 
separately isolating primary cultures of aortic valve endothelial cells from either side of the 
aortic valve.  In addition, in situ analysis of the mechanical properties of endothelial cells shows 
they have significantly different baseline stiffness and their responses to vasoactive agents 
differ significantly.  These findings can have important research implications in allowing better 
understanding of the cellular and molecular differences between both sets of endothelial cells.  
This could help understand the pathophysiology of aortic valve calcification and allow testing 
different therapeutic strategies in vitro, such as the use of statins.  Ongoing and future studies 
will focus on 2 parallel sets of experiments.  In vitro study of endothelial cells will focus on 
better characterization of the molecular pathways activated in response to different stimuli as 
well as the role of various agents on endothelial cells in vitro, such as statins and angiotensin-
converting enzyme inhibitors (ACE-I).  In addition, using an in vitro flow system which has been 
adapted for use with cultures cells, we will examine the response of endothelial cells to different 
patterns of shear stress.  Obtained conditioned medium from these experiments will be tested 
on valve interstitial cells grown in osteogenic medium to test the proposed protective effect of 
endothelial cells against valve calcification.  Another set of experiments will be focused on 
endothelial cells in situ using SICM.  Aortic valve cusps will be exposed to different degrees, 
durations and pattern of shear stress and changes in the mechanical properties of endothelial 
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cells will be examined.  More importantly, using a tissue model of aortic valve calcification 
(discussed in the following chapter), we will evaluate the role of mechanotransduction on aortic 
valve calcification in response to altered shear stress.   
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III Modulation of 
Aortic Valve 
Calcification 
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3.1 BACKGROUND 
Aortic valve calcification is a major source of morbidity and mortality from cardiovascular 
causes.  Treatment of aortic valve calcification remains limited to surgical replacement of the 
severely calcified valve if the patient is symptomatic or develops left ventricular dysfunction 
(Bonow et al., 2006).  Until recently, aortic valve calcification was thought to be due to “wear 
and tear” of the cusps due to opening and closure leading to repetitive areas of microtrauma 
with subsequent degeneration and formation of calcium nodules.  Nevertheless, careful 
evaluation of the calcified aortic valve cusps suggested that calcification is likely due to active 
cell-mediated mechanisms which could be similar in nature to vascular calcification phenomena 
(Mohler et al., 1999; Otto et al., 1994; Reynolds et al., 2004).  It is thought that similar to 
atherosclerosis, aortic valve calcification is characterized by early endothelial dysfunction, an 
initial step in the cascade of events leading to valve calcification (Otto et al., 1994).  This 
hypothesis is corroborated by clinical assessment of patients with aortic valve disease showing 
systemic endothelial dysfunction measured by brachial flow analysis (Poggianti et al., 2003).  
Similar to atherosclerotic vessels, the site of calcium formation in the valve cusps is the body of 
the cusp, ie., the subendothelial region.  This suggests that if the endothelium is implicated in 
calcification, it necessarily communicates with the underlying interstitial cells, sending pro- or 
anti-calcification signals.  Interestingly, calcified nodules occur almost exclusively on the aortic 
side of the valve (Figure 3.1), prompting us to evaluate the potential regulatory effect of the 
endothelium from either side of the cusps on aortic valve calcification.   
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Figure 3.1 - Histological section across a human calcified aortic valve showing the presence of a 
von Kossa-positive nodule.  The calcium nodule is characteristically located on the aortic side of the 
valve (fibrosa). 
 
 Previous work from our group and others, focusing on human valve interstitial cell 
calcification suggested that aortic valve interstitial cells undergo a process of 
transdifferentiation into osteoblast-like cells demonstrating alkaline phosphatase activity after 
exposure to osteogenic medium (Mathieu et al., 2005; Lana Osman, Magdi H. Yacoub, Najma 
Latif, Mohamed Amrani, & Adrian H. Chester, 2006).  Nevertheless, because of the difficulty of 
obtaining healthy human aortic valves, it is important to develop a reliable and reproducible 
model of in vitro aortic valve interstitial cell calcification.  Various groups had previously 
published data describing such results using aortic valves from different sources including pigs, 
dogs and sheep (Jocelyn N. Clark-Greuel et al., 2007; Mathieu et al., 2005; Mohler et al., 1999).  
All the studies based their findings on the in vitro formation of cell nodules, similar to those 
observed in vascular smooth muscle cell cultures following exposure to osteogenic medium.  
However, the precise composition and characterization of these nodules has never been 
properly tested beyond the demonstration that they stain positively to Alizarin red or von 
Kossa.   
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3.1.1 Aims 
The aims of the present series of experiments were to develop a reliable and reproducible in 
vitro whole tissue model of aortic valve calcification.  Using this model, we aim to evaluate the 
differential propensity of either side of the cusp to aortic valve calcification and determine the 
role of endothelium-derived NO in regulating the calcification process. 
 
3.2 METHODS 
3.2.1 Aortic Valve Interstitial Cell Isolation and Culture 
Porcine hearts (12-18 months old) were obtained within 12 hours after sacrifice from a 
commercial abattoir (Cheale Meats, Essex, UK).  Hearts were immediately placed in cold-
buffered Hanks solution for transport.  Under sterile technique, aortic valve cusps were 
dissected and washed in 1%phosphate -buffered saline  (PBS) at room temperature, and kept in 
cold serum free M-199 (Sigma UK) until use.  Care was taken during dissection to avoid 
excessive cusp manipulation which could damage the cellular structure of the cusps.  All 3 cusps 
from a single heart were then placed in a 50mL Falcon tube containing 10mL of Collagenase 
type II solution (Clostridium histolyticum, Sigma UK [PN: C6885]) diluted in PBS (600U/mL) and 
maintained at 37C and the tube was placed in a 37C incubator (95%02, 5%CO2) for 12 minutes 
to extract the endothelial cells.  Following this initial period of digestion, the tube was place on a 
vortex at high velocity and kept for 1 minute.  The cusps were then individually removed from 
the solution and placed in a new 50mL Falcon tube containing fresh Collagenase II (10mL at 
600U/mL) at 37C.  The tubes were put in a tube shaker with their bottom dipping in a 37C 
waterbath to maintain the collagenase temperature and enzymatic activity.  After shaking the 
tubes for 1 hour, an equal volume (10mL) of cold high glucose Dulbecco’s Modified Eagle 
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Medium (DMEM) was added to inactivate the collagenase.  The digested cusps at this stage have 
a gelatinous texture and are removed from the solution under sterile conditions.  The mixture is  
centrifuged for 5 minutes at 1000g.  The supernatant was discarded and the pellet is 
resuspended in growth medium (high-glucose DMEM [Sigma UK] with 10% heat-inactivated 
fetal calf serum, 100 U/mL (1%) penicillin, 100 µmol/L (1%) streptomycin [Life Technologies, 
UK] and 4 mmol/L (1%) L-glutamine [Invitrogen, UK]) and plated in T75 flasks (75 cm2).  One 
T75 flask was used for each heart (ie, 3 cusps).  Tissue plates were placed in an incubator at 
370C in 5% CO2 in air with medium changes after 24hr then every three days thereafter. When 
confluent, cells were passaged by adding a trypsin/EDTA solution for 2 minutes.  When cells 
started detaching, the flask was gently shaken and enzymatic activity interrupted by adding an 
equal volume of cold DMEM to the flask.  The cells were aspirated and centrifuged at 1000g for 
5 minutes.  For experiments, cells were used between passages 3 and 7.   
 
3.2.2 In vitro Aortic Valve Calcification Model 
3.2.2.1 Cell-Based In Vitro Calcification 
In vitro calcification was tested by placing aortic valve interstitial cells in osteogenic medium.  
Osteogenic medium consisted of normal growth medium supplemented with 50 µg/mL 
ascorbate-2-phosphate (Sigma, UK), 10 nmol/L dexamethasone (Sigma, UK), 10 mmol/L β-
glycerol phosphate (Sigma, UK) and 10 ng/mL porcine TGF-β1 (R&D Systems, UK).  The medium 
was changed every 3 days and cells were examined at 7, 14 and 21 days.  All isolates cultured in 
osteogenic medium were compared to a control population from the same isolate grown in 
normal growth medium.    
 
3.2.2.2 Histochemical Staining for Calcium Detection 
Alizarin Red Staining 
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Cells grown on cover slips were washed 3 times in PBS then fixed using 4% paraformaldehyde 
for 10 minutes at room temperature.  Alizarin red S solution was then added for 5 minutes and 
the cover slips were then washed vigorously 3 times with ultra-distilled water to remove any 
unbound stain.  The cover slips were then examined under light microscopy.  Red-brown stains 
were considered positive markings.  Alizarin red-positive nodules were quantified in terms of 
number and size. 
Von Kossa Staining 
Cells grown on cover slips were washed 3 times in PBS then fixed using 4% paraformaldehyde 
for 10 minutes at room temperature.  Silver nitrate solution (2%) was then added to the cover 
slips which were maintained under direct light for 45 minutes.  After 45 minutes, the silver 
nitrate was washed off using ultra-distilled water and the cover slips were counterstained with 
van Giesson stain.  Cover slips were then examined under light microscope.  Black stains were 
considered positive marking.  Von Kossa-positive nodules were quantified in terms of number 
and size. 
 
3.2.2.3 Tissue-based In Vitro Calcification 
Using the same plate used for selective isolation of aortic valve endothelial cells as previously 
described, aortic valve cusps were placed in control growth medium versus osteogenic growth 
medium: normal growth medium supplemented with 50 µg/mL ascorbate-2-phosphate (Sigma, 
UK), 10 nmol/L dexamethasone (Sigma, UK), 10 mmol/L β-glycerol phosphate (Sigma, UK) and 
10 ng/mL porcine TGF-β1 (R&D Systems, UK) for up to 21 days.  The presence of Alizarin Red 
staining, von Kossa staining and markers of osteogenic differentiation were used to evaluate the 
validity of this model in mimicking aortic valve calcification in situ.   
After dehydration, formalin samples were embedded in paraffin wax and cut into 0.5µm 
sections using a microtome. Sections were collected on glass slides and heated for 24 hours at 
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60°C. The tissue samples were then dewaxed, rehydrated and incubated in Alizarin red S for 5 
minutes or 2% silver nitrate for 1 hour under direct light followed by van Giesson 
counterstaining.  Samples were blot dried and dehydrated. The slides were viewed on Nikon 
light microscope. Calcium nodules were quantified in terms of number and size. The overall 
distribution was also assessed.  
   
3.2.3 Role of the Endothelium on Aortic Valve Calcification 
3.2.3.1 Side-Specific Aortic Valve Calcification Model 
Using the same plate used for selective isolation of aortic valve endothelial cells, aortic valve 
cusps were placed in culture medium under control or osteogenic conditions for a period of 10 
days.  The aortic and ventricular sides of porcine aortic valve cusps were selectively exposed to 
control growth medium or osteogenic medium.  The presence of Alizarin red-positive nodules 
on histological sections of the aortic cusps was the primary endpoint.  The aortic and ventricular 
sides were compared to each other as well as their respective controls (cusps kept in normal 
growth medium).  All 3 aortic valve cusps were obtained from each animal.  Each aortic valve 
cusp was used for a specific subset of experiments.  Each cusp was cut into 3 pieces, forming the 
4 study groups as shown below (Figure 3.2): 
- Cusp #1 – Aortic side osteogenic vs. control 
i. Baseline control (day 0) 
ii. Aortic side in control medium for 10 days (day 10) 
iii. Aortic side in osteogenic medium for 10 days (day 10) 
- Cusp #2 – Ventricular side osteogenic vs. control 
i. Baseline control (day 0) 
ii. Ventricular side in control medium for 10 days (day 10) 
iii. Ventricular side in osteogenic medium for 10 days (day 10) 
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- Cusp #3 – Aortic side osteogenic vs. Ventricular side osteogenic 
i. Baseline control (day 0) 
ii. Aortic side in osteogenic medium for 10 days (day 10) 
iii. Ventricular side in osteogenic medium for 10 days (day 10) 
 
 
Figure 3.2 - Figure illustrating the different groups in the study.  For each group, the aortic and the 
ventricular surfaces of aortic valve cusps were exposed.  The same cusp was cut in two pieces so 
that each cusp served as its own control.  Experiments were carried for a period of 10 days and 
Alizarin red staining was used to verify the presence of calcium nodules. 
 
3.2.3.2 Evaluation of the Role of the Endothelium 
3.2.3.2.1 Pharmacological Inhibition of the Endothelium 
The capacity of the endothelium to produce NO was inhibited by adding L-NAME (100 µM), an 
inhibitor of nitric oxide synthase (NOS) activity, to the control or osteogenic medium.  L-NAME 
was replaced every 3 days while replacing the growth medium.    
 
3.2.3.3 Evaluation of Nitric Oxide Production by Aortic Valve Endothelium 
NO production from either side of the valve (n=8 for each side) was evaluated under static 
(n=4) and physiological flow conditions (n=4) using a cone and plate apparatus (as described 
below).  To evaluate side-specific production of NO, a commercially available kit to measure the 
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levels of cyclic guanosine monophosphate (cGMP) was used as a surrogate for NO production 
(K372-100, BioVision, UK).  Experiments were performed in the presence of 
isobutylmethylxanthine (IBMX), a non-specific inhibitor of phosphodiesterase (PDE), to prevent 
degradation of cGMP in the tissue.   
 All tissues were excised, flash frozen and crushed in liquid nitrogen and then 
homogenized in 0.1M HCl. After centrifuging the homogenate at 3600g for 10 minutes, the 
supernatant was collected and immediately frozen at -80C for later use to perform the cGMP 
analysis.  Reagents, supernatant and the standard solution (for the standard curve) were 
prepared as per the manufacturer’s protocol (see below). The supernatant was acetylated to 
increase the sensitivity of cGMP detection. After completion, the Protein G Coated Plate was 
read in an optical spectrometer at 450nm. 
cGMP Analysis protocol: 
1. Prepare re-agents as advised in the protocol leaflet. 
2. Prepare sample by freezing in liquid nitrogen,  crush into powder and homogenise in 5-
10 volume of 0.1m HCL. 
3. Centrifuge and collect supernatant. 
4. Prepare standard solution for the standard curve 
5. Acetylate the mixture to increase the sensitivity of the assay 
6. Add acetylated standard cGMP and samples to protein G coated well plates 
7. Add antibody, and later cGMP-HRP and one hour later the cGMP-HRP developer 
8. Stop reaction by adding 0.1M HCL 
9. Read OD at 450nm 
 10. Construct standard curve and calculate amount of cGMP/well
 
3.2.3.4 Cone and Plate Apparatus for Reproduction of Aortic and Ventricular Waveforms
In order to perform studies on ao
stress patterns on the aortic and ventricular side of the cusps, we used a cone and plate device 
developed by the biomedical engineering team at the Georgia Institute of Technology 
et al., 2008).  As mentioned in the Introd
exposed to vastly different shear stress patterns, which could have an important effect on 
endothelial cell responses.  Figure 3.
the cardiac cycle on either surface of a living aortic valve according to their calculations.
Figure 3.3 – Computed physiological shear stress variations across time as experienced by the 
aortic valve endothelial cells on a) the ventricular surface of the cusps
the cusps.  Adapted from Sucosky et al. 
2009) 
 
Aortic valve cusps were mounted in the previously mentioned plate while ensuring that
cusps were oriented in the same direction, thus exposing 
of the cusps to a particular condition
analyzed at 2 time points: 30 minutes and 4 hours.  Individua
 
 
rtic valve tissue while exerting physiological flow and shear 
uction, the aortic and ventricular sides of the cusps are 
3 depicts the variations in physiological shear stress across 
 and b) the aortic surface of 
(Sucosky, Balachandran, Elhammali, Jo, & Yoganathan, 
only the aortic or the ventricular side 
.  Cusps were exposed to their physiological 
l cusps could only be analyzed at a 
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single time point. Once cusps were obtained, they were immediately flash frozen and the steps 
described in the previous section for cGMP quantification were undertaken.  
 
3.3 RESULTS 
3.3.1 In Vitro Aortic Valve Calcification 
3.3.1.1 Cell Culture Model of Valve Calcification 
Primary porcine aortic valve interstitial cell isolates were used between passages 4 and 7 for 
these experiments.  Two groups were compared: control medium and osteogenic medium.  Cells 
were cultured for a period of 21 days without passaging, and analyzed using different 
techniques at baseline, 7, 10, 14 and 21 days.  Control cultures showed the formation of 
spontaneous nodules starting at 1 week and showing a steady but slow increase up to 3 weeks.  
When grown in osteogenic medium, cells started forming nodules within 1 week of exposure to 
osteogenic medium (Figure 3.4 and 3.5).   
 
Figure 3.4 – Light microscopy pictures of primary cultures of porcine aortic valve interstitial cells 
in A) control growth medium and B) osteogenic medium for 1 week, showing the presence of dense 
nodules.   
 
 Figure 3.5 – Higher magnification (100x) of in vitro aortic valve interstitial cell nodules following 
exposure to osteogenic medium showing a coalescence of cells in a
 
The number and density of nodules increased with length of exposure.  The number of nodules 
was significantly higher in osteogenic cultures than control cultures at 14 and 21 days (p<0.05)
(Figure 3.6).   
Figure 3.6 – Histogram showing a significant increase in the number of porcine aortic valve 
interstitial cell nodules following exposure to osteogenic medium for 2 and 3 weeks. 
 
In order to determine the presence or absence of mineralization in cell nodules, Alizarin 
red and von Kossa were performed as previously described.  As shown in 
 
nd around the nodule.
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*p<0.05 
Figure 3.7, nodules 
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grown in osteogenic medium stained showed positive Alizarin red staining.  In contrast, von 
Kossa staining was more difficult to elicit (Figure 3.8).  The positive Alizarin red staining 
suggests the presence of calcium and early mineralization in these nodules.   
 
Figure 3.7 – Alizarin Red staining of cultured aortic valve interstitial cells grown in osteogenic 
medium showing positive red staining, indicative of the presence of calcium in the nodules. 
 
 
Figure 3.8 – von Kossa staining of cultured aortic valve interstitial cells grown in osteogenic 
medium showing faint positivity as characterized by the presence of black staining inside the 
nodules. 
 
3.3.3.2 Tissue Culture Model of Valve Calcification 
We hypothesized that the mechanisms that were operative in nodule formation and 
mineralization of aortic valve interstitial cells in culture should also be operative if whole aortic 
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valve cusps were put in culture under the same conditions.  Using a custom-made tissue culture 
chamber for aortic valve cusps, 2 groups were compared as previously: control group and 
osteogenic group.  Each cusp was cut in two pieces, with each half being exposed either to 
control or osteogenic medium for a period of up to 21 days.  Thus, each cusp served as its own 
control.  Cusps were removed at 7, 10, 14 and 21 days and fixed according to the appropriate 
protocols.  Histochemical evidence of mineralization was assessed using Alizarin red and von 
Kossa staining as well as immunohistochemical evidence of osteogenic transdifferentiation. 
 Aortic valve cusps placed in osteogenic medium showed the presence of Alizarin-red 
positive nodules after 7-10 days in culture.  Cusps grown in control medium did not 
demonstrate the presence of nodules within the matrix.  Furthermore, the nodules were almost 
exclusively located on the aortic side of the cusp as shown in Figure 3.9. 
 
Figure 3.9  Representative histological sections of porcine aortic valve cusps placed in osteogenic 
medium containing TFG-beta1 for 10 days.  Alizarin-red positive nodules are seen on the aortic side 
of the cusp whereas no nodules are observed on the ventricular side 
 
Similar to cell cultures, von Kossa staining did not yield positive results in either group.  
In addition, immunohistochemical analysis of the cusps was performed to evaluate the presence 
of osteogenic transdifferentiation within the interstitial cell population.  Bone-specific markers 
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used were osteopontin, osteocalcin, cbfa-1 and bone-specific alkaline phosphatase.  Cusps were 
stained at baseline and at different time points.  No evidence of osteogenic differentiation was 
observed in aortic valve cusps including after 21 days of exposure to osteogenic medium.   
 
3.3.2 Side-Specificity of Aortic Valve Calcification  
No differences were observed between the aortic and ventricular control groups at baseline and 
after 10 days in growth medium.  Exposure of the ventricular surface of the cusp to osteogenic 
medium for a period of 10 days produced no increase in the number of Alizarin red-positive 
nodules (Figure 3.10).  In contrast, exposure of the aortic surface to osteogenic medium for 10 
days resulted in a statistically significant increase in the number of Alizarin red-positive nodules 
compared to its respective control group (Figure 3.11). 
 
 
Figure 3.10 Exposure of the ventricular surface of aortic cusps to osteogenic medium - No 
statistically significant differences in the numbers of Alizarin-red positive nodules were observed 
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between baseline aortic valve cusps (Day 0) and following exposure to control or osteogenic 
medium for 10 days. (hpf; high-power field). 
  
 
Figure 3.11 Exposure of the ventricular surface of aortic cusps to osteogenic medium – There was 
a significant increase in the number of Alizarin-positive nodules following exposure of the aortic 
surface of the cusps to osteogenic medium for 10 days compared to control medium or baseline 
cusps (Day 0) (p=0.02). P<0.05  
 
When comparing the aortic and ventricular surfaces of the same cusp to osteogenic medium 
for 10 days, there was a significantly increase in the number of Alizarin red-positive nodules on 
the aortic side (Figure 3.13). 
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Figure 3.13  Comparison of the number of Alizarin red-positive nodules between the aortic and 
ventricular surfaces of aortic valve cusps at baseline (Day 0) and following exposure to control and 
osteogenic medium for 10 days.  Each cusp served as its own control.  Following exposure of the 
aortic side to osteogenic medium, there was a significant increase in the number of calcifying 
nodules. *P<0.05 
 
3.3.3 Role of the Endothelium on Aortic Valve Calcification 
 We sought to investigate the potential role of the endothelium in modulating aortic valve 
calcification, and importantly the role of side-specific inhibition of endothelial function on 
nodule formation.  The same side-specific model of cusp exposure to osteogenic medium was 
used.  As described in section 3.2.3.2, the endothelium was inhibited using pharmacological 
agents (L-NAME) or mechanical denudation. 
 
3.3.3.1 Effect of Pharmacological Inhibition of the Endothelium on Valve Calcification  
Inhibition of NOS using L-NAME resulted in a significant increase in the number of Alizarin red-
positive nodules on the aortic side of the cusp compared to cusps kept in control medium or in 
osteogenic medium alone (Figure 3.14).  Similarly, addition of L-NAME to the ventricular side 
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resulted in a statistically significant increase in the number of nodules, although the increase 
was less pronounced (Figure 3.15).  When comparing the aortic and ventricular sides of the 
same cusp to L-NAME, there were significantly more nodules on the aortic side than the 
ventricular side (Figure 3.16).  
 
Figure 3.14 Effect of the inhibition of NO production by adding L-NAME to osteogenic medium for 
10 days on the ventricular side of aortic valve cusps.  There was a non-significant trend towards an 
increase in the number of calcifying nodules.  
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Figure 3.15 Effect of the inhibition of NO production by adding L-NAME to osteogenic medium for 
10 days on the aortic side of aortic valve cusps.  There was a significant increase in the number of 
calcifying nodules. *P<0.05 
 
 
Figure 3.16  Comparison of the role of L-NAME on the formation of calcifying nodules on the aortic 
and ventricular sides of aortic valve cusps grown in osteogenic medium for 10 days.  There was a 
significant higher number of calcifying nodules on the aortic side than the ventricular side. *P<0.05 
 
3.3.4 Side-Specific Evaluation of NO Production by Aortic Valve Endothelium 
The capacity of the endothelium to synthesize NO was assessed by evaluating the production of 
cGMP using a commercially available kit.  Following side-specific exposure of the aortic valve 
cusps to control medium (as described in section 3.2.3.3), baseline cGMP production was 
assessed.  There was significantly more cGMP production from the ventricular side of the cusp 
in static conditions than the aortic side (Figure 3.16). 
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Figure 3.16  Histogram showing NO production as demonstrated using a cGMP assay on the aortic 
and ventricular sides of the aortic valve.  The figure shows a significantly higher levels of NO 
production on the ventricular side under static conditions.  *P<0.05 
 
In order to assess the response of endothelial cells to native flow conditions, aortic valve 
cusps were selectively exposed to physiological aortic or ventricular flow waveforms in a cone 
and plate apparatus previously described (Sucosky et al., 2008).  Each side of the valve was 
exposed to its in vivo physiological flow pattern.  Aortic and ventricular flow induced a 
significant increase in the production of NO by each respective side, as suggested by an increase 
in cGMP production.  In comparison, the ventricular produced significantly more cGMP than the 
aortic side in response to flow (Figure 3.17).   
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Figure 3.17  Histogram showing changes in NO production in response to physiological sheart 
stress patterns on the aortic and ventricular sides of the aortic valve.  The figure shows an increase 
in NO production on both sides, but a maintained statistical difference in NO production between 
both sides.  *P<0.05 
 
 3.4 DISCUSSION 
In this chapter, we have described an adapted model of porcine in vitro aortic valve 
calcification, both at the cellular and tissue levels.  In both models, the presence of Alizarin red-
positive nodules was considered a surrogate for calcification, a method which is widely 
accepted and used clinically in other settings such as detection of calcium in synovial fluid 
aspirates.  In addition to forming calcium nodules in response to osteogenic mediators, the side-
specificity of aortic valve calcification to the aortic side of the valve (fibrosa) was preserved 
using our model.  In light of studies suggesting structural and functional differences between 
endothelial cells on both sides of the valve, we assessed the role of the endothelium in 
regulating the calcification process.  Our results suggest that the endothelium plays a protective 
role against calcification through an NO-mediated process.  Inhibition of NO production through 
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inhibition of NOS activity led to a significant increase in the number of calcified nodules.  This 
effect was particularly pronounced on the aortic side of the valve.  In addition, the ventricular 
side of the valve exhibits significantly more NO production than the ventricular side (using 
cGMP as a surrogate marker), both in baseline conditions as well as following exposure to 
physiological flow patterns.  Together, these data strongly support a protective role of NO in 
reducing aortic valve calcification.   
 
3.4.1 The Role of the Endothelium on Aortic Valve Calcification 
Most of the studies examining cellular and molecular mechanisms of aortic valve calcification 
have focused almost exclusively on aortic valve interstitial cells because calcium nodules in 
aortic valve cusps occur in the interstitial space.  However, from studies on atherosclerosis as 
well as a number of studies on valve calcification, it is clear that the endothelium plays an 
important role in the disease process.  The role of NO in preventing calcification, as shown in 
this chapter, can be due to several potential mechanisms.  These are the subject of ongoing and 
future research.   
 
3.4.1.1 Clinical Evidence for the Role of Endothelial Dysfunction in Aortic Valve Disease 
While the role and prognostic significance of endothelial dysfunction in atherosclerosis is well 
accepted, its importance in aortic valve disease was largely overlooked until recently.  A number 
of studies looking at different clinical cohorts suggest a strong relationship between systemic 
endothelial dysfunction and aortic valve disease.  Poggianti et al. compared subjects with aortic 
valve sclerosis to a control patient population showing a significant decrease in systemic 
endothelial function in patients with aortic valve sclerosis, evidenced by a decrease in flow-
mediated brachial artery dilatation (Poggianti et al., 2003).  In a separate study, coronary flow 
reserve was assessed as a marker of microvascular endothelial function in a population of 
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patients with aortic valve calcification but no hemodynamically significant stenosis (peak 
transvalvular gradient <25mmHg) versus a cohort of normal subjects (Huseyin Bozbas et al., 
2008).  Patients with aortic valve calcification were found to have significantly lower coronary 
flow reserve compared to controls.  In addition, patients with aortic valve stenosis were found 
to have increased circulating levels of asymmetric dimethylarginine (ADMA), an endogenous 
inhibitor of NOS (Ngo, Heresztyn, Mishra, Marwick, & Horowitz, 2007).  Similar results were 
reproduced in animal models of aortic valve calcification (Ngo et al., 2008).  Interestingly, 
endothelial dysfunction in this patient population persists despite aortic valve replacement 
suggesting that the dysfunction is part of a wider systemic process (Chenevard et al., 2006).   
 Other studies have examined the presence of local endothelial dysfunction at the level of 
the aortic valve itself.  Increased numbers of ET-1-positive cells and ETA receptor mRNA levels 
as well as a downregulation of eNOS gene expression in human stenotic valves was observed 
(Peltonen et al., 2009).  Interestingly, an eNOS knockout mouse model was reported to be 
associated with an increased incidence of bicuspid aortic valves (Lee, Zhao, Courtman, & 
Stewart, 2000).  The decrease in eNOS in this patient population has been confirmed in humans 
by comparing the expression of eNOS in explanted bicuspid and tricuspid aortic valves showing 
reduced expression of eNOS in valves and aortas of patients with bicuspid valves (Aicher, 
Urbich, Zeiher, Dimmeler, & Schafers, 2007).  The pathogenesis of bicuspid valves in eNOS-
knockout animal models has been further elucidated in accordance to phenotype.  Right and 
non-coronary cusp fusion is thought to be the product of a morphogenetic defect that happens 
before outflow tract septation and that probably relies on an exacerbated NO-dependent 
epithelial-to-mesenchymal transformation (Fernández et al., 2009). In contrast, right-left cusp 
fusion results from the anomalous septation of the proximal portion of the outflow tract, likely 
caused by abnormal behaviour of neural crest cells (Fernández et al., 2009).  Interestingly, 
bicuspid aortic valves are associated with early valve calcification.  Though some of that might 
be due to mechanical factors related to abnormal stress distribution and flow patterns on the 
cusps, decreased levels of eNOS might play an important pathophysiological role.     
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3.4.1.2 Restoration of Endothelial Function Mitigates Aortic Valve Calcification 
Our findings are corroborated by a few studies showing positive results both in vitro and in vivo 
in reducing or preventing aortic valve calcification support a critical role for the endothelium or 
endothelial-derived products in mitigating the calcification process.  Using an in vitro model of 
porcine aortic valve interstitial cell calcification such as the one described in this chapter, 
Kennedy et al. showed that supplementation of cultures maintained in osteogenic medium 
(conatinaing TGFβ) with NO donors or agents that increase intracellular cGMP (8-bromo cGMP, 
C-type natiuretic peptide [CNP] and brain natiuretic peptide [BNP]), result in a significant 
decrease in calcifying nodules (Kennedy et al., 2009).  This suggests that NO mitigates 
calcification through a direct effect on aortic valve interstitial cells.  In a study examining the 
role of statins on aortic valve calcification in a chronic high cholesterol diet rabbit model, 
treatment of the animals with atorvastatin significantly reduced the incidence of aortic valve 
calcification (Rajamannan et al., 2005).  This was associated with an increase in eNOS protein 
concentration in aortic valves from statin-treated animals, as well as a significant increase in the 
levels of circulating nitrites, suggesting preserved or improved endothelial function in these 
animals (Rajamannan et al., 2005).  These findings confirm earlier studies demonstrating the 
role of statins in upregulating eNOS expression through posttranscriptional mechanisms (Laufs, 
La Fata, Plutzky, & Liao, 1998; Laufs & Liao, 1998).  Exercise training was also shown to 
simultaneously preserve endothelial integrity and limit progression of aortic valve calcification 
in a low density lipoprotein receptor-deficient mouse model (Matsumoto et al., 2010).  These 
recently published studies shed light on a once neglected but increasingly recognized role of the 
endothelium in preserving aortic valve structural and functional integrity.  Our findings using a 
novel experimental model, confirm the protective role of the endothelium, and specifically 
endothelium-derived NO, against valve calcification.  But more importantly, our data propose a 
potential explanation for the side-selective localization of calcium nodules in human aortic valve 
cusps.  Although no differences in baseline eNOS expression were observed using 
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immunocytochemistry between the aortic and ventricular surfaces of aortic valve cusps, it is 
more likely that differences would be observed after 10 days of exposure to osteogenic medium.  
These studies are currently ongoing.  These findings are in slight contradiction with findings 
from Simmons et al. showing increased eNOS gene expression in endothelial cells isolated from 
the aortic surface of freshly-obtained porcine aortic valve cusps (Simmons et al., 2005).  This 
could be due to their use of a human gene array on porcine endothelial cells owing to the ab-
sence of dedicated porcine arrays at the time as well as the age of the animals which might play 
an important role in endothelial integrity and expression of eNOS.  It could also be explained by 
posttranscriptional regulation of eNOS protein expression in endothelial cells or the ratio of 
coupled/uncoupled eNOS.  Some pathological conditions are associated with an absolute 
increase in eNOS with closer inspection showing an increase in uncoupled eNOS,a  major source 
of oxidative stress (Hong, Mohamad, & Chris, 2007).     
3.4.1.3 Potential Mechanisms of Action of NO on Aortic Valve Calcification 
3.4.1.3.1 NO and Oxidative Stress 
Oxidative stress is an important mediator of pathological processes both in the valve and the 
vasculature.  Several studies have identified the presence of reactive oxygen species (ROS) in 
calcified aortic valves (H. Bozbas et al., 2008; Liberman et al., 2008; Miller et al., 2008; Ngo et al., 
2008; Towler, 2008).  In addition, many of the clinical conditions that predispose to the 
development of aortic valve calcification are associated with oxidative stress and endothelial 
dysfunction, such as hypertension, hypercholesterolemia, diabetes and smoking.  ROS include 
free oxygen radicals, oxygen ions and peroxides.  Oxidative stress is potentially mediated by 
several enzyme systems present in endothelial cells including the nicotinamide adenine 
dinucleotide phosphate oxidase-dependent (NADPH oxidase), uncoupling of eNOS (in which 
oxygen reduction is uncoupled from nitric oxide synthesis) and the xanthine oxidase system 
(Forstermann, 2008).  Although it remains unclear whether oxidative stress is both necessary 
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and sufficient for aortic valve calcification, it is undoubtedly an aggravating factor in disease 
progression, causing reduced NO bioavailability, upregulation of adhesion molecules and 
chemokines and apoptosis (Bedard & Krause, 2007; Cote et al., 2008).  Furthermore, in vitro 
studies show an increase in calcifying nodules in response to oxidative stress (Kennedy et al., 
2009). 
Studies examining the role of NO on oxidative stress have shown the ability of NO to 
reduce ROS generation and related cell injury.  Using cultured human microvascular endothelial 
cells, Selemidis et al. have shown that NO causes sustained suppression of NADPH oxidase-
dependent superoxide production by S-nitrosylation of the organizer subunit p47phox, one of 
the major subunits of NADPH oxidase (Selemidis, Dusting, Peshavariya, Kemp-Harper, & 
Drummond, 2007).  In a separate study examining porcine aortic valve interstitial cells grown in 
osteogenic medium supplemented with TGFβ1, supplementation of NO resulted in decreased 
production of superoxide anions, possibly through superoxide scavenging, an effect which was 
independent of NADPH oxidase activity (Kennedy et al., 2009).  Thus, it appears that however 
small NO’s contribution is to reducing oxidative injury, it is likely a contributing factor which 
requires further study, both experimentally and clinically. 
 
3.4.1.3.2 Inhibition of TGFβ Signalling by NO 
The TGFβ signalling pathway is involved in many cellular processes in both the adult organism 
and the developing embryo including cell growth, cell differentiation, apoptosis, matrix 
regulation and other important functions.  It has also been implicated in different pathological 
processes ranging from aortic aneurysms to myocardial fibrosis (Leask, 2007; Loeys et al., 2006; 
Neptune et al., 2003).  TGFβ is part of a superfamily of proteins: the TGFβ superfamily which 
also includes bone morphogenetic proteins (BMP) and growth and differentiation factors (GDF).  
Different TGFβ ligands signal by binding to a TGFβ type II receptor on the cell surface which 
recruits and phosphorylates a type I receptor.  The activated receptor then phosphorylates 
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receptor-regulated SMADs (R-Smad), most commonly Smad2, which bind the co-Smad (or 
Smad4).  R-Smad/Smad4 complexes translocate to the nucleus where they act as transcription 
factors regulating gene expression.   
The role of the TGFβ pathway in the pathogenesis of human aortic valve calcification has 
recently been recognized both in human valve explants and in vitro aortic valve interstitial cell cultures 
(Jian, Narula, Li, Mohler Iii, & Levy, 2003; Lana Osman et al., 2006).  As shown in our in vitro studies, 
addition of TGFβ1 to osteogenic medium resulted in acceleration of calcifying nodule formation, a 
finding similar to other investigators using comparable in vitro models (Jocelyn N. Clark-Greuel et al., 
2007; Kennedy et al., 2009).  TGFβ1 can contribute to aortic valve calcification through several 
mechanisms, none of which has been clearly identified.  TGFβ1 can induce valve interstitial cell 
apoptosis which might lead to formation of calcium nodules (Jocelyn N. Clark-Greuel et al., 
2007; Jian et al., 2003).  Indeed, in a model of vascular atherosclerosis, it was shown that apop-
totic bodies are formed following vascular smooth muscle cell apoptosis (Reynolds et al., 2004).  
These apoptotic bodies act as sources of calcium as well as trapping the calcium in the ECM.  
Histological analysis of human calcified aortic valves consistently shows the presence of apop-
totic markers in regions close to foci of calcification.  Alternatively, increased TGFβ1 activity can 
result in calcification by stimulating the release of various ECM proteins, including collagen I 
and III, essential elements in the formation of bone or cartilage, two elements found in sclerotic 
and calcified valves.  This can be further accentuated in the presence of transdifferentiation of 
valve interstitial cells into osteoblast-like cells, as seen following osteogenic stimulation in vitro 
(Mathieu et al., 2005; L. Osman et al., 2006).  In addition, TGFβ1 can also “activate” fibroblasts to 
express SMA, a phenotype known as myofibroblasts, which are thought to be directly involved 
in the aortic valve pathogenesis (Walker et al., 2004).  In our experiments, we performed im-
munohistochemical analysis of the aortic valves exposed to osteogenic medium and did not ob-
serve expression of osteoblatic markers such as osteopontin, Runx-2 or osteocalcin.  However, 
this could be due to the early time point chosen to analyse the specimens, which was strongly 
dictated by the cost of replacing 
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the TGFβ1-rich osteogenic medium twice weekly.  It remains to be determined whether longer 
exposure to osteogenic medium would result in osteoblastic differentiation of valve interstitial 
cells or whether the early calcifying nodules observed are the product of apoptosis and 
accumulation of calcium-rich matrix vesicles, as suggested by Reynolds et al. (Reynolds et al., 
2004).  Finally, TGFβ1 has been shown to directly affect endothelial function by disrupting 
adhered junctions and inducing endothelial barrier dysfunction (Lu et al., 2006).  This suggests 
that TGFβ1 not only has a direct effect on the underlying interstitial cells, but can also directly 
affect permeability of the endothelial layer, thereby potentially facilitating transmigration of 
inflammatory cells from the blood.   
NO has recently been shown to directly interfere with the TGFβ signalling pathway by 
inhibiting TGFβ-induced phosphorylation of Smad2/3 in cultured vascular smooth muscle cells 
(Kanno, Into, Lowenstein, & Matsushita, 2008).  This direct effect of NO is cGMP-dependent and 
also results in inhibition of the differentiation of smooth muscle cells into osteoblasts (Kanno et 
al., 2008).  In a separate study comparing aortas from wild-type mice versus eNOS knockout 
mice, NO was shown to inhibit TGFβ signalling by enhancing the proteosomal degradation of 
Smad2  in a cGMP/protein kinase 1 (PKG-1) dependent fashion (Saura et al., 2005).  In addition, 
aortas from eNOS-deficient mice showed enhanced collagen type I expression (in addition to 
enhanced TGFβ1 expression and nuclear translocation of Smads) (Saura et al., 2005). 
 
3.4.1.3.3 Effect of NO on Valve Mechanical Properties 
As shown in our previous work, the valve endothelium can regulate aortic valve stiffness 
through NO-dependent mechanisms, which likely involve the contribution of valve interstitial 
cells (El-Hamamsy, Balachandran et al., 2009).  Changes in valve mechanical properties, 
particularly in valve stiffness can affect valve structure and function in 2 ways.  First, cusp 
compliance is an important factor determining the amount and distribution of stress on the 
cusps.  Thus, localized changes in cusp stiffness accompanied by elevated mechanical stresses 
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could result in repeated microtrauma, particularly during periods of high hemodynamic stress.  
Microtrauma can lead to disruption of the endothelial cell barrier as well as initiating active cell-
mediated dystrophic changes in the interstitial space.  Second, in vitro studies have recently 
demonstrated that the calcifying potential of valve interstitial cells is partly dictated by the 
stiffness of the surrounding matrix.  Aortic valve interstitial cells grown on non-compliant 
matrices (mimicking calcified valves) in osteogenic medium differentiated to myofibroblasts 
and formed calcified aggregates that contained apoptotic cells (Yip, Chen, Zhao, & Simmons, 
2009).  Interestingly, in that same study, cells grown on a compliant matrix readily formed 
calcified aggregates of viable cells that expressed osteoblast-related transcripts and proteins, 
suggesting that the myofibrogenic and osteogenic process in aortic valves might constitute 2 
distinct processes (Yip et al., 2009).   
ET-1 is often associated with pathological vascular and valvular remodelling.  We have 
previously shown that ET-1 can significantly increase the stiffness of aortic valves, which could 
be on the pathogenic mechanisms (El-Hamamsy, Balachandran et al., 2009).  In contrast, en-
dothelium-dependent NO release resulted in decreased stiffness of the cusps, possibly contrib-
uting to the significantly lower calcification potential of healthy aortic valves, and more import-
antly of the ventricular surface of the aortic valve, where NO is more readily synthesized, both 
at rest and with flow stimulation. 
3.4.1.3.4 NO and the Adrenergic System 
Aortic valves contain a rich and highly preserved network of afferent and efferent nerves, both 
intrinsic and extrinsic, whose role on valve structure and function remains poorly understood 
(El-Hamamsy, Yacoub et al., 2009).  We have recently demonstrated the presence of β2-
adrenergic receptors on valve interstitial cells from human aortic valves.  Furthermore, 
treatment with β2-adrenergic receptor antagonists significantly reduced the risk of interstitial 
cell osteogenic differentiation (Osman et al., 2007).  In a separate study examining the link 
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between NO and β-adrenergic stimulation, Hare et al. showed a direct effect of NO 
bioavailability on the inotropic response to β-adrenergic stimulation (Hare, Givertz, Creager, & 
Colucci, 1998).  Although this does not imply an effect of NO on β-adrenergic receptors in aortic 
valves, it represents a potential important area of investigation.  Indeed, no trials have yet 
looked at β-adrenergic receptor antagonists in animal models of subjects with early aortic valve 
calcification.  
 
3.4.2 Side-Selectivity of Aortic Valve Calcification 
In human calcified aortic valves, calcium nodules occur almost exclusively on the aortic surface 
of the cusp.  This has long been an intriguing finding which had, until recently, received little 
attention.  We believe that this side-selectivity is the combined result of several factors, some of 
which have already been discussed.  These include the fact that the ventricular side is exposed 
to high shear laminar flow during each ventricular ejection phase.  In contrast, the aortic surface 
is exposed to a low shear disturbed flow pattern, which is thought to cause endothelial 
activation, triggering a cascade of events leading to myofibroblast generation and osteoblast 
differentiation.  The different flow patterns also result in unequal NO production between cells 
from either side as shown in these experiments.  The increased release of NO from the 
ventricular side might play an important protective role.  In addition, the basic ECM 
composition differs significantly between both sides of the aortic cusp: the fibrosa and the 
ventricularis.  Indeed, as discussed in the Introduction, the fibrosa in particularly rich in 
collagen, whereas the ventricularis contains a high amount of elastin.  Although attempts have 
been made to analyze their individual mechanical properties, no definitive answer results are 
yet available (Stella & Sacks, 2007).  Nonetheless, in light of the role of matrix composition and 
stiffness on the potential of valve interstitial cells to calcify, it is likely that this may be an 
important contributor to the observed side-selectivity (Karien & Kristyn, 2009; Yip et al., 2009).  
It should also be emphasized that ECM acts as more than a scaffold.  It can also regulate the 
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activity and function of interstitial cells as has been shown in vascular walls.  This cross-
communication regulates many of the functions of interstitial cells in health and disease and 
explains the pathophysiology of vasculopathies in subjects with mutations in collagen or elastin 
(El-Hamamsy & Yacoub, 2009a).   
3.5 LIMITATIONS 
This study has several limitations.  Though the nodules obtained stain positively for Alizarin red 
staining, it remains to be determined whether this model represents a valid model of in vitro 
aortic valve calcification.  Nevertheless, the consistency and reproducibility of the results 
suggests that the observed results are indeed valid.  Porcine aortic valves are commonly thought 
to be resistant to calcification although this has never been formally studied.  The use of pig 
valves as a model of aortic valve calcification raises important questions.  Nevertheless, pig 
valves are very similar to human valves in terms of macro- and microstructure and 
hemodynamic environment.  Due to the ethical and practical difficulties of obtaining healthy 
human heart valves for research purposes, we believe that pig valves constitute a useful model 
for aortic valve calcification.   
 
3.6 CONCLUSION AND FUTURE DIRECTIONS 
In conclusion, this study demonstrates the role of endothelium-derived NO in regulating aortic 
valve calcification in a porcine model of in vitro calcification.  NO exerts a protective effect 
against the production of calcifying nodules in the valves.  Inhibition of NO production, a sign of 
endothelial dysfunction resulted in a significant increase in the rate and degree of aortic valve 
calcification.  In addition, results from this study suggest that the side-selectivity of aortic valve 
calcium nodules could be partly due to differences in basal and flow-stimulated NO production.  
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These findings suggest that NO supplementation using agents like L-arginine or 
tetrahydrobiopterin (BH4) might be beneficial in the treatment of subjects with early rather 
than late signs of aortic valve calcification.  Further work is also required to assess the 
mechanisms of action of NO on valve cells as well as the overall effect on valve function.  In 
addition, advanced chemical characterization techniques such a bio-Raman spectroscopy should 
be performed to assess the precise composition of in vitro nodules and compare them to native 
aortic valve calcification (Cloyd et al., 2010). 
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4.1 BACKGROUND 
The aortic valve lies in a unique hemodynamic environment which exposes it to a variety of 
mechanical stimuli including pressure, stretch, bending and shear stress (Figure 4.1).  These 
forces can reach very high magnitudes in absolute terms.  Considering the thickness of aortic 
valve cusps (300µm - 700µm), it is remarkable that the cusps function adequately while opening 
and closing uninterruptedly over 3 billion times in an average lifetime, in constantly varying 
hemodynamic conditions.   
 
Figure 4.1 - Schematic diagram showing the various forces exerted on aortic valve cusps during the 
cardiac cycle, consisting of stretch, pressure, bending and shear stresses. 
 
For a long time, the aortic valve was considered a passive structure that opens and 
closes in response to changes in ventricular pressure and its mechanics were only considered 
from an engineering standpoint.  However, recent findings into the complex interplay between 
valve cells, matrix, neural network and surrounding environment has generated new insights 
into valve mechanics both at a cellular level as well as tissue level.   
 Aortic valve biomechanics include several aspects such as cusp stiffness and 
instantaneous movements of the cusps.  These are thought to have important clinical 
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implications both in health and disease.  In this chapter, we will focus on aortic valve stiffness as 
a key component of valve mechanical properties.  Changes in cusp stiffness can potentially 
modulate several parameters such as the pattern of flow in the aortic root which dictates 
coronary flow, particularly in systole (J. E. Davies et al., 2008) as well as stress distribution on 
the surface of the individual cusps (Grande-Allen, Cochran, Reinhall, & Kunzelman, 2001).  
Aortic valves can translate mechanical cues into biological stimuli, a process termed 
mechanotransduction, leading to changes in cell proliferation and migration, apoptosis and 
matrix remodelling.  Changes in cusp stiffness therefore hold the potential of modulating the 
response of the aortic valve to mechanical stimuli and allow it to adapt to varying hemodynamic 
conditions. 
 Stiffness of the aortic valve cusps can be measured by deriving the Young’s modulus 
from the stress-strain relationship of the tissue, as shown in these experiments.  Thus far, 
studies examining the mechanical properties of aortic valves have determined that aortic valve 
cusps possess properties of viscoelastic materials (Billiar & Sacks, 2000a, 2000b; Stella, Liao, & 
Sacks, 2007).  Another important property of aortic valve cusps is anisotropy.  Anisotropy is the 
property of having directionally dependent mechanical properties, which in the case of the 
aortic valve refers to the radial and circumferential axes of the cusps.  Indeed, it has been shown 
that aortic valve cusps are significantly stiffer in their circumferential axis than the radial one.  
This could be due to the specific content and alignment of ECM proteins or cells in each axis, as 
will be discussed later.  Because both axes of the aortic valve are part of a single unit, they 
inevitably influence each other in an inter-dependent manner.  Nevertheless, published reports 
have thus far predominantly analyzed aortic valve cusps one axis at a time, using uniaxial tensile 
testing methods.  In addition, most studies have mainly focused on the baseline mechanical 
properties of the cusps, leaving aside the potential contribution of its cellular components.   
 As discussed earlier, the endothelium forms a monolayer on the surface of aortic valve 
cusps and as such is exposed to all mechanical stimuli including shear stress.  It is now well 
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accepted that valve endothelial cells have unique signalling and gene expression profiles, 
different from endothelial cells in other parts of the body, including aortic-derived vascular 
endothelial cells (Butcher & Nerem, 2006; Butcher et al., 2004; Farivar et al., 2003).  While in 
the vasculature, endothelial cells are responsible for regulating vascular tone, the role of valve 
endothelial cells on valve mechanical properties remains completely undetermined.  As 
mentioned in our hypothesis, the definition of a living structure is its capacity to adapt its 
structure and function in response to different stimuli. 
 
4.1.1 Aims  
The aims of this series of experiments is to evaluate the mechanical properties of aortic valve 
cusps using a biaxial micromechanical tensile testing apparatus.  Importantly, the capacity of the 
cusp to modify its mechanical properties in response to various stimuli will be specifically 
examined, with a particular focus on the role of endothelium-derived signals.  
 
4.2 METHODS 
4.2.1 Tissue Procurement 
Porcine hearts (18-24 months) were obtained from a commercial slaughterhouse (Cheale 
Meats, UK).  Hearts were immediately placed in a cold Hanks solution prior to transport.  All 3 
aortic cusps were then isolated from each heart by careful dissection, ensuring minimal 
manipulation of the cusp surface to avoid damaging the endothelial cells.  Aortic cusps were 
placed in ice-cold Kreb’s buffer solution (in mM: KCl 2.7, NaCl 136.9, CaCl2 2.5, NaHCO3 11.9, 
NaH2PO4 0.4, MgCl2 2.5, Dextrose 11.1, Na2EDTA 0.04) and used within 12 h of sacrifice. A 
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square-shaped cutter was used to isolate identical 10 x 10 mm sections from the “belly” of each 
cusp in a radial-circumferential direction (Figure 4.2).  
 
Figure 4.2 - Figure showing the belly region of the aortic valve cusp (grey) which was used for all 
mechanical testing experiments.  The radial and circumferential axes were noted for each cusp to 
evaluate tissue anisotropy 
 
4.2.2 Biaxial Micromechanical Testing System 
The Bose micromechanical tensile testing system (Bose Electroforce, Eden Prairie, MN) allows 
for the evaluation of the mechanical properties of a solid structure through a variety of 
protocols.  It is composed of 4 orthogonally-placed load-cells which can be individually 
controlled.  The motors can be used under load control or strain control, ie, controlling the 
amount of tension applied to a tissue or the degree of “stretch”.  By performing controlled 
experiments, stress-strain relationship of the tissue can be determined, which forms the basis 
for determining the elastic modulus of the tissue.  The Bose system allows applying and 
measuring biaxial data, which in our case, provides specific data for the circumferential and 
radial axes separately, all the while taking into account the interdependence of tissue mechanics 
in both directions.  Figure 4.3 shows a representative stress-strain curve from a porcine aortic 
valve illustrating 2 important elements.  First, the anisotropic nature of aortic valve cusps, ie, 
the mechanical properties of the tissue vary significantly between both axes.  Second, it 
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illustrates a typical stress-strain curve, which can be decomposed into 3 parts: the toe, the 
transition and the linear region.  To derive the elastic modulus of a given tissue, data from the 
linear region of the stress-strain relationship is used.   
 
Figure 4.3 – Representative figure showing typical stress-strain relationship in an aortic valve cusp 
in the radial and circumferential direction.  The anisotropic nature of aortic valve cusps is 
illustrated by the differences in elasticity between both directions.  As shown, circumferential 
stiffness is significantly higher than radial stiffness (load increases rapidly with strain increments).  
In addition, this figure illustrates the 3 phases of stress-strain curves, with the linear phase being 
the region used to derive the elastic modulus (stiffness). 
 
4.2.3 Experimental Protocol 
Stainless steel springs (McMaster-Carr, Atlanta, GA) were threaded through each side of the 
leaflet sections.  Care was taken to preserve the valve endothelium while mounting the springs.  
Four dots were marked on the central region of the specimen forming a square. The specimens 
were then mounted in a biaxial micromechanical testing device (Bose Electroforce, Eden Prairie, 
MN) in a Kreb’s bath maintained at 37°C and continuously gassed with 95% O2 / 5% CO2 (Figure 
4.4).  
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Figure 4.4 – Overhead picture showing a square sample of aortic valve belly region mounted 
between the four loads of the Bose biaxial tensile testing system using springs passed through all 
four edges of the cusp and hooked to hooks attached to the load cells. 
 
The pH of the solution was tested before and after every experiment and held constant between 
7.35 and 7.45.  Strain gauge force transducers (Bose Electroforce®) were mounted along the 
two orthogonal axes to continuously monitor the changes of force in the radial and 
circumferential directions. A single camera two-dimensional measuring system (Bose 
Electroforce®) was used to track the movement of the four dots, measuring real-time strains on 
the specimen (Figure 4.5). Samples were initially allowed to stabilize in the bath for 5 min 
before being preloaded to 10 mN. In order to maintain the stability of the entire setup, all 
protocols were conducted under displacement control. All mechanical tests were conducted 
equibiaxially. 
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Figure 4.5 – Photograph showing the overall setup for the Bose micromechanical tensile testing 
system.  The sample is placed in the test chamber in a Krebs solution maintained at 37C.  The 
solution is continuously oxygenated by inserting a cannula in the bath, attached to an oxygenator.  
The load cells are separately controlled to apply equibiaxial strain on the tissue.  Tissue 
deformations are recorded by an overhead high-resolution camera and transmitted to a computer 
monitor where live data is readily displayed. 
 
Aortic valve physiological load was estimated using Laplace’s law for cylinders (T=Pr), where T 
is mean valve membrane tension, P is transvalvular pressure and r is radius. A transvalvular 
pressure of 80mmHg (106.7 kPa) was used.  Figure 4.6 illustrates the experimental protocol.  
Each sample was first preconditioned to this level at a frequency of 0.1 Hz for twenty cycles to 
allow the load-strain response of the valve to become repeatable. If the mechanical data at this 
point were not consistent, the specimen was subjected to twenty further preconditioning cycles. 
Following this, three cycles of load versus strain measurements were recorded (baseline elastic 
modulus). The sample was then stretched to 55 N/m (half the maximum physiological load) on 
both its axes to approximate diastolic conditions, and allowed to relax with the load held 
constant for 10 min. The tissue was then challenged with increasing concentrations of the 
selected vasoactive agent while load measurements were carried out every 0.1 s. Three more 
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cycles of load versus strain were then recorded and the resultant elastic modulus was compared 
to baseline. Thus, each sample served as its own control.  Each sample served as its own control 
and was used only once. Load data was plotted against areal strain (calculated using the radial 
and circumferential strains obtained above) for baseline and treated groups. Percentage change 
in cusp stiffness in response to different agents is reported.  
 
 
Figure 4.6 – Diagram illustrating the experimental protocol.  After mounting the cusps in the test 
chamber, they were preconditioned through a series of 20 strain cycles.  Baseline stress-strain was 
then measured by averaging 3 cycles.  The tissue was then stretched to 50% of maximal load, then 
allowed to reach equilibrium over a period of 10 minutes, and increasing concentrations of a 
specific mediator were added to the Krebs solution.  Tissue contractions or relaxations were 
measured during that period.  This was then followed by another series of 3 cycles of stress-strain 
to measure the post-exposure elastic modulus of the tissue. 
 
4.2.3.1 Evaluation of Tissue Stiffness 
To account for the coupling between the radial and circumferential axes in determining valve 
mechanical properties, areal strain was used as a measure of cusp tissue stiffness.  Areal strains 
are calculated by incorporating simultaneously measured radial and circumferential strains as 
Chapter 4 
   139 
detailed below.  The gradient of the linear portion of the load-areal strain curve was used as a 
measure of the stiffness/modulus of the valve leaflet. This is the region where the collagen 
fibers are fully uncrimped and the load-bearing components of the valve cusp are recruited. In 
the following sections, the terms stiffness, modulus and elastic modulus are used 
interchangeably.  
Areal Strain Calculation 
Areal (Green’s) strain: EA = ½ ([λRλC]2 – 1) 
λR =  (2ER + 1) ½ 
λC =  (2EC + 1) ½ 
λR = Radial stretch ratio  
λC = Circumferential stretch ratio  
EC = Radial (Green’s) strain 
ER = Circumferential (Green’s) strain 
 
 
4.2.3.2 Evaluation of Contraction and Relaxation Responses 
Contraction and relaxation responses of the tissue were also measured to evaluate 
concentration-dependent tissue responses to the addition of various endothelial-dependent 
mediators. 
 
4.2.4 Study Groups 
4.2.4.1 Experimental Groups 
Aortic valve cusps were randomly allocated to four different groups according to the vasoactive 
agent used: 5-HT (10-8 to 10-5M; n=6; Sigma-Aldrich, UK), ET-1 (10-10 to 10-8M; n=6; Sigma-
Aldrich, UK), sodium nitroprusside, (SNP; 10-7 to 10-5M; n=6; Sigma-Aldrich, UK), and control 
(n=4).  5-HT was chosen for several reasons: it has been shown to induce nitric oxide (NO) 
release from coronary endothelium (Tschudi, Richard, Buhler, & Luscher, 1991).  Additionally, 
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5-HT receptors have previously been characterized in aortic valve tissue (Roy, Brand, & Yacoub, 
2000), and importantly 5-HT is also capable of inducing valve contractions (Chester, Misfeld, & 
Yacoub, 2000) by inducing release of intracellular calcium in valve interstitial cells (Taylor et al., 
2000).  Therefore, it is perfectly suited to evaluate relaxation or contraction responses in aortic 
valves.  ET-1 is an endothelium-derived peptide that has previously been localized in valvular 
endothelial cells (Misfeld, Morrison, Sievers, Yacoub, & Chester, 2002).  Each tissue section was 
only exposed to a single vasoactive agent to avoid interactions between various agents. 
 
4.2.4.2 Role of the Endothelium 
The role of the endothelium was evaluated by pharmacological and mechanical means.  Cusps 
were exposed to L-NAME (100 µM; Sigma, UK), a nitric oxide synthase inhibitor, to evaluate the 
role of endothelial-derived NO responses (n=4) .  In other cusps, the endothelium was 
mechanically removed using a cell-scraper as previously described in Chapter 2, before 
exposing the tissue to vasoactive agents (denuded group; n=4).   
 
4.2.4.3 Contribution of Interstitial Contractile Responses 
In order to evaluate the contribution of interstitial cell contractions to changes in cusp 
mechanical properties, specimens (n=4) were incubated for 4 hours in cytochalasin B (CyB; 2 
µM; Sigma-Aldrich, UK), an actin depolymerizing agent, prior to testing (Carter, 1967). 
 
4.2.4 Tissue Imaging 
Valve cusps were fixed in formalin and stained for von Willebrand factor (endothelial cells) and 
smooth muscle α-actin ([SMA]; smooth muscle cells) to evaluate the integrity and distribution of 
the endothelium before and after testing (as previously described).  Intact and denuded 
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specimens were fixed in glutaraldehyde and scanning electron microscopy was also performed 
to assess cellular composition. 
 
4.2.5 Statistical Analysis 
Data are expressed as mean ± standard error.  For each valve specimen, the percentage change 
in load from pre-test values was calculated in the radial and circumferential axes, as a function 
of the vasoactive agent concentration. Mixed effect models were used to account for the 
correlation between measurements in the radial and circumferential directions and between 
repeated measurements in each valve specimen (the MIXED procedure in SAS software, version 
9.1; SAS Institute, Cary, NC). Valve percentage changes in load versus control, were tested in 
order to assess if any of the mean responses were different from control.  If this test was 
significant, we tested the percentage change at each concentration using a Dunnett correction.  
To further characterize the concentration-response relationship, more parsimonious models 
were fitted using linear trend over the log of the concentrations with or without an interaction 
term, i.e. allowing different slopes for the linear trend in radial and circumferential directions. 
Additionally, 2-sided Student t-tests for independent samples were used to compare the 
changes in elastic modulus between groups.  P values < 0.05 were considered statistically 
significant.  The statistical analyses were performed using SAS version 9.1.   
 
4.3 RESULTS 
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4.3.1 Cellular Integrity of the Cusps Before and After Experiments 
4.3.1.1  Endothelium 
Endothelial integrity of all aortic valve cusps was assessed by immunohistochemistry.  In 
addition, electron microscopy was performed on randomly selected specimens to ensure 
presence of the endothelial monolayer.  Figure 4.7A is a representative section showing positive 
vWF staining, a marker of endothelial cells whereas as Figure 4.7B is an electron micrograph 
showing preserved endothelial cell integrity on the cusp surface after biaxial testing. 
 
Figure 4.7 - A) Histological section (original magnification x40) showing preservation of the 
endothelial cells after biaxial testing by positive von Willebrand factor staining (brown). B) 
Scanning electron micrograph (x1000) of aortic cusp before biaxial testing, showing preserved 
endothelial monolayer (Note: areas of apparent endothelial denudation are due to air drying of 
specimens with hexamethyldisilazane. Both ridges of the endothelium are juxtaposable). 
 
lectron micrographs were also performed on all cusps undergoing mechanical denudation.  If 
more than 10% of the cusp surface was covered by intact endothelial cells, cusps were 
dismissed from analysis (n=0).  Figure 4.8 shows a representative cusp following mechanical 
denudation of the endothelium.  Only the underlying matrix is apparent. 
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Figure 4.8 - Scanning electron micrograph of a mechanically denuded aortic valve cusp showing 
complete absence of endothelial cells and intact subendothelial matrix (x500). 
 
4.3.1.2  Smooth Muscle Cells 
All cusps showed intact SMA expression before testing. No differences in expression or 
distribution of SMA were observed after stretching, including in cusps presenting contractile 
responses (Figure 4.9). 
 
Figure 4.9 – A) Representative immunohistochemical analysis of smooth muscle α-actin (SMA) 
expression before stimulation with ET-1 (x20); B) SMA expression after stimulation with ET-1 
showing no changes in overall SMA expression (x20). 
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4.3.2 Endothelial Regulation of Aortic Valve Relaxation and Contraction 
4.3.2.1  Endothelial-Dependent Relaxation 
When challenged with 5-HT, the valve specimens relaxed in a concentration-dependent manner 
(-0.29% ± 0.1% change in load per 10-fold increase in 5-HT concentration; p=0.03; Figure 4.10). 
 
Figure 4.10 - Concentration-dependent changes in contraction or relaxation (±SE) of porcine aortic 
valve cusps in the radial and circumferential directions in response to 5-HT alone.  
* Dunnett-adjusted p<0.05 vs. control    
** Dunnett-adjusted p<0.01 vs. control 
 
In the denuded specimens (Figure 4.11), the cusps exhibited significant concentration-
dependent contractions to 5-HT in both axes (+0.29% ± 0.06% change in load per 10-fold 
increase in 5-HT concentration; p=0.02).   
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Figure 4.11 - Concentration-dependent changes in contraction or relaxation (±SE) of porcine aortic 
valve cusps in the radial and circumferential directions in response to 5-HT following mechanical 
endothelial denudation of the cusps.   
* Dunnett-adjusted p<0.05 vs. control    
** Dunnett-adjusted p<0.01 vs. control 
 
 
Similarly, in the presence of L-NAME, the cusps exhibited a significant concentration-
dependent contraction in response to 5-HT in both axes (Figure 4.12).  
 
Figure 4.12 - Concentration-dependent changes in contraction or relaxation of porcine aortic valve 
cusps in the radial and circumferential directions in response to 5-HT in the presence of L-NAME, a 
specific inhibitor of NOS.  
* Dunnett-adjusted p<0.05 vs. control    
** Dunnett-adjusted p<0.01 vs. control 
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4.3.2.2  Endothelial-Independent Relaxation 
Valve specimens relaxed in a concentration-dependent fashion when challenged with SNP 
confirming the capacity of contractile cells to relax (p=0.02; data nor shown).  
 
4.3.2.3  Tissue Contractility 
Aortic valve cusps significantly contracted in response to increasing concentrations of ET-1 
(+0.29% ± 0.08% change in load per 10-fold increase in ET-1 concentration; p=0.02; Figure 
4.13A). When valve specimens were pre-incubated in CyB, the contractile response to ET-1 was 
mitigated (Figure 4.13B). 
 
Figure 4.13 - Concentration-dependent changes in contraction or relaxation of aortic cusps in the 
radial and circumferential axes in response to A) ET-1 and B) ET-1 + cytochalasin B, an inhibitor of 
actin polymerization.   
* Dunnett-adjusted p<0.05 vs. control    
** Dunnett-adjusted p<0.01 vs. control 
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4.3.3 Aortic Valve Stiffness 
4.3.3.1  Baseline Aortic Valve Stiffness 
Baseline stiffness was evaluated for 4 initial groups with respect to areal strain: control, 
endothelial denudation, L-NAME alone, and CyB alone (Table 4.1).  Mean baseline stiffness for 
control aortic cusps was 0.82±0.08 kN/m.  The modulus was not affected by endothelial 
denudation (0.72 ± 0.09 kN/m; p=0.4 vs. control) nor by the addition of L-NAME (0.66±0.18; 
p=0.5 vs. control).  Addition of CyB to control cusps significantly reduced the baseline stiffness 
compared to control (0.36±0.11; p<0.05 vs. control). 
Table 4.1 Baseline aortic valve elastic modulus in the radial and circumferential axes and following 
treatments with L-NAME, endothelial denudation and CyB.  
 Circumferential (kN/m) Radial (kN/m) 
Normal (n=6) 3.47±0.38 0.97±0.11 
L-NAME alone (n=4) 1.73±0.17 1.30±0.22 
Denuded leaflet (n=4) 2.13±1.05 1.00±0.30 
CyB alone (n=4) 3.32±0.99 1.16±0.12 
 
 
4.3.3.2  Endothelial Regulation of Uniaxial Aortic Valve Elastic Modulus 
Individual variations in the radial and circumferential moduli in response to various stimuli are 
presented in Table 4.2.  Tissue stiffness was significantly decreased by 5-HT in both the 
circumferential and radial directions (-28.3 ± 7.6% and-16.1 ± 5.4% versus control, 
respectively).  In endothelium-denuded aortic valve cusps, addition of 5-HT resulted in a 
significant increase in the circumferential elastic modulus (+19.4. 1% versus control) and trend 
towards increased stiffness in the radial direction (+8.1 ± 5.6% versus control).   Similarly, in 
the presence of L-NAME, there was a marked increase in the circumferential elastic modulus 
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(+58.3 ± 9.4% versus control), however was no significant change was observed in the radial 
direction (-4.6 ± 5.8% versus control).   
Table 4.2 - Percentage change from baseline of aortic valve elastic modulus in the 
radial and circumferential axes following treatment with 5-HT alone, 5-HT following 
L-NAME administration and 5-HT following endothelial mechanical denudation. 
 Circumferential Radial 
5-HT (n=6) -28.3±7.6 % -16.1±5.4 % 
5-HT + Denudation (n=4) +19.9±4.1 % +8.1±5.6 % 
5-HT + L-NAME (n=4) +58.3±9.4 % -4.6±5.8 % 
 
4.3.3.3  Role of the Contractile Elements on Uniaxial Aortic Valve Elastic Modulus 
Addition of ET-1 to aortic valve cusps resulted in a significant increase in tissue elastic modulus 
in both the circumferential (+21.4 ± 6.4% versus control) and the radial directions (+19.6 ± 
4.7% versus control).  Addition of CyB to inhibit actin polymerization resulted in a decrease in 
stiffness in both axes individually (-12.1 ± 4.6% versus control in the circumferential axis and -
19.5 ± 2.1% in the radial axis) (Table 4.3). 
Table 4.3 - Percentage change from baseline of aortic valve elastic modulus in the 
radial and circumferential axes following treatment with ET-1 and ET-1 + CyB, an 
inhibitor of actin polymerization. 
 Circumferential Radial 
ET-1 (n=6) +21.4±6.4 % +19.6±4.7 % 
ET-1 + CyB (n=4) -12.1±4.6 % -19.5±2.1 % 
 
4.3.3.4  Overall Changes in Aortic Valve Stiffness 
As mentioned in the introduction, due to the interdependence between both the radial and 
circumferential axes of the aortic valve, it is necessary to evaluate total areal strain which is a 
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measure of overall tissue stiffness.  Using the same study groups, changes in aortic valve 
stiffness were compared to normal controls.  Figure 4.14 demonstrates changes in tissue 
stiffness following different study protocols.  Addition of 5-HT alone results in a decrease of 
stiffness by 25.0 ± 4.0% (p<0.01 vs. control).  In contrast, in endothelium-denuded specimens, 
addition of 5-HT resulted in a significant increase in cusp areal strain compared to control 
(+14.7 ± 1.8%; p<0.05 vs. control).  Similarly, when L-NAME was present in the tissue bath, 
there was a trend towards an increase in cusp areal strain after addition of 5-HT (+17.5 ± 5.3%; 
p=0.07 vs. control).  Furthermore, the changes in elastic modulus in response to 5-HT in 
denuded cusps or after addition of L-NAME were each statistically different from the changes 
following addition of 5-HT alone (both p<0.01).  ET-1 significantly increased the areal stiffness 
of aortic valve cusps (+34.4 ± 13.8%; p<0.05 vs. control).  After incubation of the cusps in CyB, 
addition of ET-1 did not result in a significant difference in cusp stiffness (p=0.29 vs. control).  
However, direct comparison of changes following ET-1versus ET-1 and CyB was statistically 
significant (p<0.05). 
 
Chapter 4 
   150 
 
Figure 4.14 - Percentage change in aortic valve areal strains versus control in response to 
various agents.  The percentage change in areal strain (±SE) of aortic cusps (normal and 
denuded) in response to the various vasoactive agents and their inhibitors.  Areal strains were 
measured before and after addition of the compounds (each valve served as its own control). 
* Dunnett-adjusted p<0.05 vs. control   
**  Dunnett-adjusted p<0.01 vs. control 
#  Dunnett-adjusted p<0.1 vs. control 
†  p<0.05 vs. ET-1 alone 
††  p<0.01 vs. 5-HT alone 
 
4.4 DISCUSSION 
Findings from the present series of experiments provides evidence for the critical role of 
endothelial-derived NO in regulating the stiffness of aortic valve cusp under physiological 
loading conditions.  In addition, this work demonstrates direct communication by paracrine 
mechanisms between endothelial-derived NO and underlying valve interstitial cells, in 
particular SMA-positive cells.  These findings represent the first evidence of the presence of 
active cell-mediated pathways regulating valve mechanical properties.   
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4.4.1 Rationale for Study Design 
4.4.1.1 Choice of Mediators 
The endothelium releases a number of bioactive substances in vivo, notably NO and ET-1.  
Whereas NO is a smooth muscle relaxant, ET-1 is a one of the most potent endogenous 
vasoconstrictor peptides causing contraction of smooth muscle cells via stimulation of specific 
receptor subtypes (Yanagisawa et al., 1988).  ET-1 is stored and released by endothelial cells, a 
process strongly controlled (inhibited) by NO under normal conditions (Boulanger & Luscher, 
1990; Luscher et al., 1990), creating a balance between both mediators.  There are 2 ET 
receptors: ETA and ETB receptors.  Both endothelial cells and smooth muscle cells have 
receptors to ET-1 and both receptors subtypes have been shown to be functional in aortic 
valves (Misfeld et al., 2002).  Use of exogenous ET-1 serves to demonstrate the effect of this 
peptide if released in high quantities by endothelial cells such as observed in pathological 
conditions associated with aortic valve disease such as coronary artery  
In this study, 5-HT was used to stimulate NO release by endothelial cells (Shimada et al., 
1999; Tschudi et al., 1991; Vanhoutte, 1991).  There are multiple known 5-HT receptor 
subtypes, a number of which have been characterized in aortic valve tissue (Rothman et al., 
2000; Roy et al., 2000).  They can be present on endothelial cells as well as smooth muscle cells.  
The overall effect of 5-HT stimulation represents the balance of receptor stimulation in both 
types of cells.  With the addition of L-NAME however, the non NO-dependent effects of 5-HT was 
highlighted.  Interestingly, this showed that under the present experimental conditions, it 
appears that the endothelium does not release basal NO or keep the tissue in a constitutively 
relaxed tone as evidenced by the absence of change in valve stiffness after pharmacological 
inhibition or mechanical denudation of the endothelium.  However, after addition of 5-HT under 
these conditions, valve responses are reversed.  The observed increase in stiffness suggests that 
5-HT acts on normal endothelium by inducing a release of NO.  By inhibiting NO synthesis, the 
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direct effect of 5-HT on valve interstitial cells is left unopposed and results in valve contraction 
and stiffening. 
4.4.1.2 Experimental Setup 
Though the experimental setup is not perfect to reproduce the full mechanical environment of 
aortic valves, it represents significant progress compared to previously published experimental 
models in terms of the actual study protocol (Merryman, Huang, Schoen, & Sacks, 2006; Stella et 
al., 2007; Stella & Sacks, 2007).  Hearts were immediately placed in cold preservation solution 
following explantation.  Aortic valve cusps were dissected and handled gently to avoid injuring 
the endothelium.  Unlike other studies where experiments were performed in the days 
following animal sacrifice, all experiments were performed within 12 hours in this case, which 
we think has an important role in preserving cell-mediated responses.  In addition, the organ 
chamber was filled with oxygenated Krebs solution maintained at 37C and at physiological pH.  
These elements are worth mentioning because they could individually or collectively account 
for differences in observations between various studies in the literature.   
 Nevertheless, the model fails to address several mechanical and hemodynamic elements 
which are relevant in vivo such as shear stress, bending and blood viscosity among other 
factors.  These various components can each activate the endothelium into releasing different 
mediators through specific mechanotransduction pathways.  Thus, the overall state of the aortic 
valve cusp in vivo remains to be defined.  In order to do so, we are currently collaborating with a 
team of engineers from the Georgia Institute of Technology to develop a bioreactor which would 
combine both stretch and shear stress through flow.   
 In this study, the belly region from each aortic valve cusp was used to assess mechanical 
properties of the aortic valve.  The choice of the belly region was related to the fact that it is the 
major load-bearing region of the cusp (Grande-Allen et al., 2000; Grande et al., 1998).  However, 
histological analyses of aortic valve cusps often show a non-homogeneous distribution of 
interstitial cells, particularly SMA-positive cells (data not presented), which are predominantly 
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found closer to the base of the cusps.  Thus, global mechanical properties of the valve could be 
ascertained through an in vivo model using microsonometric crystals, as was previously used to 
evaluate the 4-dimensional dynamics of the aortic root (Dagum et al., 1999; Lansac, Lim, 
Shomura, Lim, Rice et al., 2002).  
4.4.2 Physiological Significance of Changes in Valve Stiffness 
The precise physiological significance of changes in aortic valve stiffness are yet to be fully 
determined.  It remains however undoubtable that a living valve capable of adapting its 
structure and function to the surrounding environment bears major clinical importance, both in 
terms of patient quality of life, survival as well as the ability of the cusps to withstand major 
hemodynamic forces over many years.  Changes in stiffness can optimize stress distribution 
across the surface of the cusps.  Although the belly region is thought to be the major load-
bearing region, in the absence of regulation of the mechanical properties of the cusps, this might 
be accentuated, which can inevitably lead to cellular and molecular changes.  Indeed, one can 
speculate that early valve calcification observed in some patients with bicuspid aortic valves 
could be in part due to the inability of the cusps to adapt their stiffness to changing 
hemodynamic and humoural conditions due a deficiency in eNOS (Aicher et al., 2007; Lee et al., 
2000).   Changes in valve mechanical properties can also be beneficial in hypertensive patients 
with high diastolic pressure.  Increasing the stiffness of the cusps could maintain an adequate 
surface of coaptation and ensure valvular competence despite the elevated afterload.   
Along with the aortic annulus, the sinuses of Valsalva ad the sinotubular junction, aortic 
valve cusps are one of the component parts of the aortic root.  These different parts operate in 
harmony to ensure adequate function of the aortic root, thereby minimizing ventricular 
workload and optimizing coronary flow (J. E. Davies et al., 2008; M. H. Yacoub, Kilner, Birks, & 
Misfeld, 1999).  Because of the extreme mechanical forces in that region, tissue stress is 
distributed between the sinuses and the cusps (Grande-Allen et al., 2000; Katayama et al., 2008; 
Robicsek & Thubrikar, 1999; M. J. Thubrikar, Nolan et al., 1986).  Therefore, the stiffness of the 
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cusps could have a direct impact on the function of the sinuses of Valsalva and the magnitude of 
stresses at that level, which could contribute to changes in its structure (El-Hamamsy & Yacoub, 
2009a), such as observed in bicuspid aortic valve disease for instance (El-Hamamsy & Yacoub, 
2009b).  Indeed, Grande-Allen et al. (Grande-Allen et al., 2001) showed that with every change 
in leaflet dimension, elastic modulus and surface of coaptation, there is a significantly altered 
distribution of strains over the aortic leaflet with a marked increase at the free edge. This 
increase in strain is thought to contribute to the observed aortic regurgitation in these patients.     
An important consideration for in vivo mechanical properties is that the half-life of NO in 
the cellular environment is very short and thus it may have an impact on the beat-to-beat regu-
lation of valve biomechanics.  On the other hand, ET-1, which has much longer duration of action 
is more likely to affect the general tone of the valve, allowing it to adapt to its environment over 
a longer period of time.  In addition, the impact of other endothelial-derived  mediators such as 
prostacyclin and endothelium-independent mediators certainly have an impact on valve mech-
anics.  Therefore, the true functional significance of these findings will be fully understood once 
4 - dimesional functional imaging techniques which can track the instantaneous movements of 
the cusps and changes in Young’s modulus are available. 
4.4.3 Link Between Tissue Relaxation/Contraction Responses and Tissue Stiffness 
One of the striking findings of our study was the significant disproportion between the 
magnitude of tissue relaxation or contraction responses to the different treatment conditions 
(<5%) and the magnitude of changes in cusp stiffness (up to 35%).  It is likely that both sets of 
responses are related to each other since in all cases, relaxation responses resulted in a 
decrease in tissue stiffness and vice versa.  The small magnitude of relaxation/contraction 
responses is physiologically expected since larger responses would in effect compromise valve 
function by reducing coaptation.  However, the large changes in stiffness were unexpectedly 
large.  From a mathematical standpoint, this might be explained by the fact that tissue stress (σ) 
is inversely proportional to the surface area (A) of the tissue (σ ∞ 1/A). Therefore, small 
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changes in the leaflet area (A) through contraction or relaxation cause much larger changes in 
stresses and consequently in the elastic modulus.  Nevertheless, this could not explain the full 
extent of the response.  Tissue contraction or relaxation is a result of cellular contractions or 
relaxations in response to ET-1 or NO.  Changes in tissue stiffness are thought to be the result of 
changes in cell-cell interactions or cell-matrix interactions in response to the various agents.  
This could be evaluated by assessing the number and distribution of cell adhesions.  As it is now 
well understood that interstitial cells are intimately linked to the ECM through the cytoskeleton, 
it is likely that changes in cell shape or tone would also affect the ECM proteins.  The differential 
changes in stiffness between the radial and circumferential directions strongly suggests that 
these factors are operative, in light of the specific orientation of collagen and elastin fibers in 
both axes.  It is hoped that current work using scanning ion conductance microscopy on valve 
interstitial cells following addition of different mediators could shed light into the underlying 
mechanisms. 
4.4.4 Clinical Significance of Current Findings 
The current findings introduce a new paradigm into the role of the endothelium in aortic valve 
pathology.  It is well accepted that endothelial damage or dysfunction – through the loss of anti-
inflammatory and anti-oxidant mediators - is an early occurrence in the cascade of events 
leading to structural valve disease (Otto et al., 1994).  This work suggests that endothelial 
dysfunction can additionally result in changes in mechanical responses to different stimuli, 
which could potentially contribute to the pathophysiology of valve disease.  In our experiments, 
following pharmacological inhibition or mechanical denudation of the endothelium, changes in 
valve elastic modulus in response to endogenous mediators was significantly altered.  As 
mentioned earlier, this may expose specific regions of the cusps to abnormally high stresses, 
increasing the risk of local microtrauma, which in turn leads to further endothelial damage and 
structural degeneration.  A loss of the capacity of aortic valves to adapt to their mechanical 
environment can significantly compound and possibly accelerate structural valve degeneration.   
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 Aside from its role as an endothelium-dependent agonist, 5-HT has been directly linked 
to valve pathologies, namely the carcinoid syndrome (Rajamannan et al., 2001) and secondary 
to treatment with fenfluramine and phentermine, two appetite suppressants which have since 
been withdrawn by the Food and Drug Administration (FDA) (Connolly et al., 1997; Gustafsson 
et al., 2005).  In both instances, 5-HT appears to play an important role in valve pathology.  The 
valvular pathologies reported in both these entities have focused on the structural changes in 
the valves which include plaque-like encasement of the leaflets and chordal structures (Connolly 
et al., 1997).  Although these are the major determinants of disease manifestation, no studies 
have evaluated the mechanical properties of these valves, but in light of our findings, they are 
expected to be altered which can have an important on their function and response to changing 
hemodynamics. 
4.5 LIMITATIONS OF THE STUDY 
The local mechanical and hemodynamic environment of the aortic valve is extremely complex 
which makes any attempt at studying these factors ex vivo a major challenge.  The current study 
represents one such example and at best, constitutes an approximation of the actual in vivo 
loading conditions.  However, while actual values of the mechanical parameters may differ from 
in vivo values, ex vivo mechanical testing offers the advantage of being extremely sensitive to 
small changes between test groups, and is ideal for a study of this nature. In this report, we 
focused on the immediate changes related to administration of different mediators.  This acute 
experimental setup does not account for the trophic effects of these agents or their ability to 
modulate the extracellular matrix following longer exposure (Hafizi, Taylor, Chester, Allen, & 
Yacoub, 2000; Jian et al., 2002).  Finally, in vivo, aortic cusps are simultaneously exposed to a 
number of mechanical stimuli in addition to strain, such as bending and shear stress.  Our 
present experimental setup does not yet allow us to combine these stimuli into a single setup.  
Nevertheless, decomposing the response of valve cusps to each stimulus is useful in singling out 
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their unique effects on the tissue.  The biaxial testing system used in this work has 2 major 
limitations: the volume of medium required for each experiments is relatively high (~200mL) 
and chronic experiments (>24 hours) are difficult because it is only a semi-sterile system.  The 
total volume represents an obstacle if one is to study the effect of expensive molecules such as 
TGFβ1 on valve mechanical properties, a study which would be particularly helpful considering 
its effect on valve pathophysiology. 
4.6 CONCLUSION AND FUTURE DIRECTIONS 
In conclusion, we have demonstrated that the mechanical properties of aortic valve 
cusps are actively regulated through endothelial-dependent pathways.  The valve endothelium 
exerts its effects by modulating aortic valve cusp relaxation and contraction to different 
mediators, but most importantly by regulating the changes in the stiffness of the cusps.  Changes 
in valve mechanical properties, especially its elastic modulus, could explain the unique ability of 
aortic valves to withstand severe mechanical stresses during each cardiac cycle.  These findings 
introduce a new paradigm in the understanding of aortic valve disease in patients with risk 
factors associated with endothelial dysfunction.  In addition, they further our understanding of 
valve physiology and establish a more complete blueprint of adaptive responses of valve 
mechanical properties for future tissue-engineered heart valves. 
Further work is required to assess the effects of these changes on the function of the 
valves in an in vivo setting.  Work from another group looking at the mechanics of the mitral 
valve in an in vivo ovine model was performed using small radio-opaque videofluoroscopic 
markers placed at predefined points on the mitral leaflets (Itoh et al., 2009).  In particular, it 
would be interesting to assess the effect of chronic endothelial dysfunction (with or without 
treatment with NO donors) in an animal model on aortic valve mechanical properties.  In 
addition, we are currently working with our collaborators from the Georgia Institute of 
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Technology to develop in vitro testing systems that allow a combination of strain and flow on 
the tissue, while minimizing the overall volume of medium necessary in the apparatus.  
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5.1 BACKGROUND 
One of the salient features of a living structure, organ or being is their ability to adapt to 
changing environmental conditions.  In the case of heart valves, hemodynamics represent the 
main environmental stimulus to heart valves, characterized by changes in the mechanical forces 
the valves are subjected to, such as pressure, shear stress opening and closing velocities and 
bending forces.  Adaptation is not only a reaction to the environment but is also aimed at 
improving the function of the involved organ.  Examples of adaptation abound in the body and 
in nature.  A compelling example of adaptation in nature is the capacity of swifts to morph their 
wings to control their glide performance (Lentink et al., 2007).  Swifts are capable of modifying 
the size and shape of their wings to exploit the profound effect of wing morphology on 
aerodynamic performance.  Though these adaptations are acute and temporary during the 
bird’s flight, long-term changes in the structure of an aortic valve can have important effects on 
its function and represent an important feature of a living organ.   
 To date, no data is available to evaluate changes in valve structure during the cardiac 
cycle similar to those observed in the swifts’ wings, mainly due to the absence of sensitive 
imaging techniques to detect such intricate changes.  Nevertheless, the adaptation capacity of 
heart valves can be tested in vivo in the context of the Ross procedure.  The Ross procedure 
consists of replacing the patient’s aortic root with his own pulmonary root (autograft) while 
placing a pulmonary homograft in the pulmonary position.  It is the only valve replacement 
operation which guarantees very long-term viability of the aortic root.  Even homovital 
homografts which were once thought to maintain long-term viability, have been shown to 
become acellular within a few weeks after implantation.  Retrospective series using the Ross 
procedure suggest excellent long-term clinically relevant outcomes such as survival (Elkins, 
Thompson, Lane, Elkins, & Peyton, 2008; Kouchoukos, Davila-Roman, Spray, Murphy, & Perrillo, 
1994; M. H. Yacoub et al., 2006).  We hypothesized that these observed outcomes are in large 
part a result of the capacity of the autograft root to adapt to changing hemodynamic conditions.  
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Opening and closing dynamics of the aortic valve are essential determinants of ventricular 
workload and the pattern of flow at the outlet which can strongly influence downstream 
systemic flow propagation, as well as affecting coronary flow (Bellhouse & Bellhouse, 1968; 
Bellhouse, Bellhouse, & Reid, 1968; J. E. Davies et al., 2008).   
 
5.1.1 Aims 
The aims of the present work was to evaluate the adaptation capacity of a living aortic root by 2 
means: 
• Assessing the structural adaptation of the autograft root following the Ross procedure at 
a microstructural level.  It is well known that the number of elastic lamellae is maximal 
in the ascending aorta in response to strong radial mechanical forces.  The capacity of 
the much thinner pulmonary root to modify its structure in response to these external 
forces would represent evidence of adaptation. 
• Evaluating the pattern of flow across the aortic valve and in the aortic root following the 
Ross procedure.  These results will be compared to a set of normal controls in addition 
to a number of patients undergoing aortic root replacement using non-living aortic 
substitutes (homografts and xenografts).  The pattern of flow through the aortic is a 
function of the instantaneous movements of the aortic cusps and of the 
multidimensional expansion movements of the aortic root components during the 
cardiac cycle.  Flow patterns mirroring the normal aortic root would suggest adequate 
adaptation capacity.  
   
5.2 METHODS 
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5.2.1 Long-Term Viability of the Autograft Root  
A total of 6 explanted autograft roots from patients who had undergone the Ross procedure 
were collected at the time of surgery after obtaining patient consent and immediately fixed in 
1% formalin.  Tissue sections from the wall of the autograft wall and autograft cusps were 
obtained and stained using hematoxylin and eosin, elastin van Giesson and alcian blue/sirius 
red staining protocols.  Immunohisteochemical staining using vWF and CD31 for endothelial 
staining and SMA  was used to evaluate the cellular composition of the sections.   
 
5.2.2 Assessment of Aortic and Pulmonary Wall Elastic Laminae Count 
Using the same sections stained with van Giesson, the number of elastic lamellae of the 
autograft cusps and root wall was assessed.  This was compared to normal control aortic roots 
obtained from patients undergoing cardiac transplantation as well as pulmonary roots from the 
same individuals. 
 
5.2.3 Aortic Root Biomechanics 
To evaluate the role of a living aortic valve and root on overall aortic root biomechanics, 
patients undergoing 3 types of aortic root replacement procedures were evaluated using 
functional imaging techniques and compared to a total of 15 normal individuals.  All patients 
underwent imaging 10 or more years after aortic root replacement to allow for adaptation and 
remodelling of the implanted aortic valve and root (if any).  The 4 different groups were as 
follows: 
- Autograft root replacement: n=13 patients 
- Xenograft aortic root replacement: n=10 patients 
- Homograft aortic root replacement: n=6 patients 
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- Normal individuals: n=15 patients 
All the patients analyzed had normal or near-normal echocardiographic valve function.  Written 
consent was obtained from all patients to undergo these studies prior to imaging.  Functional 
analyses comprised 2 main areas: tissue mechanics and fluid mechanics.  Tissue mechanics 
provides tensile stress maps of the aortic root during the cardiac cycle whereas fluid mechanics 
provide information on the pattern, shape and velocity of flow across the aortic valve and root 
as well as endothelial shear stress on the aortic wall.  This work was performed in collaboration 
with Dr. Ryo Torii, PhD, a post-doctoral research fellow at Imperial College London.   
 
5.2.3.1 Tissue Mechanics 
Tissue (or solid) mechanics were obtained by performing multislice gated CT studies.  Only 
patients undergoing autograft root replacement and normal individuals underwent CT imaging 
as described.  Thus, comparison of tissue mechanics were limited to these 2 groups.  Gated CT 
images of the aortic root (pulmonary autograft or native aorta) were obtained.  Images were 
acquired at 10 timepoints (phases) during the cardiac cycle, ie, on average, images were 
obtained every 100 msec (for a hear rate of 60 beats/min).  Slice thickness is 2mm, with in-
plane resolution of 0.4-0.5mm/pixel.  Patient peripheral blood pressure was simultaneously 
recorded for all patients and used for calculations.  The first step to analyze tissue mechanics is 
to record the temporal variation in inner and outer diameter of the aortic wall at each phase of 
the cardiac cycle as shown in Figure 5.1. 
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Figure 5.1  Figure showing the first step in evaluating tissue mechanics.  Temporal variations in 
inner and outer diameter are measure at each phase of the cardiac cycle and plotted against time.   
 
Based on data obtained, aortic wall stiffness (Young’s modulus) and pressure waveform can be 
calculated using the following formulae and displayed as in Figure 5.2: 
- Stiffness (Young’s modulus): 
 
- Pressure waveform estimation: 
where:  
E: Young’s modulus 
N: Poisson’s ration (0.5) 
Dp: inner pressure (Psystole-Pdiastole) 
ri : inner wall diameter 
ro : outer wall diameter 
u: inner wall displacement 
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 Figure 5.2  Temporal variation in inner 
estimation (black) in the aortic root.  
Next, using the elastic modulus and the temporal pressure variation, 
variation in tensile stress in the aortic root wall can be estimated.
 
5.2.3.2 Fluid Mechanics 
For fluid mechanics analysis, gated time series of phase
the level of the aortic valve.  Each cardiac cycle was divided into 20 phases (or timepoints).  
First, patient-specific aortic geometr
Next, velocity maps were calculated at the level of the aortic valve based on the phase
data obtained, which then allowed flow simulation in the aorta (
 
(blue) and outer diameter (red) and pressure waveform 
 
 
 the temporal and spatial 
 
-contrast MR images were acquired at 
y was reconstructed based on the acquired stacked
Figure 5.3).  
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Figure 5.3  Velocity maps are obtained from the phase-contrast images at the level of the aortic 
valve.  These results are then projected onto the 3-D reconstruction of the aorta based on the 
obtained stacked images of the aorta.  Based on these data, flow simulation profiles can be obtained 
providing information on endothelial shear stress levels and velocity profiles.    
 
5.3 RESULTS 
5.3.1 Long-Term Viability of the Autograft Root Following the Ross Procedure 
5.3.1.1  Trilaminar Structure 
All explants obtained showed a trilaminar structure similar to that of the native aortic root, both 
at the level of the aortic wall and the aortic valve cusps.  Normal aortic valve cusps are 
composed of a collagen-rich fibrosa, an elastin-rich ventricularis and a spongiosa rich with 
glycosaminoglycans.  Autograft explants show a similar overall architecture along with a few 
differences.  The first observation is a marked thickening of the ventricularis in autograft cusps 
and the adventitia in the aortic wall as observed in Figure 5.4.  In addition, the amount of 
glycosaminoglycans appeared to be lower than in native aortic valve cusps.  Due to the lesser 
thickness of both the native pulmonary cusps and wall compared to the aortic cusp and wall, 
this thickening represents an adaptive process to the higher mechanical loads in the left-sided 
 circulation.  The adventitia is the layer of the vascular wall responsible for providing mechanical 
strength.  In the cusp however, the collagen
Therefore a thickening of the elastin
an effort to provide more elasticity to the cusp in the face of higher diastolic loads.
 
Figure 5.4 Immunohistological section of the autograft cusps at explantation (42 years after 
surgery) showing preservation of the trila
staining showing the presence and distribution of collagen 
Alcian blue/Sirius red staining showing the presence and distribution of glycosaminoglycans 
and collagen (pink). 
 
 
-rich fibrosa is typically the strength provider.  
-rich ventricularis is counterintuitive, but could be due to 
minar structure of the cusp.  A) Elastin v
(dark pink) and elastin 
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an Giesson 
(purple).  B) 
(blue) 
 5.3.1.2  Cellular Composition
All samples were stained for the presence of endothelial cells (CD31 and vWf), smooth muscle 
cells (SMA) and inflammatory infiltrates (CD45 and CD68).  Naturally, native aortic and 
pulmonary specimens were posi
inflammatory cells were observed in healthy native aortic and pulmonary cusps or wall.  
Explanted aortic autografts showed preservation of the endothelial cell layer and the presence 
of interstitial cells in the thickness of the tissue
tissue, inflammatory infiltrates were present in the explanted roots, suggesting an active 
chronic remodelling process. 
 
 
tive for endothelial and smooth muscle cell markers.  No 
 (Figure 5.5).  However, in contrast to native 
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Figure 5.5 Immunohistological section of the explanted autograft cusp 42 years after implantation 
showing preservation of cusp cellularity as shown by A) positive von Willebrand factor staining, a 
marker of endothelial cells and B) smooth muscle α-actin staining in the body of the cusp, a marker 
of interstitial cells. 
 
5.3.2 Adaptation of the Autograft Root to Local Mechanical Conditions 
As clearly demonstrated by Wolinsky and Glagov (Wolinsky & Glagov, 1967), the lamellar unit 
represents the structural and functional unit of any vascular wall.  The number of lamellar units 
varies between different segments of the vascular tree as a reflection of the different 
biomechanical and biochemical environments (Wolinsky, 1970).  In the specimens examined by 
counting the number of lamellar units using elastin van Giesson staining, there were no 
observed differences in the number of lamellae between native aortic sinus wall, native 
pulmonary sinus wall and explanted autograft sinus wall (number of lamellae: 64±17, 59±12 
and 62±22, respectively; p=NS) (Figure 5.6).   
 
Figure 5.6 – Representative histological sections stained with elastin van Giesson showing the number of 
elastic laminae in A) native aortic sinus wall, B) native pulmonary sinus wall and C) autograft sinus wall.  
No significant differences were observed between the 3 groups.   
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5.3.3 Role of a Living Aortic Root on Aortic Root Biomechanics 
5.3.3.1 Patient Characteristics 
All patients studied for evaluation of aortic root biomechanics had undergone aortic root 
replacement using homografts, xenografts (Medtronic Freestyle porcine bioprosthesis 
implanted as a total root, Medtronic Inc, Minneapolis, USA) or autografts.  All patients had 
undergone surgery 10 or more years before the study and all had normal or near-normal aortic 
valve function assessed by echocardiography (maximum trivial to mild aortic insufficiency).  
Patients were randomly selected to undergo these studies from a pool of patients that had been 
randomized in two different studies to evaluate clinical outcomes following aortic root 
replacement surgery.  Patients were comparable for most aspects but differed significantly in 
terms of age.  Patients in the homograft and the xenograft groups were significantly older than 
those in the autograft group.  Similarly, they were significantly than normal individuals (Table 
5.1).   
Table 5.1 – Age and gender of individuals undergoing functional imaging studies.  Note that homograft 
and xenograft recipients only underwent MR imaging whereas autograft recipients and normal 
individuals underwent both MR and CT imaging.  
 
   Autograft
 
 Homograft  Xenograft  Normal  
n  13 6 10 15 
Age (years)  47 ± 9 71 ± 11 76 ± 8 32 ± 5 
Sex (M:F)  11 : 2 4 : 2 6 : 4 11 : 4 
BSA (m2) 2.05 ± 0.27 1.92 ± 0.20 2.06 ± 0.13 1.98 ± 0.15 
HR (beats/min) 71.6 ± 15.7 75.8 ± 18.1 67.8 ± 19.9 72.1 ± 10.2 
BP (mmHg) 117/68 118/86 127/75 122/66 
   M:F, male:female; BSA, body surface area; HR, heart rate; BP, blood pressure 
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5.3.3.2 Aortic Wall Tensile Stresses 
Mean autograft aortic root stiffness measured at the level of the sinuses of Valsalva was higher 
than normal individuals, thought his did not reach statistical significance because of the high 
variability of results in the autograft group.  Mean Young’s modulus in the autograft group was 
1364 ± 1231 kPa versus 492 ± 191 kPa in normal individuals (p=0.3).  There was also a trend 
towards higher strain levels in native healthy aortas compared to autograft roots, with a mean 
strain of 7.6 ± 4.1 % in the autograft group and 12.9 ± 3.5 in the normal group (p=0.2).  
Nevertheless, importantly, maximum tensile stress levels at the level of the root were 
comparable between both groups (Figure 5.7).  Mean maximal tensile stress in the autograft 
wall was 248 ± 66 kPa versus 218 ± 72 kPa.  These figures are well below suggested values for 
aortic wall rupture or dissection (~800 kPa). 
 
Figure 5.7 – Representative examples of 3-D stress maps following autograft aortic root replacement 
versus native healthy aortic roots showing comparable levels of aortic wall stresses in both groups 
despite the wide variability in aortic root shape in the autograft group and the differences in stiffness 
between the groups. 
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5.3.3.3 Pattern, Shape and Velocity of Flow in the Aortic Root 
Relative orifice area was estimated as the ratio between the opening area at the level of the 
valve and the area at the mid-sinus level.  There was no difference between relative orifice area 
in the autograft group or normal individuals (Figure 5.8 and 5.9).  In contrast, relative orifice 
area was significantly smaller in the homograft group (p<0.05 versus normal individuals) and 
xenograft group (p<0.01 versus normal individuals).      
 
Figure 5.8 – Representative example of the relative orifice area measurement as the ratio between open 
aortic orifice area (Aopen) and the area of the mid-sinus of Valsalva (Asinus). 
 
 
 
Figure 5.9 – Relative orifice area following autograft, homograft or xenograft (Freestyle) aortic root 
replacement, compared to normal individuals.  The figure shows no differences between the autograft 
and normal groups, whereas the homograft and xenograft groups have significantly lower relative orifice 
areas. 
Chapter 5 
   173 
 
In addition, the shape profiles of blood flow through the aortic valve and root were compared 
between all 4 groups.  As shown in Figure 5.10, the shape of flow through the aortic valve in the 
autograft most closely reproduced the normal triangular shape when exiting the left ventricular 
outflow tract.  In contrast, in the homograft and xenograft groups, the shape of the outflowing 
blood was more circular, suggesting less optimal movements of the aortic cusps in both groups.         
 
Figure 5.10 – Shape and velocity of aortic flow across the aortic root following autograft, homograft and 
xenograft aortic root replacement, compared to healthy controls.  Autograft root replacement best 
reproduces normal aortic root flow dynamics both in terms of shape and velocity. 
 
Blood flow velocity profiles were also compared between the different groups.  Individual 
velocity profiles across the cardiac cycle in all 4 groups are presented in Figure 5.11.  
Interestingly, flow profiles in the autograft group show negative flow velocities in early diastole, 
reflecting the presence of recirculating flow in the sinuses, an important contributor to coronary 
blood flow.  Negative blood flow could also be a result of aortic regurgitation.  However, 3-
dimensional cine reconstructions of aortic root flow patterns demonstrates the backward flow 
in the periphery, rather than in the center of the root, as would be expected in the presence of 
central aortic regurgitation.   
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Figure 5.11 – Individual variability in flow velocity profiles across the cardiac cycle in the 4 study groups.  
Notice the negative flow rate in early diastole in the autograft group, indicating the presence of 
recirculating flow in the sinuses of Valsalva. 
 
Comparison of the maximum velocity profiles in the 4 groups shows no differences between the 
autograft group and normal individuals.  Similarly, there were no statistical differences between 
the homograft group and normal individuals, although this might be due to the small number of 
patients in the homograft group, as there was a clear trend towards higher velocities in the 
homograft group.  In contrast, velocities following xenograft root replacement were significantly 
higher than in normal individuals as shown in Figure 5.12. 
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Figure 5.12 – Comparison of mean maximum flow velocity in the 4 study groups.  Maximum flow velocity 
was significantly higher in the xenograft roots compared to normal individuals.  Although homografts 
showed higher velocities, these were not statistically significant.  There were no differences between the 
autograft and normal individuals. 
 
Figure 5.13 shows a representative sagittal view through the aortic root of flow shape and 
velocity in the 4 different groups, summarizing the previous findings. 
 
Figure 5.13 – Representative sagittal view of flow shape and velocity across the aortic valve in the 4 
different groups, illustrating the triangular shape of the outflow and the low velocities in the autograft 
group, comparable to normal individuals.  In contrast, homograft and xenograft roots show a more 
circular flow profile and higher velocities. 
 
The 3-dimensional flow velocity profile across the ascending aorta was estimated using the 3-
dimensional reconstruction of individual aortic geometry.  The data obtained are similar to the 
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data already described, with lower and more homogeneous velocity profiles in the autograft 
group compared to the homograft and xenograft groups (Figure 5.14). 
 
Figure 5.14 – Flow velocity profiles across the aortic root and ascending aorta in the 4 study groups.  The 
autograft group shows more homogeneous and lower flow velocity profiles than the homograft and 
xenograft groups. 
 
5.3.3.4 Endothelial Shear Stress 
Endothelial wall shear stress values were estimated in the entire aorta based on the velocity 
profiles obtained from the MR images.  Data obtained show that shear stress levels in the 
autograft are lower than values obtained in normal individuals.  In contrast, shear stress levels 
were significantly higher in the xenograft group compared to healthy subjects.  Homograft 
recipients showed areas of increased shear stress  in the ascending aorta.  However, the overall 
pattern of shear stress distribution was similar to healthy controls (Figure 5.15). 
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Figure 5.15 – Endothelial shear stress profiles across the aortic root and ascending aorta in the 4 study 
groups.   
 
5.4 DISCUSSION 
In this chapter, we have attempted to examine the capacity of living human valves to adapt to 
their hemodynamic and biochemical environments.  The Ross procedure represents a unique 
means of assessing the capacity of a living valve to adapt to its host hemodynamic environment.  
All other currently available surgical valve substitutes consist of non-living tissues, including 
homovital homografts which have been shown to become completely decellularized within 
weeks following implantation.   
 The changes observed in explanted autografts have previously been characterized as 
degenerative changes by some authors (Mookhoek, de Heer, Bogers, Takkenberg, & Schoof, 
2010).  It appears from the current data that the changes observed represent an adaptation to 
the hemodynamic and biochemical environment at the level of the left ventricular outflow.  
Indeed, in its native location, the pulmonary root is exposed to significantly lower systolic and 
diastolic blood pressures.  The pulmonary valve cusps are exposed to lower mechanical loads 
(lower diastolic pressure).  In addition, venous blood differs markedly from systemic blood: it 
has a lower oxygen content and a lower pH, it is warmer, it has lower concentrations of glucose 
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and other nutrients, and has higher concentrations of urea and other waste products.  
Nevertheless, in their native environment, pulmonary roots (cusps and wall) whose 
microstructural composition is very similar to aortic roots, function normally and are very 
rarely involved in acquired heart valve pathologies.  Although most of this might be due to the 
“gentler” hemodynamic conditions that pulmonary valves lay in, its biochemical environment 
might also play a contributory role.  For instance, hydroxyapatite is 1.99 times more soluble in 
venous blood pH than arterial blood pH which could explain the absence of calcification on the 
venous side.   
 Once exposed to systemic pressures such as in the arterial circulation, pulmonary 
autografts undergo a process of remodelling mainly characterized by an increase in the 
thickness of the ventricularis at the level of the cusps and the fibrosa at the level of the 
pulmonary wall.  This is secondary to deposition of collagen fibers which provide mechanical 
strength to both the cusp and wall.  Indeed, the elastic modulus of collagen is significantly 
higher than elastin, indicating that collagen is much stiffer than elastin.  In vitro studies from 
our group and others have demonstrated that cyclic stretching of aortic valve interstitial cells or 
vascular smooth muscle cells mainly results in increased synthesis of collagen (Ku et al., 2006; 
Shyu, 2009).  Although our policy following the Ross procedure is to ensure a tight control over 
patient blood pressure to maintain systolic pressure below 110mmHg, this still represents a 
significant increase in stretch for all of the of the root, both in systole and diastole (especially for 
the valve cusps).  Although in the present analysis we did not observed any significant changes 
in the number of elastic lamellae between native aortic and pulmonary roots and autograft 
roots, this could be attributable to several elements.  The specimens were not obtained from the 
same patients.  Therefore, individual variability at various levels: genetic, developmental, 
epigenetic and hemodynamic could constitute significant biases.  In addition, the autografts 
obtained also represent an important selection bias considering they originated from patients in 
whom a reoperation is required.  As has been shown in several retrospective series, autografts 
have very good long-term performance (T. E. David, Woo, Armstrong, & Maganti, 2010; Elkins et 
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al., 2008; Kouchoukos et al., 2004; M. H. Yacoub et al., 2006).  A more representative analysis 
would include post-mortem specimens from patients with well functioning autograft roots, 
though that may prove difficult.  Nevertheless, in a separate study examining young and adult 
heart to compare the structure of aortic and pulmonary walls, Hokken et al. determined that the 
number of elastic lamellae in the sinus region did not differ between both trunks, both in 
children and in adults (Hokken, Bartelings, Bogers, & Gittenberger-de Groot, 1997).  In contrast, 
there was a significantly larger number of lamellae in the ascending aorta (above the 
sinotubular junction) compared to the pulmonary artery at the same level (78 lamellae in the 
aorta versus 59 lamellae in the pulmonary artery).  All autograft wall specimens obtained 
corresponded to the sinus region because all autografts are implanted as total aortic roots and 
only 2-3mm of supra-sinotubular junction autograft wall is left for the distal anastomosis.  This 
could be an important contributing factor to the long-term stability of the autograft roots as will 
be discussed in the next chapter.  Beyond the histological changes to the autograft root, the main 
question we tackled in this chapter was to analyze the functional impact of these adaptive 
changes.  In conjunction with the computer engineering and imaging team at Imperial College, 
we were able to address this issue using advanced imaging techniques and computer 
simulation.  Our findings show that in autografts implanted >10 years after surgery, thus 
representing a phase where they are fully remodelled, there are differences in the intrinsic 
mechanical properties of the autograft wall.  This is characterized by reduced elasticity, 
distensibility and circumferential strain at the level of the autograft wall compared to the native 
aortic wall.  Nevertheless, maximum wall stress in the autograft root was not statistically 
different from that seen in the native aortic wall (244 ± 71 kPa versus 208 ± 55kPa).  In 
addition, these values are markedly below levels commonly thought to result in dissection or 
rupture of the aorta, ie ~800-900kPa (Elefteriades J., personal communication).  These data 
represent novel insight into the mechanical behavior of autograft wall, although their clinical 
applicability remains yet to be determined.  We are currently undertaking more studies in 
different patient populations in an effort to test the correlation between these intrinsic wall 
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biomechanics and other predictors of high-risk aortas (e.g., rapid rate of progression of root 
diameter and root diameter >45mm) as well as the role of biomechanics in prediciting clinical 
events.       
 In addition to the mechanical properties of the autograft, another important issue is the 
ability of the living autograft root to reproduce the sophisticated functions of the aortic root.  
One of the major functions of the aortic root is to ensure laminar and unobstructed blood flow 
through the aortic valve and into the aorta.  This has a major impact on coronary and systemic 
blood flow patterns and distribution.  It also constitutes a reflection of left ventricular function.  
Unobstructed flow translates into optimal ventricular dynamics and optimizes ventricular 
workload.  The data obtained from the 3D phase contrast MRI studies performed on the patients 
suggest that the flow pattern following the Ross procedure best reproduces that of the native 
aortic root.  Several physiological studies of aortic root dynamics over the last decades have 
clearly demonstrated the active participatory role of all aortic root component parts during the 
cardiac cycle to optimize cardiac function (Cheng, Dagum, & Miller, 2007; Dagum et al., 1999; 
Lansac, Lim, Shomura, Lim, Goetz et al., 2002; Lansac, Lim, Shomura, Lim, Rice et al., 2002; 
Lansac et al., 2005).  The most prominent feature is the role of the root in anticipating events 
during the isovolumic contraction phase as well as in the second half of systole, where the cusps 
start their gentle excursion back towards a closed position, to reduce impact between shutting 
cusps.  The pattern of flow in the autograft root showed a laminar, low-velocity, triangular-
shaped flow through the aortic valve.  The shape and velocity gradient of the flow was 
qualitatively comparable to native aortic flow.  In contrast, following xenograft or homograft 
root replacement, both of which constitute a non-living aortic substitute, flow shape was more 
square- or circle-shaped, with a higher velocity of flow and more flow gradient.  Importantly, 
there appeared to be increased vortex formation in the autograft root compared to xenograft or 
homograft roots, despite the fact that all 3 were implanted using a full root technique.  This may 
be in part due to the larger autograft root diameter, but also could constitute the ability of the 
living sinuses to approximate normal function.   
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 The clinical consequences of differences in aortic root flow pattern remain to be defined.  
However, our preliminary work examining the impact of these differences on endothelial wall 
shear stress levels represents an important finding.  As mentioned previously, shear stress 
represents the most important mechanical signal to which endothelial cells respond through 
activation of various receptors and signalling pathways (P. F. Davies, 1995; Hahn & Schwartz, 
2009; Pahakis et al., 2007; White & Frangos, 2007).  Histological analysis of aortas explanted at 
the time of surgery from patients with bicuspid aortic valve disease (in whom flow pattern 
through the aortic root is different from normal tricuspid valves) show spatial differences at the 
cellular and extracellular matrix levels (Cotrufo et al., 2005; Della Corte et al., 2008).  In 
addition, differences in the expression pattern and levels of matrix proteins is spatially-
dependent, suggesting that mechanical forces from jet orientation, as well as differences in 
shear stress levels along the aorta can have immediate impact into matrix metabolism, leading 
to structural changes such as aortic dilatation (Della Corte et al., 2006).   
 One of the major challenges in terms of functional imaging using MRI is imaging of 
coronary artery flow pattern and velocity.  This is mainly due to the position of the coronaries, 
their small diameter and the complexity of the flow pattern through them.  Various authors have 
repeatedly raised the importance of the sinuses of Valsalva in modulating coronary artery flow 
(Bellhouse, Bellhouse, & Reid, 1968; J. E. Davies et al., 2008).  In fact, Leonardo da Vinci was the 
first to model the importance of the sinuses in redirecting flow into the coronaries.  Currently, 
there is ongoing research to try to reproducibly obtain phase-contrast flow images in the 
coronaries and to validate these results.  These could help explain in large part the survival 
benefit observed in patients following the Ross procedure. 
 
5.5 LIMITATIONS 
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This study has several limitations.  As mentioned earlier, histological examination of explanted 
autograft roots inevitably bears a selection bias since these roots are always removed for 
dysfunction or dilatation.  Nevertheless, this provides insight into the adaptive mechanisms of 
autograft roots.  The imaging studies comparing different aortic root replacement procedures 
comprised patients that varied in age.  Autograft recipients were significantly younger than 
homograft and xenograft recipients.  Healthy individuals were themselves younger than 
autograft recipients.  It is an established fact that the mechanical properties of the tissues 
change with increasing age, therefore this could have an impact on the observed flow patterns.  
Nevertheless, besides their age, all patients were similar in terms of demographics, 
hemodynamics and echocardiographic valve function.  Therefore, the observations still 
represent a valid look into the role of the valve substitute itself on flow through the aortic root.  
 
5.6 CONCLUSIONS AND FUTURE DIRECTIONS 
In conclusion, living heart valves are capable of adaptation in response to changes in their 
hemodynamic and biochemical environment, which reflects the dynamic nature of heart valves.  
Adaptation of heart valves is illustrated by the changes in the structure of pulmonary roots 
implanted in the aortic position (Ross procedure).  These roots undergo structural changes as a 
result of activation of different mechanotransduction pathways.  Although the autograft root 
differs from the native aortic root in its intrinsic mechanical properties, its adaptation translates 
into wall stress levels remarkably close to the native aorta.  In addition to the mechanical 
adaptation, viability of the aortic root apparatus appears to have a direct impact on aortic flow 
pattern, a major determinant of coronary and systemic flow.  Combined, these different 
elements are thought to translate into clinically relevant outcomes as will be seen in the 
following chapter.  In addition, these studies underline the importance of having living heart 
valve substitutes capable of reproducing the sophisticated functions of the native valve.  In the 
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future, continued work aimed at developing a tissue-engineered living heart valve remains the 
ultimate objective.  In the immediate future, ongoing work is currently underway to examine 
patients with moderately dilated aortic roots following the Ross procedure, in order to evaluate 
the clinical sensitivity of in vivo assessment of aortic wall biomechanics in clinical decision-
making.  Furthermore, we are currently comparing patterns of flow through the aortic root 
following stented aortic valve replacement versus stentless aortic root replacement to evaluate 
the role of maintaining the structural unity of the aortic root on flow dynamics.     
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6.1 BACKGROUND 
Aortic valve replacement has been shown to improve the natural history of severe symptomatic 
aortic valve disease(Iivanainen, Lindroos, Tilvis, Heikkilä, & Kupari, 1996; Ross & Braunwald, 
1968).  The degree of improvement depends, at least in part, on the type of aortic valve 
substitute.  However, to date, there are very few randomized trials comparing different surgical 
options with regards to survival and quality of life. Recent work has shown that the aortic valve 
performs several sophisticated functions which depend on its viability(Dagum et al., 1999; El-
Hamamsy, Balachandran et al., 2009; M. Yacoub & Nerem, 2007).  The Ross operation is the only 
operation which provides continued long-term viability of the valve tissue.  We hypothesized 
that the regulatory and adaptive properties of a living substitute can translate into improved 
long-term patient outcomes.   
 
6.1.1 Aims 
The aims of this prospective randomized trial were to evaluate late outcomes following 
Autograft (Ross procedure) versus Homograft aortic root replacement.   
 
6.2 METHODS 
6.2.1 Study Population 
From 1994 to 2001, 228 patients undergoing aortic root replacement were randomly assigned 
to receive a Homograft or an Autograft (Ross procedure).  All patients with aortic valve disease 
requiring surgery were considered.  Exclusion criteria were the presence of Marfan syndrome, 
rheumatoid arthritis, Reiter’s syndrome and age >69 years.  Patients presenting with bicuspid 
aortic valve disease, active endocarditis, rheumatic heart disease, ascending aortic aneurysms, 
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decreased ejection fraction or emergent surgery were not excluded from the study.  In the initial 
study period, children <18 years were included (n=12).  Due to early homograft failure in 2 of 
those patients, all patients <18 years of age were excluded from the trial.  The present analysis 
therefore includes 216 adult patients (n=108 in each group; Figure 6.1).  Sample size was 
calculated based on an estimated survival following homograft root replacement of 80% at 10 
years (Lund et al., 1999), a population survival of 97% at 10 years (ONS) and the assumption 
that the Ross procedure would restore population survival.  A total of 85 patients in each group 
would be needed to show a 15% survival difference at 10 years, with α<0.05, β>0.80 and a 
dropout rate of 10%.  The primary endpoint was long-term survival.  Secondary endpoints were 
freedom from reoperation, valve-related morbidity, quality of life and changes in valvular and 
ventricular function determined echocardiographically. Approval for the study was obtained 
from the local ethics committee and all patients gave written informed consent to the study 
before enrolment. 
 
Figure 6.1 Trial profile 
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6.2.2 Surgical Technique 
 All procedures were performed by a single surgeon (MY) using the same technique over the 
study period.  Total aortic root replacement was performed in all patients.  For autograft root 
replacement, the pulmonary root was harvested in a scalloped fashion, leaving 1-2mm below 
the attachment of the cusps.  The proximal aortic anastomosis was performed using close 
interrupted sutures.  The left-facing sinus was positioned in the left coronary sinus and the 
autograft was placed in an intra-annular position to provide external fibrous support to the 
muscular pulmonary root.  The coronary ostia were anastomosed to their respective sinuses.  
The distal anastomosis was performed 2-3mm above the level of the commissures to reduce the 
risk of autograft dilatation.  No foreign material was used to support the proximal or distal 
anastomoses.  A pulmonary homograft was placed in the pulmonary position using the largest 
available size.  Strict blood pressure control (systolic blood pressure <110mmHg) was 
maintained perioperatively and for the first 6 months, to allow adaptive remodelling of the 
autograft.  For patients undergoing homograft aortic root replacement, a standard previously 
described technique was performed (M. Yacoub et al., 1995).   
 
6.2.3 Clinical Follow-up 
Follow-up was actively conducted on a yearly basis and consisted of outpatient appointments, 
patient call-ups or contact with the patient’s family physician.  Mean duration of clinical follow-
up was 10.2±3.2 years (total: 2173 patient-years) and was 97% complete within 12 months of 
study closure.  Indications for reintervention were symptomatic valve dysfunction (moderate or 
severe) and/or progressive ventricular dilatation.  Perioperative death was defined as hospital 
mortality or death <30 days after operation. 
 
Chapter 6 
   188 
6.2.4 Echocardiographic Follow-up 
Serial echocardiographic examinations were performed.  These studies were performed every 2 
years if patients were asymptomatic and last echocardiography showed no signs of valvular or 
ventricular dysfunction, and more frequently in the remaining patients.  Completeness of 
echocardiographic follow-up was 80% within 24 months of study closure.  A total of 1505 
complete echocardiographic examinations were analyzed to produce mixed effect models of 
aortic valve function, ventricular dimensions and function and aortic sinus diameter.  Aortic 
regurgitation was quantified by measuring the ratio of the maximal regurgitant jet diameter to 
the systolic left ventricular outflow tract diameter directly under the aortic valve in the 
parasternal long-axis view (jet diameter ratio) (Perry, Helmcke, Nanda, Byard, & Soto, 1987).  
  
6.2.5 Quality of Life Assessment 
Short-Form 36 Health Survey Questionnaires (SF-36) were used to assess patients’ quality of 
life (Annex 1).  Questionnaires were sent to all living patients between September and 
December 2008.  Questionnaires were resent to non-responders.  Response rate was 75% in the 
Autograft group (76/102 eligible patients) and 71% in the Homograft group (64/90 eligible 
patients) at a mean 11±2 years after surgery.   
 
6.2.6 Statistical Analysis 
Data are expressed as mean ± standard deviation for continuous variables and analyzed using 
Student’s t-test.  Categorical variables are expressed as a number (percentage) and compared 
using Fisher’s exact test.  Survival analyses were performed using the Kaplan-Meier method and 
the log-rank test was used to compare curves.  Kaplan-Meier survival estimates were compared 
to survival of the general population matched for age, gender and year of surgery using 1996-
1998 to 2005-2007 United Kingdom interim lifetables (ONS). Variables with a P<0.2 in the 
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univariable analyses were considered in the multivariate analyses.  The effect of each variable 
was assumed to be constant over time.  A stepwise backward elimination process was used and 
as for all other analyses, variables with a P<0.05 were considered statistically significant.  Mixed 
effects models were used to assess changes in echocardiographic measures over time and 
account for the correlation between repeated follow-up measurements (the MIXED and 
NLMIXED procedures in SAS software, version 9.1; SAS Institute, Cary, NC).  Fully parameterized 
mixed effect models were built including a coefficient for each time point for each group 
(baseline preoperatively “B”, postoperatively prior to discharge “A”, and yearly thereafter).  
Since most patients underwent echocardiography every 2 years, piecewise linear random effect 
models using time as a continuous measure were constructed with time knots at 1 month, 1 
year and every 2 years. For aortic regurgitation grade, piecewise multinomial ordinal random 
effect model was performed using the same time knots. Between-group differences as well as 
changes over time were assessed. For patients with missing echocardiographic measurements 
at a given time point, the outcome data were considered to be missing at random. 
 SF-36 scores for all 8 domains were normalized using the Oxford Healthy Life Survey UK 
population estimates(Jenkinson, Coulter, & Wright, 1993) with a mean at 50 and a standard 
deviation at 10. Physical Component Scores (which correlate with 6 of the 8 domains) and 
Mental Component Scores (which correlate with 5 of the 8 domains) were computed using UK 
corrected weights (Jenkinson et al., 1993).  Scores were expressed as median and interquartile 
range and group differences assessed using the Wilcoxon signed-rank test. 
 
6.3 RESULTS 
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6.3.1 Patient Characteristics 
Mean age of the patients was 39±13 years in the Autograft group versus 41±13 years in the 
Homograft group (P=0.312; Table 6.1).  Active endocarditis was the indication in 8% of the 
patients in each group (P=0.816); and 42% of Autografts and 44% of Homografts had 
undergone prior surgery (P=0.784). 
 
Table 6.1 Patient characteristics 
Variable 
Homograft 
(n=108) 
Autograft 
(n=108) 
P-value 
Age 41 ± 13 39 ± 13 0.312 
18-34 46 (43%) 47 (44%)  
35-49 28 (26%) 39 (36%)  
50-59 24 (22%) 13 (12%)  
≥60 10 (9%) 9 (8%)  
Sex (% male) 89 (82%) 92 (85%) 0.712 
BSA (m2)  1.9 ± 0.2 1.9 ± 0.2 0.823 
Smoking   0.193 
Current 23 (21%) 18 (17%)  
Previous 26 (24%) 18 (17%)  
No 59 (55%) 72 (66%)  
Comorbidities    
Hypertension 29 (29%) 21 (20%) 0.193 
Dyslipidemia 4 (4%) 3 (3%) 0.717 
Diabetes 2 (2%) 1 (1%) 0.616 
Renal failure* 7 (8%) 6 (6%) 0.776 
Preoperative AR   0.248  
0 14 (13%) 8 (7%)  
1 5 (5%) 1 (1%)  
2 16 (15%) 21 (19%)  
3 28 (26%) 34 (31%)  
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4 44 (42%) 44 (41%)  
Preoperative AR grade 3-4 72 (67%) 78 (72%) 0.460 
Surgical Indication   0.652 
Primary isolated AS 35 (32%) 30 (28%)  
Primary isolated AR 46 (43%) 49 (45%)  
Mixed AS/AR 27 (25%) 29 (27%)  
Thoracic Aortic Aneurysm 1 (1%) 2 (2%)  
Etiology   >0.99 
Degenerative 48 (44%) 48 (44%)  
Congenital 54 (50%) 53 (49%)  
Rheumatic 6 (6%) 7 (6%)  
Endocarditis   0.816 
None 86 (80%) 89 (83%)  
Active 9 (8%) 9 (8%)  
Treated 13 (12%) 10 (9%)  
Previous Interventionǂ (%) 48 (44%) 45 (42%) 0.784 
Homograft 31 22  
Mechanical/Tissue 
prosthesis 
11 12  
Aortic valve repair 8 11  
Coarctation repair 2 8  
NYHA    0.206 
I   22 (20%) 33 (31%)  
II 48 (45%) 49 (45%)  
III 29 (27%) 21 (19%)  
IV 9 (8%) 5 (5%)  
Heart Rhythm   0.144 
Sinus rhythm 101 (94%) 103 (95%)  
Atrial fibrillation 5 (5%) 1 (1%)  
Pacemaker 1 (1%) 4 (4%)  
Type of Operation   0.488 
Emergent 8 (7%) 5 (5%)  
Urgent 8 (7%) 5 (5%)  
Elective 92 (85%) 98 (91%)  
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6.3.2 Operative Results 
There was one perioperative death in the Autograft group (0.9%) and 3 in the Homograft group 
(2.8%; P=0.621) (Table 6.2).  Three of the 4 perioperative mortalities were due to low output 
syndromes in patients operated for acute infectious endocarditis.  The fourth patient had 
undergone successful homograft root replacement and died suddenly at home on postoperative 
day 6.  Post-mortem examination revealed no valvular dysfunction, but severe left ventricular 
hypertrophy and intramyocardial fibrosis.  
 
Table 6.2 Operative data and results 
Variable 
Homograft 
(n=108) 
Autograft 
(n=108) 
P-value 
Perioperative Deaths† 3 (2.8%) 1 (0.9%) 0.621 
Concomitant Procedures    
CABG 3 (3%) 2 (2%) >.999 
Mitral valve 4 (4%) 5 (5%) >.999 
Bypass time (min) 117 ± 49 163 ± 37 <0.001 
Ischemic time (min) 85 ± 23 110 ± 21 <0.001 
Cardioplegia   >.999 
Blood 41 (38%) 42 (39%)  
Crystalloid 67 (62%) 66 (61%)  
Aortic Homograft    
Homovital 36 (33%)   
Antibiotic sterilized 41 (38%)   
Cryopreserved 32 (30%)   
Inotropes   0.961 
<24 h 68 (63%) 69 (64%)  
24-48 h 23 (21%) 21 (19%)  
>48 h 17 (16%) 18 (17%)  
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Ventilatory support   0.815 
<24 h 93 (86%) 96 (89%)  
24-48 h 5 (5%) 4 (4%)  
>48 h 10 (9%) 8 (7%)  
Complications    
Reexploration for bleeding 4 (4%) 13 (12%) 0.041 
Pacemaker 2 (2%) 2 (2%) >.999 
Atrial fibrillation 17 (16%)  17 (16%) >.999 
CVA/TIA 3 (3%) 2 (2%) 0.682 
     Renal failure 2 (2%) 3 (3%) >.999 
     Sternal wound infection 1 (1%) 4 (4%) 0.369 
ICU length of stay (d) 1 [0, 9] 1 [1, 14] 0.774 
Hospital length of stay (d) 9 [0, 46] 9 [4, 44] 0.451 
 
6.3.3 Survival 
Actuarial survival in the Autograft group was 97±2% and 95± 3% at 10 and 13 years, 
respectively (1 early death and 3 late deaths: 1 cardiac, 1 non-cardiac and 1 unknown cause) 
versus 83±4% and 78±5%, respectively in the Homograft group (P=0.002; Figure 6.2).  There 
were 3 early deaths and 12 late deaths in the Homograft group (2 valve-related, 3 cardiac, 4 
non-cardiac and 3 of unknown cause).  Autograft group survival was comparable to an age- and 
sex- matched UK population (Figure 6.2).  On multivariate analysis, the only independent 
predictor of late mortality was homograft use (hazard ratio 8.64 [2.76 – 27.06]) whereas higher 
creatinine clearance was protective (hazard ratio 0.97 [0.96 – 0.99]).    
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Figure 6.2 Actuarial survival following Autograft (green) versus Homograft (red) aortic root 
replacement (P=0.002). 
 
6.3.4 Freedom from Reoperation 
One patient in the Autograft group who had undergone surgery for prosthetic valve dysfunction 
required pulmonary autograft reoperation 9.5 years after surgery.  The indication was mild 
autograft dilatation (44mm) with moderate aortic regurgitation and progressive left ventricular 
enlargement.  Overall, actuarial freedom from aortic valve reoperation in the Autograft group 
was 99±1% at 13 years (Figure 6.3).   
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Figure 6.3 Actuarial freedom from aortic valve reoperation for patients following Autograft 
(green) versus Homograft (red) aortic root replacement (P<0.001). 
 
 In addition, there were 8 pulmonary homograft reoperations in 7 patients due to 
stenosis (n=6) and endocarditis (n=2).  Four of the 8 pulmonary reoperations (50%) occurred 
within the first 18 months after surgery. Freedom from pulmonary homograft reoperation in 
the Autograft group was 95±2% and 94±3% at 10 and 13 years, respectively (Figure 6.4).  
Overall freedom from any reoperation in the Autograft group was 95±2% and 94±3% at 10 and 
13 years, respectively (Figure 6.5).   
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Figure 6.4 Actuarial freedom from pulmonary homograft reoperation in patients 
undergoing the Ross procedure. 
 
 
 
Figure 6.5 Actuarial freedom from any valve reoperation following Autograft (green) 
versus Homograft (red) aortic root replacement (P<0.001). 
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 In contrast, actuarial freedom from reoperation in the Homograft group was 82±5% and 
51±8% at 10and 13 years, respectively (P<0.001 versus all Autograft reoperations).  Of the 27 
total reoperations in the Homograft group, 18 were due to structural valve deterioration and 9 
were due to infective endocarditis.  Use of a homograft was an independent predictor of the 
need for reoperation on multivariate analysis (hazard ratio 5.69 [2.46 – 13.15]), whereas older 
age at surgery was a negative predictor (hazard ratio 0.74 [0.57 – 0.97]). 
 
6.3.5 Long-Term Morbidity 
There were no cases of aortic endocarditis and 2 late cases of pulmonary homograft 
endocarditis in the Autograft group.  In contrast, 9 cases of infective endocarditis occurred in 
the Homograft group at a median time of 10 years after surgery (range 2 – 12 years).  Actuarial 
freedom from all endocarditis was 98±1% and 97±2% in the Autograft group at 10 and 13 
years, respectively versus 94±3% and 82±6% in the Homograft group (P=0.002) (Figure 6.6).   
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Figure 6.6 Actuarial freedom from endocarditis following Autograft (green=aortic valve and 
blue=pulmonary valve) and Homograft (red) aortic root replacement (P=0.002). 
 
One patient in the Autograft group (59 years old) suffered a stroke 4 years after surgery 
versus 3 patients in the Homograft group at 2, 10 and 11 years after surgery (Figure 6.7).   
 
Figure 6.7 Actuarial freedom from cerebrovascular accident following Autograft (green) 
versus Homograft (red) aortic root replacement (P=0.246). 
 
One of those cases occurred in the perioperative period following redo surgery for 
homograft endocarditis.  No cases of bleeding or thrombosis were reported in both groups.  
Overall, freedom from the composite endpoint of endocarditis, stroke, bleeding or thrombosis 
was 97±2% and 96±2% in the Autograft group at 10 and 13 years, respectively versus 93±3% 
and 82±6% in the Homograft group (P=0.075; Figure 6.8).    
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Figure 6.8 Actuarial freedom from the composite endpoint of endocarditis, cerebrovascular 
accident, bleeding or thrombosis following Autograft (green) versus Homograft 
(red) aortic root replacement (P=0.075). 
 
 
6.3.6 Echocardiographic Data 
6.3.6.1 Aortic and Pulmonary Valve Function 
Using mixed effect models, Figure 6.9a shows no change in trans-aortic gradients in the 
Autograft group up to 13 years after surgery (gradients <10mmHg) versus a steady increase in 
the Homograft group (P<0.001).  Figure 6.9b shows time-related changes in aortic regurgitation 
in the two groups.  Overall, actuarial freedom from aortic regurgitation grade 3-4 is 94±3% in 
the Autograft group versus 82±5% in the Homograft group at 10 years (P=0.029).  Figure 6.9c 
depicts the progression of echocardiographically measured transpulmonary gradients across 
the pulmonary homograft in the Autograft group with a mean value of 25±5mmHg at 13 years.   
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Figure 6.9a Mixed effect models of echocardiographic parameters following Autograft 
(green) versus Homograft (red) aortic root replacement looking at the 
progression of trans-aortic gradients.  
*P<0.05 between groups at each given time point. 
B, Preoperative measure; A, 1 month after surgery. 
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Figure 6.9b Mixed effect models of echocardiographic parameters following Autograft 
(upper) versus Homograft (lower) aortic root replacement looking at the 
progression of aortic regurgitation (green, grade 1+; blue, grade 2+; yellow, grade 
3+; red, grade 4+). 
  *P<0.05 between groups at each given time point. 
B, Preoperative measure; A, 1 month after surgery. 
 
 
Figure 6.9c Mixed effect models of the progression of transpulmonary gradient by 
echocardiographic measurement following  Autograft root replacement. 
B, Preoperative measure; A, 1 month after surgery. 
 
6.3.6.2 Ventricular Function 
In both groups, left ventricular end-systolic and end-diastolic dimensions significantly 
decreased after surgery and remained relatively stable thereafter.  No differences were 
observed between both groups (Figure 10a).  Similarly, there was a marked improvement in left 
ventricular ejection fraction up to 3 years after surgery in both groups which remained stable 
up to 10 years, followed by a slight decrease (P=0.047 for change in time for both groups; Figure 
10b).   
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Figure 6.10a Mixed effect models of the echocardiographic changes in left ventricular end-
diastolic and end-systolic diameters following Autograft (green) versus 
Homograft (red) aortic root replacement.  
*P<0.05 between groups at each given time point. 
B, Preoperative measure; A, 1 month after surgery; LVEDD, left ventricular end-
diastolic diameter; LVESD, left ventricular end-systolic diameter. 
 
 
Figure 6.10b Mixed effect models of the echocardiographic changes in ejection fraction 
following Autograft (green) versus Homograft (red) aortic root replacement.  
*P<0.05 between groups at each given time point. 
B, Preoperative measure; A, 1 month after surgery 
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6.3.6.3 Autograft Root Dimensions 
Figure 6.11 represents changes in echocardiographic aortic root dimensions up to 13 years 
following surgery.  From the outset, autograft roots are slightly larger than homograft roots 
(P=0.004).  However, in each group, the diameter remained stable and showed no statistically 
significant change up to 13 years after surgery (P=0.463 for autografts). 
 
Figure 6.11 Mixed effect models of the echocardiographic changes in aortic sinus diameter 
following Autograft (green) versus Homograft (red) aortic root replacement.  
*P<0.05 between groups at each given time point. 
B, Preoperative measure; A, 1 month after surgery. 
 
6.3.7 Quality of Life Assessment 
Data consistency measured by Cronback’s α was >0.8 (range: 0.81-0.93) on all domains, 
indicating high reliability of the questionnaire.  Autograft recipients registered significantly 
higher scores than Homografts in the physical functioning (51.0 [45.9-56.1] versus 48.5 [38.3-
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56.1]; P=0.041) and general health domains (51.9 [43.1-55.4] versus 48.0 [35.8-52.9]; P=0.019, 
respectively) (Figure 6.12).  This resulted in a significantly higher Physical Component Score in 
the Autograft compared to the Homograft group (53.5[47.3-56.5] versus 49.1[33.9-54.8]; 
P=0.018).    
 
Figure 6.12 Overall results from the SF-36 questionnaire performed on patients following 
Autograft (blue) versus Homograft (red) aortic root replacement. 
 PF, physical functioning; RP, role physical; BP, body pain; GH, general health; Vit, 
vitality; SF, social functioning; RE, role emotional; MH, mental health; PCS, physical 
component score; MCS, mental component score. 
 
6.4 DISCUSSION 
With the increase in world population and improved access to health care, it is estimated that 
the number of aortic valve surgeries worldwide will triple within the next 30 years (M. H. 
Yacoub & Takkenberg, 2005).  To date, surgery remains the only effective solution to alter the 
natural history of the disease; however survival following surgery is often inferior to the general 
population (Kvidal, Bergstrom, Horte, & Stahle, 2000) and appears to depend on the type of 
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valve substitute (Svensson, Blackstone, & Cosgrove, 2003).  Randomized controlled trials 
represent the only definitive means of enabling rational, evidence-based decision making 
regarding the choice of valve substitute.  Nevertheless, very few randomized studies have 
attempted to compare long-term outcomes after different valve replacement procedures in 
patients with aortic valve disease (Hammermeister et al., 2000; Stassano et al., 2009).  Several 
observational studies have shown excellent pattern of survival after the Ross operation in 
adults which could have been contributed to by selection bias (Elkins et al., 2008; Sievers et al., 
2006; M. H. Yacoub et al., 2006).  The current study is the first to show enhanced survival after 
the Ross procedure in a randomized trial compared to homografts.  Survival following the Ross 
operation was comparable to the general population.  The study cohort included patients with 
endocarditis, poor ventricular function and redo surgery. 
 The choice of the 2 valve substitutes in this study stems from the fact that both offer 
excellent hemodynamic function and do not require anticoagulation, with homografts having a 
long track record (Lund et al., 1999; M. F. O'Brien et al., 2001; Smedira, Blackstone, Roselli, 
Laffey, & Cosgrove, 2006).  Aortic root replacement with implantation of the coronary arteries 
was used for all patients to maximize aortic orifice area and preserve the exact spatial and 
functional relationship of the component parts of the aortic valve mechanism (M. H. Yacoub et 
al., 1999).  The Ross procedure is the only operation which guarantees long-term viability of the 
aortic root which could explain the enhanced survival observed in this study (Mitchell, Jonas, & 
Schoen, 1998; Rabkin-Aikawa, Aikawa et al., 2004).  There is rapidly accumulating evidence that 
the aortic root performs several sophisticated functions which allow its constituent parts to 
change their shape and function during the different parts of the cardiac cycle (Dagum et al., 
1999; Lansac, Lim, Shomura, Lim, Rice et al., 2002).   This can influence left ventricular 
workload and possibly coronary flow as well as stress distribution on the cusps (J. E. Davies et 
al., 2008; Katayama et al., 2008).  In addition, aortic cusps modify their stiffness in response to 
humoral and endothelial signals, allowing them to adapt to varying hemodynamic conditions 
(El-Hamamsy, Balachandran et al., 2009).    
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 Apart from survival, patient quality of life constitutes a major endpoint following valve 
surgery.  In this study, although a number of patients failed to respond to the questionnaire, 
their quality of life scores were significantly better following the Ross operation.  This could be 
due to the ability of the living valve to rapidly adapt to changing hemodynamic conditions 
during exercise in addition to the higher rate of reoperations in the Homograft group.  
 The incidence of progressive autograft root dilatation and neo-aortic regurgitation has 
been reported in several series following the Ross operation (Tirone E. David et al., 2000; 
Takkenberg et al., 2006).  In contrast, with 97% completeness of follow-up in this series, 
freedom from aortic root reoperation is 99% at 13 years.  Using mixed effects models, no 
statistically significant change in autograft diameter was observed over the study period.  This 
could be attributable to specific technical elements as well as postoperative management of the 
patients.  Unlike the aortic valve, the pulmonary valve has no fibrous annular support.  
Therefore, it is critical to trim the infundibular muscle down to 1-2mm below the cusps and to 
position the root inside the annulus, ensuring adequate fibrous support.  Strict blood pressure 
control (systolic blood pressure ≤100-110mmHg) is critical in the immediate postoperative 
period and thereafter for 6-12 months to allow adaptive remodelling of the autograft root to 
systemic pressures.   
 Pulmonary allograft stenosis has been another area of concern following the Ross 
procedure.  The incidence, pathology and location have previously been described and are 
characterized by intimal hyperplasia at the distal anastomosis and an inflammatory-mediated 
external compression by fibrous tissue (Carr-White et al., 2001).  Based on this experience, our 
approach consists of systematic oversizing of the pulmonary homograft, interrupted sutures for 
the distal anastomosis and the use of anti-inflammatory agents in order to reduce the 
hemodynamic impact of this inflammatory reaction.  In this cohort, mean transpulmonary 
gradient at 13 years was 25±5mmHg and freedom from pulmonary homograft reoperation was 
94%.  Combined with the low incidence of autograft reoperation, overall freedom from all 
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reoperations was 93.7% at 13 years in the Autograft group, which compares favourably to 
available tissue valve alternatives in a similar patient population (Svensson et al., 2003).     
 Freedom from the composite endpoint of endocarditis, bleeding, thrombosis and 
thromboembolism was 97±2% at 10 years in the Autograft group.  This compares favourably 
with published series following aortic valve replacement (Kulik et al., 2006).  Nevertheless, 
freedom from this composite endpoint was 82±3% in the Homograft group, principally due to a 
higher than anticipated incidence of late endocarditis in these patients.   
 
6.5 LIMITATIONS 
In this single-center randomized trial, the number of patients is relatively small.  However, 
sample size was adequate and standardized techniques were used to support the main findings.  
In addition, very long-term results (beyond 25 years) are not available.  Continuing follow-up of 
our cohort should address this limitation.  This study compares autografts to homograft roots 
only.  A comparison of xenogenic tissue valves (both stented and stentless) and mechanical 
prostheses with autograft implantation needs to be addressed in a future randomized trial.   
 
6.6 CONCLUSION AND FUTURE DIRECTIONS 
In conclusion, the Ross procedure results in enhanced survival when compared to homografts 
following aortic root replacement in young adults.  In addition, it is associated with better 
freedom from reoperation and quality of life.  This supports the hypothesis that implanting a 
living valve in the aortic position can translate into significantly improved clinical outcomes.   
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The overarching aim of this thesis was to demonstrate that the aortic valve is a living organ 
which means that it has a unique and tightly regulated structure and function.  It is capable of 
regulating its own structure both at the cellular and tissue levels and actively responds to its 
biochemical environment.  In addition to regulating its structure in healthy conditions, it is 
capable of modulating tissue responses to noxious stimuli mimicking pathological conditions.  
Furthermore, heart valves have the capacity to adapt to changing mechanical and biochemical 
conditions by adapting their structure (remodelling) to optimize their function.  The importance 
of a living valve was highlighted in patients undergoing aortic root replacement using different 
valve substitutes.  Of those, the Ross procedure is the only operation which guarantees long-
term viability of the aortic valve.  Our data suggest that active adaptations of the living autograft 
valve reproduce normal solid and fluid mechanics.  Importantly, this translates into clinically 
relevant endpoints including improved survival and better quality of life.  
 For a long time, little was known about the complex regulation of the structure and 
function of heart valves.  This stems from the fact that valves initially drew less attention than 
the myocardium or the coronary arteries.  In addition, heart valves were for the most part 
considered passive structures which open and close as a result of changes in transvalvular 
pressures and myocardial contraction/relaxation.  With the improvement in diagnostic 
techniques, the advent of echocardiographic screening and the increase in life expectancy, it 
became apparent that valve disease was a significant source of morbidity and mortality (Ross & 
Braunwald, 1968).  This prompted renewed interest into valve-related research, first from a 
broad physiological and anatomical point of view (Bellhouse & Bellhouse, 1968; Roberts, 1970; 
Zimmerman, 1966), leading into more intricate research orientations such as cell physiology, 
genomics and proteomics.  In this thesis, we put a particular emphasis on the biomechanics of 
aortic valves which represents an essential element towards a better understanding of the 
complex regulation of these structures.    
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 Aortic valves lie in a unique hemodynamic environment, characterized by a range of 
stresses - shear stress, bending forces, loading forces and strain – which constantly change in 
intensity and direction throughout the cardiac cycle.  To make matters even more complex, 
stresses (particularly shear stress) exerted on one side of the valve vary significantly from those 
on the other side.  Yet, aortic valves open and close over 100.000 times a day, and in the 
majority of human beings, function normally over a lifespan of 70-90 years.  This structural and 
functional longevity requires an ability to withstand these mechanical forces as well as to adapt 
to changing conditions.  It has been shown experimentally and using computer simulations that 
the flow patterns on either side of the valve result in significant differences in the magnitude 
and direction of shear stresses on the overlying endothelium.  Using high-resolution numerical 
simulations of the blood flow through a polymeric trileaflet valve, Ge et al. have recently shown 
that the aortic side of the valve is exposed to disturbed flow patterns and importantly that 
complicated patterns of flow were observed near the regions where focalized calcium deposits 
are typically found (Ge & Sotiropoulos, 2010).  This highlights the physiological relevance of the 
valve’s mechanical environment in valve pathogenesis.  It is a widely accepted concept that 
areas of low shear stress or complicated patterns of blood flow are at a significantly greater risk 
of developing atherosclerotic changes.  This is thought to be due to endothelial responses to 
shear stress, the main mechanical stimulus, leading to activation of inflammatory mediators and 
a cascade of events characterized by expression of adhesion molecules, rolling and penetration 
of inflammatory cells into the subendothelial cells, followed by interaction with oxidized low 
density lipoproteins, forming foam cells and leading to hydroxyapatite formation (K. D. O'Brien, 
2006).  The current work adds a new paradigm to the traditional endothelial activation, 
inflammation-mediated theory of aortic valve disease which lays the foundation for 2 new 
important areas of research into aortic valve calcification.   
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 First, from a structural standpoint, using scanning ion conductance microscopy to 
evaluate endothelial cell biomechanics in situ, we showed that endothelial cells on the 
ventricular side are significantly stiffer than those on the aortic side.  Moreover, cells from 
either side exhibited different responses to the same vasoactive agents.  Cell stiffness represents 
more than a mere structural characteristic of cells.  The degree of cell stiffness (also termed 
tensegrity) is a product of the particular arrangement of cytoskeletal proteins within that cell 
(Luo et al., 2008).  In cells, “form meets function” (Wang, Tytell, & Ingber, 2009).  In other terms, 
the architectural organization of the cytoskeleton has a direct impact on the biological 
responses of the cell to mechanical stimuli (mechanotransduction), such as activation or 
repression of specific genes (Alenghat & Ingber, 2002; Hahn & Schwartz, 2009; White & 
Frangos, 2007).  It remains unclear why cells on the ventricular side of the valve are stiffer than 
their aortic counterparts.  It could in reaction to the higher degrees of shear stress on the 
ventricular side due to high velocity laminar flow which require stiffer cells to prevent 
significant structural deformations during systole.  It could also be due to the composition of the 
extracellular matrix in the spongiosa and ventricularis.  Indeed, the cytoskeleton is intimately 
linked to its extracellular environment and can have direct interactions with the various 
structural proteins such as elastin or collagen as well as microfibrillar proteins such as fibrillin 
and filamin.  The spongiosa is rich in collagen which provides solid tensile strength, whereas the 
ventricularis is mainly composed of elastin which is less stiff.  The stiffer endothelial cells on the 
ventricular side might be a compensatory response to the softer underlying matrix.   
 Second, the role of the endothelium in regulating the mechanical properties of the aortic 
valve by communicating directly with interstitial cells as shown in vitro using a biaxial 
micromechanical testing system is an area of major interest.  It represents the first study to 
establish a direct functional link between valve endothelial and interstitial cells in situ.  
Importantly, it suggests that valves are capable of changing and adapting their stiffness in 
response to their local mechanical, hemodynamic and biochemical environments.  This adaptive 
capacity is probably one of the major reasons explaining the long-term durability of aortic 
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valves in their highly stressful and dynamic local environment.  Changes in the capacity of 
valves to adjust their mechanical properties causing them to become softer or stiffer are 
thought to have direct implications in aortic root function as well as valve integrity and 
durability.  The function of the aortic root is to ensure unobstructed unidirectional laminar 
blood flow through the root in systole while minimizing ventricular workload.  Instantaneous 
movements of the aortic valve and root components are major determinants and partly depend 
on the mechanical properties of the tissue.  In addition, optimal coronary flow is determined by 
the structure and function of the aortic root.  The shape of the root is mainly dependent on the 
sinuses of Valsalva but also by the underlying aortic valve cusps.  Contractile changes or changes 
in stiffness of up to 30% are likely to affect the patterns of flow generated in the root and the 
blood recirculation phenomenon.  These various implications remain speculative for the 
moment because of the difficulty in inducing controlled changes in cusp stiffness in vivo while 
measuring the immediate in vivo effects.  Using radiopaque crystals in a close-chest animal 
model such as performed by the Stanford group (Dagum et al., 1999) combined with functional 
imaging techniques such as the ones presented in this thesis using 3-dimensional phase 
contrast-enhanced MRI could provide important answers. 
Nevertheless, our findings on the regulation of valve mechanical properties may have 
important implications in valve pathophysiology.  It has been known for a long time that foci of 
aortic valve calcification mainly occur at sites of high mechanical stresses on the cusps, such as 
the commissures.  This is possibly due to repeated microtrauma exceeding the regenerative 
capacity of the endothelium or in local activation of inflammatory pathways, which in the long-
term result in valve calcification.  Therefore, stress distribution along the surface of the cusps is 
an important determinant of valve durability.  Changes in the shape or stiffness of any living 
structure inevitably results in alterations in local stress maps.  The same is likely to hold true 
for aortic valves with endothelial dysfunction.  In addition to changes in stress distribution and 
potential increased susceptibility to calcification, a recent study by Yip et al. from the University 
of Toronto suggests an important direct effect of matrix stiffness on valve calcification  (Yip et 
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al., 2009).  The authors demonstrated a significant difference in the calcifying potential of aortic 
valve interstitial cells in vitro when seeded on soft or stiff matrices (Yip et al., 2009).  This sup-
ports the notion that cells directly interact with their extracellular environment and changes in 
the stiffness of the matrix can influence cell responses to osteogenic stimuli.  It is therefore im-
mediately apparent that dysregulation of the tightly controlled balance of aortic valve stiffness 
can directly impact cell responses to calcifying stimuli in vivo.   
The link between ex vivo and in vivo research on aortic valves remains challenging and 
elusive.  Unlike blood vessels, aortic valves are not tubular structures, the pattern of local flow as 
discussed is complex and highly variable and no surrogate imaging or biomarkers of whole aortic valve 
dysfunction or valve endothelial dysfunction have yet been developed.  In addition, computer 
simulations of valve motion based on high resolution imaging techniques also represents a sig-
nificant challenge because of the highly dynamic nature of the aortic root.  The aortic annulus as 
shown by Dagum et al. undergoes torsional deformations during the cardiac cycle and the annu-
lus undergoes a significant longitudinal excursion during the cycle which makes motion tracking 
necessary but complex.  Thus far, few groups have managed to adjust for dynamic aortic annular 
motion, led by efforts from research groups at Imperial College.  Tracking the cusps on the other 
hand constitutes an even greater challenge for several reasons: their motion is non-linear, they 
undergo important conformational changes during the cycle (particularly bending changes) and 
their movements dictate changes in the volume of blood flowing through them which adds an 
added element of difficulty.  Therefore, descriptive findings on aortic valve physiology inevitably 
precede in vivo functional validation but offer important clues into the level of detailed imaging 
required to truly understand valve function in health and disease.  Molecular imaging is an 
exciting area of research which has shown initial promising results in characterizing the early 
inflammatory changes in diseased vessels (Aikawa, Nahrendorf, Figueiredo et al., 2007; Deguchi 
et al., 2006).  A similar attempt at examining the proteolytic and osteogenic markers in aortic 
valve disease has also been demonstrated (Aikawa, 
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Nahrendorf, Sosnovik et al., 2007).  This could have important significance in understanding the 
mechanisms of aortic valve disease. 
 The ultimate objective behind research on the aortic valve is to alleviate the burden of 
disease in the population.  Aortic valve disease remains a major source of morbidity and 
mortality in the developed world and is expected to continue increasing in a significant fashion 
over the next 20-30 years (M. H. Yacoub & Takkenberg, 2005).  Clinical trials aimed at 
improving endothelial function in patients have almost consistently produced little 
encouragement and have always represented an important gap between laboratory findings 
and clinical reality.  Few studies have however focused on aortic valve disease, partly because 
for a long time, it was considered a passive, “degenerative”, “wear and tear” disease.  The largest 
trials have mainly focused on the role of statins in halting the progression of aortic valve disease 
but have produced disappointing results, including studies in patients with mild forms of 
disease.  The reasons behind the absence of real observed benefit remains elusive.  However, it 
is now well established that signalling pathways and mechanisms involved in early 
morphogenesis remain operative in adult life and can contribute to pathophysiology of disease.  
Therefore the absence of observed benefit with the various therapeutic strategies aimed at 
improving endothelial function might be directly linked to the timing of treatment initiation.  
Patients with mild forms of aortic valve disease are currently thought to represent early stages 
of the disease.  Nevertheless, considering the various roles of the endothelium on valve 
physiology as presented in this thesis (regulation of valve mechanical properties, local 
differences in single-cell mechanical properties, direct effect of valve interstitial cell 
calcification), the true impact of these therapies may not be realized unless treatment is 
administered in very early stages.  Of course, this raises important cost and ethical issues which 
are beyond the scope of this discussion.  Nevertheless, if predictive biomarkers or genetic 
screening tests can identify subjects at a high risk of developing aortic valve disease, the real 
benefit of medical therapy may only be achieved if administered early to prevent the long-term 
slow progression of local endothelial and aortic valve dysfunction.   
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 Currently, the only means to alter the natural history of aortic valve disease remains 
surgical intervention to replace the diseased valve.  Studies in patients undergoing aortic valve 
replacement show an improvement in patient survival which nevertheless does not match that 
of the general population.  The study presented in this thesis represents the first prospective 
randomized trial to demonstrate restored survival following aortic valve replacement to levels 
matching an age- and gender-matched population (El-Hamamsy, Eryigit et al., 2010).  As 
previously mentioned, this is thought to be due to the long-term preserved viability of aortic 
valve cusps, allowing them to adapt to their changing local mechanical and hemodynamic 
conditions and to ensure long-term valve durability as well as normal root physiology.
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In the present thesis, I have attempted to show that the aortic valve is a living structure with 
unique characteristics and specific intrinsic properties, both at the cellular and tissue levels.  I 
have further tried to demonstrate the clinical relevance of the capacity of an aortic valve to 
adapt and remodel in response to its local hemodynamic and biochemical environment.  The 
findings support the original hypothesis that the valve has unique structural and functional 
properties which affect clinically relevant outcomes.  At the cellular level, we have shown that 
aortic valve endothelial cells from either side of the aortic valve have different baseline 
mechanical properties and, in addition, exhibit different responses to similar stimuli.  
Furthermore, using a novel technique to separately isolate endothelial cells from both sides of 
the cusp, we have performed gene expression analyses of primary cultures of aortic- versus 
ventricular-side endothelial cells, showing differential expression of a range of genes.  
Unfortunately, until the pig genome is fully characterized, the precise identity of divergent genes 
remains elusive.  Nevertheless, once the genome is published, this will represent a unique set of 
information and a robust look into potential explanations of the differences in disease 
expression on both sides of the valve.   
The observation that aortic valve calcification occurs almost exclusively on the aortic 
side of the valve (fibrosa) has always intrigued researchers looking into the pathophysiology of 
aortic valve calcification, and represents a major hurdle into the understanding and treatment 
of aortic valve disease.  We have postulated that the heterogeneity in endothelial cell properties 
could have a direct link to differential disease expression.  Our findings suggest that endothelial 
cells from the aortic surface of the valve express less NO than their ventricular counterparts 
both in static and under physiological flow conditions.  Using a custom-developed side-selective 
tissue culture setup, we have established a firm link between endothelial function as 
determined by NO production and the formation of calcium nodules in the matrix.  Inhibition of 
NO production using L-NAME resulted in a significant increase in nodule formation, confirming 
the protective role of NO against valve calcification.   
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In an attempt to further understand the role of aortic valve endothelium in regulating aortic 
valve structure and function, we have studied endothelial-dependent regulation of the 
mechanical properties of aortic valve cusps in vitro.  Our findings establish 2 new important 
findings.  First, the endothelium communicates directly with the underlying interstitial cells to 
control the stiffness of aortic valve cusps.  And importantly, different endothelial-dependent 
signals result in significant changes in the stiffness of the cusps.  Considering the highly dynamic 
environment where aortic valves lie and their constant movement to optimize aortic root 
function, changes in aortic valve shape and stiffness can have major functional implications. 
 The implications of a living aortic valve capable of remodelling and adapting to its local 
milieu was examined in an in vivo human setting by studying aortic root biomechanics and 
clinical outcomes following different aortic root replacement procedures.  The Ross procedure 
is the only operation which guarantees long-term viability of the aortic valve and root, and 
therefore serves as the only illustration of the role of a living aortic valve substitute.  It was 
compared to homografts, xenografts and normal individuals with healthy native valves.  Our 
results suggest that a living aortic valve and root substitute most closely reproduces the tissue 
and fluid mechanics of a normal aortic root.  In addition, a living valve translates into clinically 
relevant endpoints, characterized by restored patient survival to an age- and gender-matched 
general population as well as improved quality of life.  These findings reinforce the need for 
living tissue engineered heart valve substitutes capable of reproducing the sophisticated 
structure and function of native heart valves. 
 
8.1 FUTURE DIRECTIONS 
Based on the findings from this work, current and evolving work will focus on several important 
directions: 
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1- Further explore the structural and functional intrinsic differences between aortic valve 
endothelial from both sides of the cusps with particular focus on: 
a. Proteomics 
b. Specific stimuli which cause endothelial dysfunction characterized by a 
decreased production of NO or dysregulation of their mechanical properties as 
assessed by SICM 
c. Determining the major stimuli affecting aortic valve endothelial cells, whether it 
is shear stress, cell stretch, inflammatory mediators etc... 
d. Studying various agents such as statins or NO donors (e.g., tetrahydrobiopterin) 
which might improve or restore endothelial function following exposure to 
noxious stimuli. 
 
2- Understand the functional significance of changes in the mechanical properties of aortic 
valve endothelial cells in response to mechanical (flow, pressure, strain) or biochemical 
stimuli, by looking at the activated downstream signalling pathways. 
 
3- Work in conjunction with imaging engineers to develop robust and reliable means of 
examining the instantaneous movements, deformations and stress levels on aortic valve 
cusps during the cardiac cycle in vivo.  Once this has been validated, several avenues 
need to be explored: 
a. Analyze the changes in stress levels and distribution on aortic valve cusps with 
changes in the stiffness or shape of the cusps using computer simulation 
techniques. 
b. Analyze the changes in flow mechanics with a particular focus on aortic root 
flow dynamics with changes in aortic valve stiffness. 
c. Evaluate the role of circulating mediators (ET-1 or 5-HT) as would be observed 
in pathological situations (hypertension or carcinoid syndrome) on the 
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instantaneous movements of aortic valve cusps and stress distribution on the 
cusps with changes in their mechanical properties.  
 
4- Continue ongoing work aiming at developing a tissue-engineered functional heart valve 
by elaborating specific protocols to differentiate stems cells into endothelial cells with 
similar structural and functional properties to valve endothelial cells. 
 
5- From a clinical standpoint, continue ongoing work into the relevance and clinical 
importance of a living heart valve substitute by comparing various valve replacement 
procedures in a randomized trial aimed at analyzing biomechanics in a population of 
patients who are fully comparable.        
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Annex X Short form (SF-36) quality of life questionnaire sent to patients. 
 
For each of the following questions, please mark with an ( X ) the best answer that 
describes your condition 
 
 
GENERAL HEALTH 
 
1) In general, would you say your health is: 
 
(   )  Excellent 
(   )  Very good 
(   )  Good 
(   )  Fair 
(   )  Poor 
 
2) Compared to one year ago, how would you rate your health in general now? 
 
 (   )  Much better now than one year ago 
 (   )  Somewhat better now than one year ago 
 (   )  About the same as one year ago 
 (   )  Somewhat worse now than one year ago 
  (   )  Much worse now than one year ago 
 
 
HEALTH and DAILY ACTIVITES 
 
3) The following questions are about activities you might do during a typical day. 
Does your health now limit you in these activities? If so, how much? 
 
       Yes,  Yes,  No, not 
                limited           limited             limited 
       a lot            a little    at all 
 
• Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports…………………………………….(   )…………..(   )…………….(   ) 
 
• Moderate activities, such as moving 
a table, pushing a vacuum cleaner, bowling, 
or playing golf……………...……………………….(   )…………..(   )…………….(   ) 
 
• Lifting or carrying groceries…….…………….(   )…………..(   )…………….(   ) 
 
• Climbing several flights of stairs…...………….(   )…………..(   )…………….(   ) 
 
• Climbing one flight of stairs..………………….(   )…………..(   )…………….(   ) 
 
• Bending, kneeling, or stooping…………..…….(   )…………..(   )…………….(   ) 
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• Walking more than a mile………….………….(   )…………..(   )…………….(   ) 
 
• Walking several hundred yards……………….(   )…………..(   )…………….(   ) 
 
• Walking one hundred yards…………..……….(   )…………..(   )…………….(   ) 
 
• Bathing or dressing yourself…..……………….(   )…………..(   )…………….(   ) 
 
 
4)  During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health? 
         YES    NO 
• Cut down on the amount of time you spent on work 
or other activities……………………………………….…………..(   )…………….(   ) 
 
• Accomplished less than you would like……………….……....(   )…………….(   ) 
 
• Were limited in the kind of work or other activities…………(   )…………….(   ) 
 
• Had difficulty performing the work or other activities 
(for example, it took extra effort) ………..………………..……....(   )…………….(   ) 
 
5) During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional problems (such 
as feeling depressed or anxious)? 
 
YES    NO 
• Cut down on the amount of time you spent on 
Work or other activities……………………………………………(   )……………(   ) 
 
• Accomplished less than you would like……………………….(   )……………(   ) 
 
• Did work or other activities less carefully 
than usually…………………………………………………………(   )……………(   ) 
 
 
6) During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbours, or groups? 
 
(   )  Not at all 
(   )  Slightly 
(   )  Moderately 
(   ) Quite a bit 
(   )  Extremely 
 
 
7) How much bodily pain have you had during the past 4 weeks? 
 
(   )  None 
(   )  Very mild 
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(   )  Mild 
(   )  Moderate 
(   )  Severe 
(   )  Very severe 
 
 
8) During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
 
(   )  Not at all 
(   )  A little bit 
(   )  Moderately 
(   )  Quite a bit 
(   )  Extremely 
 
9) These questions are about how you feel and how things have been with you 
during the past 4 weeks. For each question, please give the one answer that 
comes closer to the way you have been feeling. 
 
10) How much time during the past 4 weeks….. 
 
        All of       Most       A good       Some       A little       None 
          the        of the         bit of        of the        of the        of 
the 
         time        time       the time       time          time           time 
 
 
• Did you feel full of life?...................(   )……...(   )………(   )……..(   )……….(   )………(   ) 
 
• Have you been a very nervous 
person?...................................................(   )………(   )………(   )……..(   )………(   )………(   ) 
 
• Have you felt so down in the 
dumps that nothing could cheer 
you up………………………………….(   )……..(   )……….(   )……...(   )………(   )………(   ) 
 
• Have you felt calm and 
peaceful?.................................................(   )……..(   )……….(   )……...(   )………(   )………(   ) 
 
• Did you have a lot of energy?.........(   )……..(   )……….(   )……...(   )………(   )………(   ) 
 
• Have you felt downhearted 
and blue?................................................(   )……...(   )………(   )……...(   )………(   )………(   ) 
 
• Did you feel worn out?....................(   )……...(   )………(   )……...(   )………(   )………(   ) 
 
• Have you been a happy person?....(   )……...(   )………(   )……..(   )…........(   )………(   ) 
 
• Did you feel tired?...........................(   )……...(   )………(   )……...(   )………(   )………(   ) 
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11) During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, 
relatives, etc…)? 
 
(   )  All of the time 
(   )  Most of the time 
(   )  Some of the time 
(   )  A little of the time 
(   )  None of the time 
 
 
HEALTH in GENERAL 
 
12) How TRUE or FALSE is each of the following statements for you? 
 
                       Definitely       Mostly       Don’t       Mostly       Definitely 
      true             true           know        false              false 
 
• I seem sick a little easier 
than other people………………………(   )………..(   )………(   )………(   )………….(   ) 
 
• I am as healthy as anybody 
I know…………………………………..(   )………..(   )………(   )………(   )………….(   ) 
 
• I expect my health to get 
worse……………………………………(   )………..(   )………(   )………(   )………….(   ) 
 
• My health is excellent……………...(   )………..(   )………(   )………(   )………….(    
 
 
 
 
EMPLOYMENT SITUATION 
 
Questions 12 -15 are related to your work and employment status. Please complete these 
questions to the best of your capability? 
 
 
12-a) Are you employed? 
 
(   )  YES – please go to question 13 
(   )  NO – please go to question 12b 
 
 
12-b) Are you not working because of? 
 
(   )  Child care reasons 
(   )  Retired – please go to question 12c 
(   )  Other – please state reason……………………………………………… 
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12-c) Are you retired on medical grounds? 
  
 (   )  YES 
 (   )  NO 
 
 
13) What is your job? 
 …………………………………………………………………………………... 
Are you in? 
(   )  FULL time employment 
(   )  PART time employment 
 
 
14) On average how many hours do you work every week? 
 
 (   )  0-10 hours 
 (   )  10-20 hours 
 (   )  20-25 hours 
 (   )  26-30 hours 
 (   )  30-40 hours 
 (   )  40+ hours 
 
 
15)  How stressful do you find your job? 
 
 (   )  Not at all 
 (   )  A little stressful 
 (   )  Moderately stressful 
 (   )  Very stressful 
 (   )  Extremely stressful 
 
MEDICATION 
 
Please list your current medication in the space below along with the doses and the 
frequency of administration. Please use separate sheet if necessary. 
 
Drug     Dose   Number of times per day 
1)……………………………………………………………………………………….. 
2)……………………………………………………………………………………….. 
3)……………………………………………………………………………………….. 
4)……………………………………………………………………………………….. 
5)……………………………………………………………………………………….. 
6)……………………………………………………………………………………….. 
7)……………………………………………………………………………………….. 
8)……………………………………………………………………………………….. 
9)……………………………………………………………………………………….. 
10)……………………………………………………………………………………… 
 
End 
Thank you for completing these questions 
